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ABSTRACT 
Ian Williamson: Developing High Throughput Organoid-based Platforms to Study Enteric Physiology In 
Vitro (Under the direction of Scott T. Magness) 
 
The human gastrointestinal lumen is a complex environment where microbial 
resents (microbiota) interact symbiotically and pathogenically with the host intestinal 
mucosa. Intestinal health is regulated by these interactions as they relate to host 
genetics and food consumption. Human genetic diversity has long been recognized as a 
key factor in intestinal health and disease. Recently, appreciation has grown for the 
importance of microbiota interactions with the host mucosa in maintaining homeostasis 
and disease. The lack of quantitative in vitro models to investigate interactions in the 
intestinal mucosa is considered a substantial barrier to investigate intestinal physiology. 
Organoids represent an attractive model system because they are derived from primary 
tissues and embody key properties of the native mucosa; however, assaying organoids 
specifically in high throughput is technically challenging. Organoids grow as spherical 
monolayers imbedded in hydrogel limiting access to the enclosed ‘lumen’ compartment 
and complicating longitudinal tracking. Furthermore, the homogeneous composition of 
the three-dimensional culture environment and the heterogeneity of organoid grown 
patterns complicates readouts based on organoid grown, size, and morphology. Here, I 
report on the development and validation of several technologies to address the 
sampling limitations of organoid systems, facilitating high throughput assays describing 
mucosa physiology, renewal, and interactions with the microbiota.
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Chapter 1: Introduction to Intestinal Physiology 
The Intestinal Lumen is our Primary Interface with the Environment 
Absorption of ingested nutrients occurs in the intestine where components of 
digested food are both actively transported and passively diffuse into the body. The 
intestine is a complex tissue consisting of mucosa, muscularis, and serosa layers with 
distinct cellular composition and function. The innermost mucosa layer of the intestine is 
responsible for the bulk of absorptive processes. The intestinal mucosa consists of a 
supportive lamina propria of fibroblasts, myofibroblasts, capillaries, and lymphocytes 
underlying a monolayer of columnar epithelium (intestinal epithelium) that directly 
interfaces with the luminal space. The outer submucosa, muscularis, and serosa layers 
of the intestine drive the movement of ingested material down the gastrointestinal (GI) 
tract and regulate the transport of absorbed nutrients to the rest of the body. This 
dissertation focuses on the mucosa layer and developing in vitro approaches to study 
physiology and renewal of the epithelial surface of the lumen.1,2 
Organization and physiology of the intestinal mucosa 
The small intestinal epithelium is organized into microstructure functional units of 
regularly dispersed invaginations into the lamina propria termed ‘crypts’ surrounding villi 
projections into the lumen. The intestinal epithelium renews rapidly to maintain function 
with near-total turnover every 5-7 days. The kinetics of intestinal renewal were 
established by “lineage tracing” models where actively dividing cells were labeled with 
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titrated thymidine and their migration was observed at various times following 
administration1. These approaches identified a pluripotent intestinal epithelial stem cell 
population (IESC) in the base of each crypt that divides roughly every 24 hour, 
producing transit-amplifying progenitors (TA) that populate the crypt neck.  TAs 
differentiate as they migrate up the crypt and eventually reach the villus tip before 
sloughing off into the luminal space. Similarly, to the small intestine, the colonic 
epithelium is renewed by actively cycling IESCs residing in crypt invaginations into the 
lamina propria. The colon lacks villi projections, instead forming a smooth surface that 
interacts with the luminal contents. Renewal of the colonic epithelium is similarly rapid, 
with near-total turnover every 7-10 days driven by crypt residing stem cells. The crypts 
are largely devoid of differentiated cells, which are subdivided into absorptive and 
secretory lineages based on their function and expression of associated peptides. 
Absorptive lineages have distinct columnar morphology and express digestive enzymes 
such as sucrase isomaltase (SIS) and lactase (Lct). The intestinal epithelium is 
dominated by absorptive cells, but secretory lineages dispersed throughout the tissue 
serve important homeostatic functions.  Goblet and enteroendocrine cells, dispersed 
throughout the intestinal epithelium, secrete protective and signaling peptides 
maintaining homeostasis. Goblet cells produce mucins that collect in the lumen to 
maintain epithelial barrier integrity and are traditionally identified by intracellular Muc2 
peptide expression. Enteroendocrine cells release hormones into the lumen and 
underlying lamina propria to carry signals to far regions of the intestine or other tissues. 
Enteroendocrine cells are conventionally identified by their cytosolic hormone peptides 
like Chromogranin A (CHGA).  One secretory cell type, the Paneth cell (PC), resides 
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exclusively in the base of small intestinal crypts where they secrete protective 
antimicrobials like lysozyme that form a niche for resident stem cells.1–3 
Components of the mucosa produce secreted and membrane bound ligands forming 
localized signaling gradients that regulate renewal. The Wingless-related integration site 
(Wnt), Bone morphogenic protein (BMP), and Notch signaling pathways are the most 
substantially linked to epithelial proliferation and differentiation. Niche cells near the 
crypt base secrete Wnt ligands that bind to receptors on crypt-based cells, stabilizing 
cytoplasmic β-catenin. Stabilized β-catenin translocates to the cell nucleus, where it 
activates the TCF and LEF transcription factors that drive targets generally associated 
with cellular growth and proliferation. Wnt signaling decreases as cells migrate away 
from the crypt base reducing access to niche ligands. BMP signaling acts opposite of 
Wnt signaling, driving differentiation as cells migrate up the crypt villus axis. Bmp4 and 
related ligands are strongly expressed in the villus mesenchyme, where it binds to 
serine/threonine kinase receptors on epithelial cells to activate genes through the 
SMAD transcription factor4–7. Notch signaling is mainly restricted to the crypt 
compartment, where active stem cells and TAs express Notch1 and Notch2 receptors. 
High levels of notch signaling are necessary for terminal absorptive cell formation, while 
lower levels drive progenitors towards secretory lineages. Redundancies in signaling 
ligands and receptors rendering individual components of each pathway expendable 
under homeostatic conditions, making the signal transduction network regulating 
intestinal renewal highly complex. The intricacies of the molecular functions of each 
pathway have been described at great length elsewhere.8–10 
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The dynamics of intestinal epithelial renewal have been well understood for decades 
but direct studies of IESCs were hampered by a lack of specific genetic biomarkers. In 
2007, the G-protein coupled receptor Lgr5 was validated by in vivo lineage-tracing as an 
IESC biomarker expressed in crypt-base columnar cells (CBCs) intercalated between 
PCs in the crypts of the small intestine11. Tracing the progenitors of Lgr5 cells through 
genetic lineage tracing showed that progeny formed long-lived clonal units containing all 
post-mitotic lineages persisting for 60 days or longer. These studies confirmed the self-
renewal and multipotency of Lgr5 CBCs and established the gold standard of in vivo 
lineage tracing used to identify additional CBC IESC biomarkers including Olfm4, Ascl2, 
and Sox912–15. Following the identification of the CBC IESC population, a second IESC 
population residing above the PC compartment was described by lineage tracing from 
Bmi1 expressing cells16. Subsequently, other genes associated with the super-Paneth 
position were validated as in vivo IESC biomarkers, including mTert and Hopx17.  While 
all the super-Paneth IESC populations have some stem cell capacity under normal 
physiological conditions, reports show increased lineage tracing from super-Paneth 
IESC biomarkers following damage. The field consents that super-Paneth IESCs 
represent a reserve population, normally quiescent, that activates to initiate repair 
following damage to CBC IESCs16–18. This model has been confirmed by genetically 
ablating Lgr5 IESCs in animal models, which were able to compensate by activating 
super-Paneth IESC populations. 
Rapid renewal allows the intestinal epithelium to change composition, by changing 
the abundance of absorptive and secretory lineages as well as the digestive, transport, 
or protective peptides they produce. These mechanisms allow the intestinal epithelium 
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to act as a dynamic, selectively permeable barrier to allow absorption of essential 
nutrients while sealing the body from harmful toxins and microbial invasion. The 
intestinal mucosa responds dynamically to nutrient availability in specific and non-
specific manors to increase or decrease absorption. Villi projections extend further into 
the lumen in response to feeding, grossly increasing the absorptive surface area and 
potential19. The apical surface of absorptive epithelial cells is coated with membrane 
projections called microvilli that are highly concentrated with transport proteins and 
digestive enzymes. Digestive enzymes on the apical surface break down 
macromolecules like carbohydrates into monomers for active transport by absorptive 
enterocytes into the body. Other polar nutrients like ions are also actively transported by 
proteins on the apical membrane of enterocytes. Lipids are digested into 
monoglycerides and free fatty acids that passively diffuse into the cytosol. Absorptive 
enterocytes change their expression of transport proteins and digestive enzymes to 
increase or decrease specific nutrient uptake in response to nutritional requirements 
and availability.20 
Microbiota colonizing the intestinal lumen affect host physiology 
Nutrient availability in the intestine is strongly influenced by the thousands of 
symbiotic microbial species, collectively referred to as the enteric microbiota, that 
colonize the lumen in stable populations. The microbiota is comprised of bacteria, fungi, 
protozoa, and archaea that inhabit specific regions of luminal space in complex 
overlapping communities. Bacteria are the best characterized component of the enteric 
microbiota with 300-1000 species observed in the microbiota of healthy adults. 
Microbiota bacteria ferment digested material into bioactive metabolites that are 
6 
 
absorbed by the epithelium, where they act as energy sources, mitogens, and 
morphogens effectively preserving normal physiology. The classical example of host-
microbiota molecular interactions is butyrate, produced by bacterial fermentation of 
dietary fiber in the colonic lumen. Enterocytes prefer butyrate to glucose as an energy 
source promoting stem cell driven renewal. Butyrate also acts as a morphogen by 
inhibiting epigenetic changes in histone methylation. The microbiota also produce 
neuroactive peptides like serotonin and gaba that grossly effect host digestion and 
peristalsis.21–23  
The bacterial component of the enteric microbiota is dominated by gram-positive 
species of the Firmicutes, Bacteroidetes, Actinobacteria, or Proteobacteria phylum that 
compete for suitable luminal space. The composition of the microbiota is stabilized by 
competition for key nutritional and environmental factors. Changes in the luminal 
environment caused by pathogens, antimicrobial treatment, or dietary changes can lead 
to the overgrowth of specific members inside or outside of their normal habitat, termed 
dysbiosis. Dysbiosis is particularly important in modern health care due to an epidemic 
of Clostridium difficile colitis caused by the overgrowth of an anaerobic motile bacteria 
normally inhabiting the small intestine. C. difficile dysbiosis occurs in about 500,000 
Americans every year, reoccurring in nearly 25% and causing mortality in about 5% of 
cases due to severe colon inflammation and diarrhea.  
Enteropathies involve aberrant renewal and/or barrier function dysregulating the 
intestinal luminal interface. 
Nonpathogenic enteropathies result from dysregulation of the complex balance 
between intestinal renewal, barrier function, and nutrient absorption. The most well 
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characterized non-pathogenic enteropathies result from aberrant renewal or 
differentiation caused by mutations in Wnt, BMP, or Notch signaling components. 
Mutations causing IESC populations to become hyperproliferative lead to crypt 
hyperplasia and adenomas, arising in 20-50% of Americans by age 70. Adenomas lead 
to the formation of polyps, which dramatically increase cancer risk. Nearly 1 million new 
cases of colorectal cancer (CRC) are diagnosed each year with familial risk associated 
with about 30% of cases. Some cases are caused by autosomal dominant mutations 
that drive polyposis or nonpolyposis forms of hereditary colorectal cancer. These two 
conditions cause 5-10% of CRC and are directly inherited by an effected individual. The 
other 20% of new cases with concurrent familial risk have recessive or partially 
functional mutations in key tumor-suppressor and oncogenes. In these cases, cancer is 
initiated through subsequent mutations in the Wnt or BMP signaling pathways. 
Accumulation of cell signaling changes, rather than the order of occurrence, initiates 
tumor formation.24–27  
Mutations in genes coding for key transporters or structural peptides can also drive 
enteropathies, causing nutrient malabsorption. Microvillus inclusion disease (MVID) is 
caused by mutations in myosin Vb, which stunts enterocyte differentiation. Without 
myosin Vb enterocytes lack microvilli and distinct apical-basal lateral polarity. MVID is 
often fatal early in life due to intractable diarrhea and metabolic acidosis. MVID is an 
autosomal recessive disorder with the defective myosin Vb gene inherited from both 
parents that may not be effected.  An autosomal recessive mutation in the ion 
transporter, cystic fibrosis transmembrane conductance regulator (CTFR), also drives 
malabsorptive enteropathy. Loss of function prevents the secretion of chloride and 
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carbonate ions, leading to a syndrome termed cystic fibrosis (CF). CF causes thickening 
of the mucous secreted into the lumen, causing blockages and preventing ingested 
material from reaching the apical surface. More than 5,000 specific mutations in CTFR 
are known to cause CF though the effect of CTFR dysfunction that leads to the CF 
phenotype is still under debate.28–30 
Inflammatory bowel diseases and the enteric microbiota  
There is considerably less consensus on the kinetics of enteropathies driven by the 
dysregulation of host immune responses. In these syndromes, inappropriate responses 
by enteric immune cells cause prolonged inflammation of the mucosa that can disturb 
nutrient absorption and barrier function. In Celiac disease, dietary glutens that are 
absorbed by the mucosa interact with type II major histocompatibility complexes to 
activate lymphocytes. Prolonged lymphocyte activation leads to lesions of flat villi and 
hyperplastic crypts to form. Similar lesions occur in cases of inflammatory bowel 
disease (IBD) where microbial cues activate and prolong inflammation. The specific 
microbial taxa, epithelial receptors, and cell signaling pathways initiating and prolonging 
IBD are still under debate despite extensive investigations. Our understanding of the 
microbiota’s role in IBD has been reviewed in detail elsewhere and will be summarized 
here.31,32 
Dysbiosis is thought to drive IBD by dysregulating cell signaling patterns and 
affecting host gene expression. This is directly accomplished through the binding of 
microbe associated patterns (MAMPs) to pattern recognition receptors (PRRs) on the 
apical epithelial surface. The involvement of the Toll-like receptor (TLR) family of PRRs 
in cell signal transduction has been well characterized. Bacteria cell wall components 
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like peptidoglycan and flagellin are known TLR ligands that increase the expression of 
nuclear factor-KB regulated targets when bound to TLRs33,34. In healthy states the host 
intestine becomes habituated to commensal microbiota taxa and reduces its 
inflammatory response. Habituation is accomplished through the expression of 
redundant inhibitory peptides (reviewed by 28,32,35–38) regulating paracrine interactions 
between the intestinal epithelium and regulatory lymphocytes in the lamina propria. 
Various metabolic biproducts produced by commensal microbiota enhance the 
expression of anti-inflammatory peptides by the host epithelium. In this way the 
microbiota can directly modulate host immunity to relieve inflammatory responses and 
maintain homeostasis. 
Short-chain fatty acids (SCFAs) produced by commensal microbiota have been most 
directly linked to host immune response. These 2-6 carbon bioactive metabolites, 
produced by dietary fiber fermentation, have been implicated as regulators of T-cell and 
dendritic lymphocyte activity. Propionate and acetate support the development of Th1, 
Th17, and IL-10 regulatory T-cell populations, while Butyrate acts as a systemic T-cell 
inhibitor.  SCFAs are metabolized into acetyl-CoA in epithelial cells, which acts as an 
activator for mTOR-mediated gene expression. Valproate, propionate, and butyrate also 
inhibit the maturation and trafficking of dendritic cells by reducing epithelial release of 
proinflammatory ligands. The anti-inflammatory effect of microbiota produced SCFAs is 
exemplified by propionate and butyrate reducing IL-6 and IL-12 production resulting 
from liposaccharide (LPS) binding to TLR-4. Commensal microbiota taxa also reduce 
host immune response by less direct means than the secretion of anti-inflammatory 
factors. Certain microbiota taxa including Bifidobacterium are thought to stimulate 
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mucous production, increasing mucosa barrier integrity and reducing interactions 
between luminal contents and the mucosa.28,32,38–40 
Considerable evidence links dysbiosis to IBD pathogenesis but direct evidence has 
not been convincingly demonstrated. IBD cases are sub-classified by the tissues that 
they affect. Ulcerative Colitis (UC) primarily effects the distal colon and rectum, while 
Crohn’s disease (CD) is more systemic with affects observed in the small intestine, 
colon, mouth, esophagus, and stomach. The microbial load of the intestinal lumen is 
increased in both forms of IBD, with significantly more anaerobic and aerobic bacteria 
recovered from IBD patient stool samples compare to controls. IBD symptoms are most 
severe in the distal colon where the highest load of microbiota is found. Rodents with 
mucosal defects in PRRs or downstream ligands have chronic intestinal inflammation. 
These rodent models fail to achieve pathogenesis when raised in germ-free (GF) 
conditions further implicating the enteric microbiota in IBD. Microbiota composition is 
considerably altered in both IBD types with increases in Bacteroidetes, Lactobaccillus, 
and Proteobacteria taxa observed. Outgrowth of Bacteroidetes taxa coincides with 
decreases in Firmicutes taxa, significantly increasing the ratio of Bacteroidetes 
compared to Firmicutes comprising the microbiota. This ratio has become key in 
diagnosing IBD and measuring theopoetic relief. More direct evidence links dysbiosis to 
CD than UC. CD is associated with polymorphisms in PRRs by genome-wide 
association studies. Also abundant taxa like Escherichia coli isolated from CD patients 
shows enhanced virulence compared to strains from healthy controls.29,38,41,42 
The strongest evidence for the microbiota’s involvement in IBD may be the relief 
patients experience when receiving microbially-targeted treatments.  Early research 
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found that CD symptoms were relieved when the luminal fecal stream was diverted and 
reoccurred once fecal flow was restored. Microbial treatments for IBD have expanded 
since that finding to include antibiotic and probiotic treatments aimed at correcting 
dysbiosis. IBD patients experience symptom relief when treated with antibiotics, which 
is lost with long term use.  This fits the model of acquired antibiotic resistance observed 
in many bacterial pathogens. Probiotic treatments delivering live Bifidobacterium and 
Lactobacillus microbes can prevent IBD lesion reoccurrence in some patients and 
rodent models. But the relief is not ubiquitous across patients and symptomatic profiles. 
Expanding microbiota-targeted IBD treatments has been difficult, in part due to the 
interpersonal variability in microbiota profile and symptom presentation in IBD 
patients.43–48 
Colitis associated colorectal cancer.  
Dysbiosis is also strongly linked with CRC initiation and progression. The link 
was originally described in rodent models employing mucosa irritants like Dextran 
Sulfate Sodium (DSS) to cause inflammation making the intestine susceptible to 
carcinogens. Carcinogenesis stimulated by these approaches is limited in GF 
individuals with reduced tumor size and burden compared to colonized controls. This 
linked inflammation, known to be regulated by the microbiota in humans, to CRC. Case 
studies show that more than 20% of IBD patients develop CRC within 30 years of 
developing colitis with high mortality observed in colitis-associated cancers. Even CRC 
patients without clinically detected IBD display robust inflammation and increased levels 
of inflammatory cytokines. The composition of the enteric microbiota is altered in CRC 
patients compared to healthy controls but changes in individual taxa are inconsistent. 
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Microbiota composition also varies within individual CRC patients when sampled at 
tumor sites or healthy regions of mucosa. Despite the high variability in CRC-associated 
dysbiosies, several microbiota species meet the Bradford Hill criteria for epidemiologic 
causality of CRC. Enterotoxigenic Bacteroides fragilis, Enterococcus faecalis, 
Escherichia coli, and Fusobacterium necrophorum can produce Wnt and pro-
inflammatory ligands that can dysregulate intestinal renewal and repair potentially 
driving carcinogenesis.23,44,49–53 
Gastrointestinal organoids are a reductionist in vitro platform to model intestinal 
physiology and enteropathies 
The lack of techniques to culture primary intestinal tissues has limited the 
mechanistic description of GI biology during health and disease states. Many of the 
early studies on molecular regulation of intestinal renewal relied on in vivo models that 
limit the scope of longitudinal IESC studies. Transplanting human fecal microbiota 
samples into GF animal models have been fruitful in describing human diseases, but 
GF facilities are rare and GF animal housing is costly, limiting scale and the use of 
transgenic animals54–56. Recently, concerns have been raised around the metabolic 
profiles of mice raised GF, and their differential expression of epithelial transport 
proteins confounds interpretations made following colonization52,55,57. 
Organoid Structure and physiology.  
Controlled testing of the molecular kinetics behind variable phenotypes of the 
intestinal epithelial represented in human disease states is a daunting task. More robust 
in vitro studies of intestinal physiology have historically been limited to immortalized 
cancer cell lines. However, these lack lineage identity and normal metabolic processes, 
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limiting their power as physiologic models56. Recent reports utilize advanced, three-
dimensional (3D) culture techniques that produce intestinal epithelial organoids from 
isolated IESCs58. Organoids recapitulate the native tissue patterning, renewal, 
membrane transport, and other physiologic properties. Embedding IESCs in protein 
hydrogel mimics the extra cellular matrix (ECM) of the lamina propria. Ligand peptides 
and small molecule inhibitors targeting the Wnt, Bmp and Notch are delivered in the 
culture media driving niche signaling. All these components are necessary to drive IESC 
renewal in vitro forming complex multicellular monolayers in 3D space. 59 
Organoids self-pattern into hollow structures as they grow, with proliferative 
IESCs restricted to specific regions. Organoid IESC populations are often concentrated 
in crypt-like ‘buds’ projecting from the enclosed organoid ‘lumen’ where they produce 
adjacent progenitors that differentiate as they migrate toward the organoid lumen. In this 
way, organoids recapitulate normal renewal with cycling stem cells producing all the 
differentiated lineages of the native epithelium60. Importantly, organoid cells maintain 
native polarity, exhibited through differential expression of transporter proteins on their 
inner apical and outer basolateral membranes61.  
Organoids retain tissue and regional identity transferring the full profile of 
endogenous stem cell populations to laboratory settings. Organoid technology was 
initially described for murine small intestine IESC culture but has been expanded to 
culture colon, liver, pancreas, and esophagus of animal models and human samples. 
The lack of associated tissue layers makes organoids a truly reductionist model of 
epithelial physiology free of artifactual effects of feedback from other tissues. In 
attempts to reduce such artifacts, organoid culture techniques have become more 
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refined. Synthetic Polyethylene glycol (PEG) hydrogels are replacing the animal derived 
ECM hydrogels employed in early reports. Groups are also expanding the use of small 
molecules to replace peptide ligands that have variable activity, confounding studies. 
Small molecule treatment can enrich organoids with specific lineages by changing cell 
signaling kinetics.58,62,63 
Modeling human diseases in organoids.  
Organoids represent an important bridge between traditional 2D cultures and in 
vivo mouse/human models. Organoids are genetically stable and recapitulate traits of 
the source tissue more completely than conventional immortalized cell cultures. IESC 
niche conditions can be more easily manipulated in organoids than animal models. 
Organoids can be grown from transgenic animals to study the genetic involvement in 
renewal processes specifically in the epithelium. Genetic manipulation of organoids 
using viral and CRISPR/Cas9 vectors has also been demonstrated allowing for novel 
transgenic lines to be produced in vitro. The self-renewal capacity of organoids can be 
used to expand specific, rare mucosa populations that are not easily collected from 
animal models.64–68 
Organoids grown from diseased patients or animal models recapitulate disease 
phenotypes, allowing researchers to study enteropothies in a laboratory setting. Patient 
derived organoids have been used most extensively when studying genetically driven 
enteropathies, which are recapitulated in vitro due to the genomic stability of organoid 
IESCs. For this reason, organoids grown from MVID patients have stunted microvilli 
with reduced digestive enzyme loads. Similarly, organoids with mutations in CFTR have 
characteristic defects in ion transport. This has been exploited to assess disease 
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restitution by treating defective organoids with small molecules to drive CTFR activity, 
which causes healthy organoids to swell in size. Induced swelling of CTFR mutant 
organs following gene editing demonstrated a gain of CTFR function effectively curing 
CF.57,63,66,69,70 
Introducing mutations to oncogene and tumor suppressor alleles causes human 
and murine organoids to adopt a cancer-like phenotype. Serial mutations to Wnt and 
BMP signaling components drives organoid IESC proliferation without the normally 
essential stimulation by niche signaling. The cancer-like phenotype of organoids is 
assessed by starving established cultures of Wnt and BMP ligands usually delivered in 
the media. Organoids with mutations in oncogenes driving WNT and BMP signaling 
survive long-term without normally essential ligands. Cancer-like human and murine 
organoids form tumors when transplanted into animal models demonstrating the extent 
that organoids can be used to model disease.15,27,71,72 
Co-cultures of intestinal organoids and microbes are being pursued to study 
host-microbiota interactions in health and disease. These studies look to leverage 
similarities between the lumen of organoids and the native tissue to cultivate microbiota 
taxa in a physiologic context. Protective mucins and antimicrobial peptides accumulate 
in the organoid lumen along with exfoliated cells that migrated from the bud tips. 
Starving organoids of Wnt signaling factors or accelerating differentiation with small 
molecules increases the rate exfoliated cells accumulate in the organoid lumen. 
Inhibitors can be used to force organoid secretory cells to release vesicle content into 
the organoid lumen delivering a variety of antimicrobial and anti-inflammatory peptides. 
32,64,69,73–77 
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Organoids also display many PRRs on their enclosed apical surface providing 
the major molecular components mechanistically involved in host-microbe interactions. 
Organoids at least express TLR2, TLR3, TLR4, TLR7, TLR8, and TLR9 that 
demonstrate various functions when activated in vitro. Activating TLR3 by 
peptidoglycans increases the expression of inflammatory cytokines. Certain 
peptidoglycans also interact with CD14 causing IESCs to divide more quickly and 
expand in number, increasing organoid outgrowth. These effects were lost in organoids 
from mouse models with defects in TLR-mediated signaling pathways. These properties 
make self-renewing intestinal organoids an attractive, new option for co-culture studies 
with enteric microbes.32,64,69,73–77  
Significant technical barriers have limited applications of organoid-based assays 
A variety of factors have limited the use of organoid technologies in studying in 
variety of GI health and disease processes, detailed in Table 1: Factors Limiting the use 
of organoid technologies  
Organoids lack components of other tissue layers that may be necessary to 
accurately demonstrate disease states. Organoids lack neural cells that form an 
extensive enteric nervous system (ENS) in vivo containing 200-600 million neurons, 
many of which are synoptically connected to enteroendocrine cells in the mucosa.  This 
allows the ENS to sense luminal signals and conduct bidirectional communication 
between the central nervous system and the intestine. Nervous system interactions 
modulate the release of local and systemic hormones affecting intestinal function. Some 
progress has been made to incorporate neural components into organoid cultures in 
hopes of studying ENS interactions with the mucosa. This approach confirmed the 
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presence of synaptic connections between ENS neurons and enteroendocrine cells77–79. 
Less progress has been made incorporating immune cells into organoid culture 
platforms, limiting their use to study IBD mechanistically. Organoid technology has 
instead been employed to assess epithelial barrier function and PC dysfunction in IBD 
contexts using genetic models and inflammatory cytokine treatment.62,63,79–83 
Organoids also lack mesentery components limiting their use in modeling 
fibrosis, a process that is also difficult to illicit in rodent models. Mesentery cell types are 
sufficiently compatible with organoid culture conditions for robust co-culture assays. 
Incorporating specific myofibroblast populations into organoid cultures allowed 
researchers to identify specific subpopulations of myofibroblasts driving fibrosis and 
evaluate the potency of anti-fibrotic drugs.68,84,85  
Adding non-epithelial cell types and tissue layers to organoid culture platforms is 
a prolific area of biotechnology innovation that will be integral in expanding the 
application of organoids to study disease. This dissertation instead focuses on 
mechanically refining organoid platforms to expand their applications. 
Culture heterogeneity and complicates organoid sampling in 3D space 
Organoid culture techniques were originally developed for the murine small 
intestine but have been expanded to culture stem cells from the colon, stomach, and 
esophagus of human samples and animal models. The expansion and modeling 
potential of these culture systems makes organoid-based assays attractive for drug 
screening and regenerative medicine, but applications have been limited due to the 
technical difficulty associated with sampling organoids grown in 3D. Specific IESCs are 
impossible to track longitudinally in 3D space preventing researchers from quantifying 
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changes in specific organoids. Organoid heterogeneity further complicates sampling, 
with highly variable starting sizes and expansion rates. This heterogeneity limits the use 
of organoid size or growth as treatment readouts without introducing artifacts into 
experimental results. Organoids grown from the same source also have variable cellular 
composition that can affect responses to treatments and challenges. Organoids lacking 
mature secretory cells have a limited response to microbial challenges, while increased 
goblet cell content protects organoids from pharmaceutically driven inflammation. 
Organoid IESC content also affects response to treatments or challenges effecting 
renewal. CBC and super-Paneth IESC populations are known to interconvert and can 
interact though Wif1 an FoxA1 cell signaling. Super-Paneth IESCs are thought to induce 
tumorigenesis in vivo and may be necessary to accurately recreate cancer initiation. 
The remainder of this dissertation will focus on my attempts to address these limitations 
through automation, microfabrication, and biomaterial innovation.11,18,63,86–88
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Chapter 2: Engineering Platforms to Expand Organoid Applications 
Introduction 
Organoid cultures require defined growth conditions that mimic the IESC niche, 
making organoid growth a physiological readout for the activity of niche factors 
delivered in vitro. Organoid formation and self-renewal has been used as a measure of 
Wnt activity and its effect on IESC activity. Mice genetically lacking the PC produced 
niche factor Wnt3 form normal crypts but fail to grow organoids in standard conditions. 
Adding exogenous Wnt driving ligands to the culture media rescues organoid formation 
allowing researchers to assess the effects of redundant signaling sources on IESC 
renewal. Inhibiting notch signaling in vitro phenocopies the manipulation in vivo, 
resulting in massive goblet cell production. Deletion of Lrig1, an inhibitor of BMP 
signaling, increases IESC numbers in vivo and in vitro. These results show that 
organoids accurately recapitulate Wnt, BMP, and Notch’s influence on IESC driven 
renewal and the effects of perturbation on epithelial physiology.  Closing the gap 
between organoid culture technologies and high throughput conventional monolayer 
culture technologies will better leverage organoids to mechanistically describe intestinal 
renewal and disease.5,88–91
20 
 
Reconstructing basal-luminal signaling gradients in vitro and measuring gradient 
influences on organoid compartmentalization 
 In standard platforms, organoids are exposed to systemically high 
concentrations of signaling ligands more closely resembling the crypt environment than 
the more differentiated epithelial compartments. Culture media ligand levels can be 
manipulated to effect extrinsic signaling but cannot recapitulate the opposing Wnt-BMP 
signaling gradients that normally regulate epithelial renewal.  A tight correlation between 
Wnt activity and IESC proliferation is observed in vivo, with the highest levels of both 
observed at the basal-lateral pole, but it has been difficult to specifically describe Wnts 
role in regulating epithelial patterning. Transgenic animal models inactivating or 
stimulating Wnt signaling have noteworthy phenotypes. Loss of signaling arrests IESC 
proliferation and constitutive activation causes hyperproliferation and crypt hyperplasia. 
Loss of Wnt target genes like EphB2 and EphB3 causes defects in PC migration with 
lysozyme expressing cells observed throughout the mucosa. 87,92–96 
Testing the impact of factor gradients in epithelial patterning in vivo is technically 
challenging, relying on indirect readouts like gene expression. We developed a 
gradient-forming device to recreate a physiologically relevant microenvironment for 
testing the kinetics of Wnt’s regulation of crypt compartmentalization. Recently the 
Allbritton lab described a microfluidic device specifically developed for optimizing growth 
factor concentrations for efficient culture of colon organoids (colonoids). Colonoids at 
each end of the produced Wnt gradient displayed distinctly different morphologies. 
Patterns associated with differentiation were observed at the low end of the gradient 
and patterns associated with high IESC content were observed at the high end of the 
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gradient. The absence of IESC segregation within a single colonoid was likely due to 
the shallow gradient imposed across each colonoid, effectively placing the entire 
colonoid within the same chemical environment. The microfluidic device to increase the 
slope of the produced Wnt gradient and test if chemical gradients of signaling factors 
can pattern individual colonoids under controlled conditions (Appendix A: Fig1).87,92–96 
Initial attempts employing a gradient of only Wnt3a were mildly successful. 
Colonoids grown under a steep linear gradient of Wnt3a demonstrated observable by 
Sox9EGFP polarity but failed to significantly affect the pattern of proliferation (Appendix A: 
Fig4). I included the Wnt co-factor R-spondin1, normally systemically delivered in 
culture, to the linear gradient in hopes of exaggerating the polarity observed under 
Wnt3a gradients. Furthermore, IESCs were being cultured in the microchannel device 
from whole crypt units containing PCs and other niche components. I hypothesized that 
the native niche components being used in the microchannel cultures might be masking 
the effects of the ligand gradients. I sought to remove these artifacts by sorting 
individual IESCs from dissociated crypts by fluorescence activated cell sorting (FACs).   
Developing self-renewing monolayers of primary colonic epithelial cells 
 Conventional immortalized intestinal cell lines have been used in high throughput 
screenings aimed at describing intestinal renewal. Cancer cell lines grow as confluent 
monolayers and can be efficiently passaged making them compatible with conventional 
high throughput cell-based assays. Though immortalized cell lines are widely applied in 
GI research, they possess many non-physiologic characteristics including somatic 
mutations, chromosomal instabilities, altered metabolism, aberrant proliferative and 
limited differentiation. The non-physiologic properties of immortalized cell lines call into 
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question their predictive ability in assays designed to understand normal epithelial 
physiology. Although organoid culture technology has had a major positive impact on 
the in vitro study of primary gut epithelium, the 3D geometry of organoids prevents 
access to the apical aspect of the epithelium, making luminally relevant studies 
challenging. The spheroidal architecture of the organoids prevents access of 
exogenously delivered compounds to the luminal surface, limiting studies focused on 
apical transporters, receptors, and metabolic enzymes.  
Furthermore, hydrogel embedded organoids exist in multiple planes, making 
imaging by conventional microscopy exceptionally challenging and low throughput. 
Unfolding the spherical organoid into a two-dimensional (2D) monolayer addresses 
these major challenges and could further transform in vitro study of the gut epithelium. 
Primary intestinal epithelial tissue is difficult to culture long-term as a monolayer 
because tissues cultured in these systems rapidly lose stem and proliferative cells 
through apoptosis. The Allbritton lab previously demonstrated that primary tissues can 
form short-lived, non-proliferative monolayers of on polydimethylsiloxane (PDMS) and 
other artificial surfaces in the absence of a hydrogel. They sought to identify parameters 
that would support self-sustaining monolayers and identified a rat tail collagen I 
hydrogel that showed promise but needed to be validated for self-renewal and 
multipotency. I sought to employ genetic lineage tracing, used to validate the 3D 
organoid culture platform, and immunohistochemical biomarker staining to confirm the 
presence of true IESCs (Appendix B: Fig. 1).57,60,103–105,62,64,97–102 
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Developing a high throughput microfabricated IESC culture platform to describe 
intrinsic and extrinsic regulation of stem cell growth 
Due to the difficulties concerning sampling in 3D space, conventional organoid-
growth based assays preclude statistically meaningful studies of clonal IESCs or IESC–
niche cell co-cultures, limiting genetic analysis of single IESCs and their organoid 
progeny. Platforms facilitating clonal stem cell studies have driven our understanding of 
renewal in the hematopoietic system and mammary glands. The lack of similar tools in 
the IESC field has hindered our understanding of key niche interactions like IESC-PC 
signaling. PCs have been shown to increase IESC organoid formation in vitro but 
studies relied on the co-culture of hundreds of IESCs with hundreds of PCs. These 
interactions may not reflect physiologically normal signaling, where much smaller 
numbers of IESCs (~15) and PCs (~8) interact in the crypt base. 7,106–110 
Understanding how IESCs self-renew and differentiate is essential for 
determining the mechanisms underlying a broad range of issues related to human 
health and disease. Although in vivo lineage tracing and genetic manipulation remain 
important techniques for the analysis of IESC behavior, developments in primary IESC 
culture have expanded the toolkit available to study mucosal physiology to include 
powerful, complementary in vitro assays. Array-based technologies are emerging as a 
powerful method to study the functional characteristics of single and/or small numbers 
of stem cells in the hematopoietic system and holds similar promise for epithelial tissues 
such as the intestine. We developed a platform to study large numbers of single IESCs 
simultaneously, either at the clonal level or in the presence of niche cells, using 
microfabricated arrays (Fig. 1). 7,106–110 
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Microfabricated culture arrays were modified for long-term 3D culture to capture 
and functionally assay clonal IESCs and IESC–niche cell co-cultures, effectively 
providing a platform for high throughput niche reconstruction using primary IESCs and 
niche cells. Rafts fabricated into the array wells allows for efficient retrieval of single 
IESCs and developed organoids for direct integration into conventional high throughput 
biochemical assays (Fig. 2).7,106–110 
Methods/Materials 
Reconstructing basal-luminal signaling gradients in vitro and measuring gradient 
influences on organoid compartmentalization 
The Sox9EGFP: CagDsRED mouse model 
The CagDsRED mouse line ubiquitously expresses the red fluorescent protein 
DsRed driven by the chicken beta-actin promoter. The Sox9EGFP mouse line possesses 
the Sox9 promoter controlling EGFP (enhanced green fluorescent protein) expression 
integrated using a modified bacterial artificial chromosome. Crossing these two 
transgenic lines provides an epithelium source where DsRED expression marks all cell 
types and low expression levels of EGFP marks CBC IESCs (Fig. 1D).92  
Isolation of Crypts from Mouse Colon 
Epithelial cells were dissociated from whole murine colons using previously 
described techniques with some modifications. Colons were resected, opened 
longitudinally and rinsed in PBS. Colons were cut into 10 mm segments and transferred 
to 3 mM EDTA (Sigma), 10 μM Y-27632 (Selleck) and incubated for 45 min at 4oC with 
gentle agitation.  Fragments were transferred into fresh PBS with 10 μM Y-27632 and 
shaken by hand for 2 min to release the epithelial layer from the submucosa.92 
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Isolation of Single Colonic Stem Cells 
Epithelial cells were dissociated from whole murine colons using previously 
described techniques with some modifications111. Colons were resected, opened 
longitudinally and rinsed in PBS. Colons were cut into 1 mm segments and transferred 
to 3 mM EDTA (Sigma), 10 μM Y-27632 (Selleck) and incubated for 45 min at 4oC with 
gentle agitation.  Fragments were transferred into fresh PBS with 10 μM Y-27632 and 
shaken by hand for 2 min to release the epithelial layer from the submucosa.  
Epithelium was separated from the remnant mucosa, washed twice in phosphate 
buffered saline (PBS) and dissociated to single cells in 0.3 U/mL dispase (Life 
Technologies), 10 µM Y-27632 in Hank’s Buffered Saline Solution (HBSS, Life 
Technologies) incubated at 37 °C for 10-14 min while shaking every 2 min. Cell 
solutions were passed sequentially through 100 μm, 70 μm, and 40 μm pore-size nylon 
filters before being transferred to intestinal stem cell (IESC) culture media (Advanced 
DMEM/F12 (Life Technologies), N2 (1×, Life Technologies), B27 (1×, Life 
Technologies), Glutamax (1×, Life Technologies), penicillin (100 unit/mL, Life 
Technologies), and streptomycin (100 µg/mL, Life Technologies), 10 mM HEPES (Life 
Technologies), 10 μM Y27632 (Selleck Chemicals) and 500 mM N -acetyl- cysteine 
(Sigma)).   
Developing self-renewing monolayers of primary colonic epithelial cells  
Lgr5EGFPCreERT2xR26confetti mouse  
Lgr5EGFP-IRES-creERT2 mice were generated by targeted insertion of the EGFP-
IRES-creERT2 cassette into the ATG of the Lgr5 allele. This generated mice where 
EGFP expression mosaically marked Lgr5+ cells in multiple tissues. This transgene was 
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crossed onto the Rosa26Confetti transgenic line where a strong CAGG promoter was 
integrated into the Rosa26 allele followed by a LoxP-flanked NeoR-cassette blocking 
transcription. This was upstream of the Brainbow-2.1 cassette112. Cre-mediated 
recombination removes the transcriptional roadblock allowing expression of one of the 
four fluorescent marker proteins, stochastically driven by the CAGG promoter, allowing 
discrimination between the clonal progeny of neighboring IESCs within the same crypt.  
Monolayer culture of colonic crypts 
The crypts were placed on top of the collagen hydrogel at a density of 1000 
crypts/cm2 (unless otherwise stated) and cultured in 4 mL medium per well in the 6-well 
plate. The medium was changed every 48 hours, and Y-27632 was added for the initial 
48 hours of culture. When the cell coverage was greater than 80% (typically after 3–4 
days for mouse cells, 5–7 days for human cells), the monolayers were sub-cultured by a 
gentle 2-step dissociation method. The first step was to lift the monolayer from the 
collagen hydrogel by scraping the collagen (with cells) from the well and transferring the 
hydrogel to a 15-mL conical tube containing 1 mL culture medium with 500 U/mL 
collagenase (type IV; Worthington Biochemical, USA). The gel was broken into small 
pieces by pipetting using a 5-mL serologic pipette, followed by a 1-mL pipet tip. The 
tube was then incubated at 37oC for 10 minutes to completely digest the collagen gel. 
The monolayers were rinsed with PBS buffer and pelleted by centrifugation at 600g for 
1 min. The second step further breaks apart the monolayer pieces into smaller 
fragments by incubating the pellet in 150 mL of 0.5 mM EDTA and Y-27632 (10 µM) in 
PBS at 37C for 2 minutes (mouse cells) or 5 minutes (human cells). The monolayers 
were broken into small fragments by pipetting up and down 30 times by using a 200-mL 
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pipet tip. The cell fragments were resus- pended in medium and subcultured on a new 
collagen hydrogel at a passage ratio of 1:3. To convert 3D organoids to a 2D 
monolayer, the organoids were extracted from Matrigel by detaching the Matrigel patty, 
breaking it into coarse pieces, and then pipetting the suspension by using a 200-mL 
pipet tip. The cells were then cultured on a collagen gel at a density of 10 
organoids/cm2. 
Genetic lineage tracing from IESCs in 2D culture 
 Lineage tracing was induced in adult Lgr5EGFP-IRES-creERT2 mice by interparitanial 
injection of 2mg of 4-hydroxy tamoxifen 24 hours prior to sacrifice and resection. 
Developing a high throughput microfabricated IESC culture platform to describe 
intrinsic and extrinsic regulation of stem cell growth 
Clonal stem cell culture 
Isolated IESCs were plated in CRAs (Cell Microsystems, USA) at ratios of ∼1.5 
cells per microraft. Sorted cells were added to array reservoirs in culture media and 
cells were seeded into microrafts by centrifugation at 51g for 5 min at 4oC. Following 
centrifugation, medium was gently aspirated and arrays were overlaid with 600 µl (2 
reservoir array) or 200 µl (4 reservoir array) of Matrigel and growth factors. Arrays were 
centrifuged a second time at 51g for 5 min at 4oC, to recapture any cells displaced by 
the addition of Matrigel. Matrigel was allowed to polymerize for 30min at 37oC before 
being overlaid with 1ml (2 reservoir array) or 600µl (4 reservoir array) of culture media. 
Matrigel for validation experiments contained previously described growth factors, with 
some modification, at the time of plating: 15 µM Jagged-1 peptide (AnaSpec, USA), 750 
ng/ml EGF (R&D, USA), 100 ng/ml Noggin (Peprotech, USA) and 500 nM LY2157299 
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(Selleck Chemicals, USA). Initial media in validation experiments contained 2.5 µM 
CHIR99021 (Selleck Chemicals, USA) and 2.5 µM Thiazovivin (Selleck Chemicals, 
USA). Growth factors were added at two-day intervals: 1 µM Jagged-1 peptide, 50 
ng/mL EGF, 100 ng/mL Noggin and 1 µg/ml RSPO1 (R&D, USA). Medium was changed 
every four days, and no CHIR99021 or Thiazovivin was used past initial plating.57,113 
Stem cell niche co-culture  
Isolated IESCs and PCs were plated in CRAs (Cell Microsystems, USA) at ratios 
of ∼1.5 cells per microraft for IESCs and ∼1 cell per 2 microrafts for PCs. Sorted cells 
were added to array reservoirs in culture media and cells were seeded into microrafts 
by centrifugation at 51g for 5 min at 4oC (Fig. 1E). Following centrifugation, medium was 
gently aspirated and arrays were overlaid with 600 µl (2 reservoir array) or 200 µl (4 
reservoir array) Matrigel and growth factors. Arrays were centrifuged a second time at 
51g for 5 min at 4oC, to recapture any cells displaced by the addition of Matrigel. 
Matrigel was allowed to polymerize for 30 min at 37oC before being overlaid with 1 ml (2 
reservoir array) or 600 µl (4 reservoir array) IESC Sort/Culture Media. In IESC/PC co-
culture experiments, growth factors, minus Jagged-1 peptide and Y27632, were 
supplemented every two days, and medium was changed every four days, as previously 
described.57,113 
CRA image acquisition  
Mircoraft arrays were tile-scanned in bright-field, GFP and DsRed wavelengths 
using an automated stage and the Scan Slide function in the Metamorph Imaging Suite 
(Molecular Devices) immediately after plating and overlaying media. Arrays were 
housed in a physiological chamber mounted on a fluorescent microscope during 
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imaging, to prevent cell death due to the imaging procedure. Scanned images were 
stitched into a single composite image using the open source image analysis suite FIJI 
and then segmented into address-associated individual well images using an algorithm, 
‘Segmenter.m’ , designed in MATLAB (MathWorks, USA). The ‘Segmenter.m’ is 
available for download at http://www. magnesslab.org/#!vstc1=page-1/vstc0=software-
downloads. 
CellProfiler 2.0 analysis.  
Computational analysis of initial microraft contents was carried out in CellProfiler 
2.0 (Broad Institute) in two steps: segmented microraft images were loaded in sequence 
into CellProfiler to determine the contents of each microraft of the array; (2) raw data 
generated by CellProfiler was converted into easily interpretable graphs and tables 
showing the desired location, survivability or growth of IESCs within the array culture. 
Our analysis pipeline (‘SCPipeline.cp’) was assembled using modules in the open 
source image analysis software package CellProfiler 2.0 (available for free download at 
http://cellprofiler.org). Autofluorescence and reflections off microraft walls distort the 
processed microraft images and can reduce the accuracy of stem cell identification. 
Raw images loaded into CellProfiler undergo thresholding using the ‘MoG Global’ 
method, which separates objects from background on the basis of an estimate of the 
amount of the image occupied by objects. The image occupation of a single cell was 
estimated from 10 microraft images and the threshold correlation factor was increased 
to prevent background identification. A Laplacian of Gaussian algorithm, which is best 
used for objects with increasing pixel intensity towards their center (such as DsRed+ 
cells), was used to distinguish between single and clumped objects. To establish 
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parameters for cell identification and debris discrimination, we randomly selected 500 
individual microraft images containing single IESCs and 500 individual microraft images 
containing debris or fluorescent noise from a two-chamber microraft array containing 
Sox9EGFP: CagDsRed IESCs (Fig. 3C). All analysis was conducted on the DsRed 
wavelength, because the CAG promoter produced a significantly stronger fluorescent 
signal than the Sox9EGFP BAC transgene. These images were subjected to general 
size/shape analysis in the CellProfiler 2.0 module ‘MeasureObjectSizeShape’, which 
compiled data on the objects’ shape and location characteristics. We focused on three 
specific parameters to develop an analytical pipeline in CellProfiler to identify IESCs: 
compactness, form factor and eccentricity. After applying standard image thresholding, 
CellProfiler identified objects in each microraft in our panel of 1,000 images, and we 
found that IESCs had a distribution of values that was distinct from debris/noise for each 
of our parameters of interest (Fig. 3D-F). Thresholds were set using these distribution 
curves to identify IESCs within total identified objects using the ‘FilterObjects’ 
CellProfiler module (Fig. 3G). The complete pipeline was named ‘SCPipeline.cp’. A 
similar approach was used to establish filtering parameters for PC identification. Data 
on identified objects and filtered cells contained in each microraft image were exported 
using the ‘ExportToSpreadsheet’ CellProfiler module and processed using Microsoft 
Excel for Mac 2011 (Microsoft, USA). The object delineated data exported by 
CellProfiler are converted to well-delineated data using ‘WellContents.xls’ , which shows 
the initial contents of each microraft, the distribution of IESC and PC containing wells in 
the array, and the addresses of microrafts containing cells with no debris or fluorescent 
noise. Comparison of pre- and post-filtering microraft contents in ‘WellContents.xls’ 
31 
 
allowed us to identify the microraft images containing only intact stem cells and no 
debris (Fig. 3G). To validate our IESC identification pipeline using unbiased microraft 
images, we manually scored the contents of 2,254 randomly selected microrafts. This 
panel of images was then subjected to analysis using our newly developed pipeline, 
which was able to identify initial microraft contents with a high degree of accuracy, 
especially for microrafts containing a single IESC (99.87% accurate; Fig. 3H). Owing to 
stringency settings, this accuracy was reduced for wells containing multiple cells. 
Source files for ‘Segmenter.m’ , CellProfiler 2.0 pipeline ‘SCPipeline.cp’ and 
‘WellContents.xls’ are available here as Supplementary Software and for download at 
http://www. magnesslab.org/#!vstc1=page-1/vstc0=software-downloads. 
Data analysis of CellProfiler results  
After the well contents are determined by automated analysis, “cell per microraft” 
data is extracted from the .csv file generated in “SCPipeline.cp” using the 
“WellContents.xls” file (available at magnesslab.org).  Data from the “SCPipeline.cp” 
generated .csv file (this file has a name generated by the user, see “CellProfiler image 
analysis”, step 3) is copies into the WellContents.xls file. Per-microraft contents of the 
CRA are automatically extracted through formatting expressions built into the 
WellContents.xls file and displayed on the sheet titled “WellDelineated”. The microraft 
addresses are displayed in the sheet titled “target wells”, and grouped by microraft 
content (intact cells only; microrafts with debris are excluded) as follows:  column A= 1 
cell; column B= 2 cell; column C= 3 cel;l column D= 4 cell. Data summary graphics, 
showing the distribution of cells within the CRA are displayed in the sheet titled 
“Distribution”. Source files for ‘Segmenter.m’ , CellProfiler 2.0 pipeline ‘SCPipeline.cp’ 
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and ‘WellContents.xls’ are available here as Supplementary Software and for download 
at http://www. magnesslab.org/#!vstc1=page-1/vstc0=software-downloads. 
Manual analysis of initial microraft contents.  
For experiments examining organoid survival relative to initial cell-to-cell contact, 
tile-scanned images of CRAs in EGFP and DsRed wavelengths were overlaid and 
manually scored by microraft address. DsRed+ cells (isolated as Sox9EGFPneg 
:CAGDsRed+ :CD24High:SSCHigh) were considered ‘PCs’ and EGFP+ cells (isolated as 
Lgr5EGFPhigh or Sox9EGFPlow ) were considered ‘IESCs’. Two or more cells were scored 
as ‘in contact’ only if their fluorescent signatures were contiguous in the overlaid 
images. For manual quantification of well contents and organoid survival, all 
investigators were blinded to prior well contents and survival outcomes.  
Statistical analysis of organoid formation.  
For cell number experiments, conditional logistic regression was performed with 
the number of organoids alive at t = 120 hr as the response and the number of IESCs 
and PCs present in initial well contents as predictors. This was done separately for each 
experiment as well as separately for each replicate within separate experiments. When 
analysis was conducted across both replicates in a single experiment, a term indicating 
individual wells was included in the model to account for well-to-well variability. To 
examine whether IESC survival was related to cell contact or cell type (IESC or PC), we 
performed a logistic regression with organoid survival at t = 120 hr as the response and 
each combination of cell contact and cell type (IESC, no contact; IESC–PC, no contact; 
IESC–IESC contact; IESC–PC contact) as the predictor. An overall test was performed 
to examine whether there was any difference in survival amongst the four groups. If 
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overall significance was found then pairwise tests were also performed. Wells were 
considered independent and therefore it was not necessary to model the correlation 
between them. No statistical method was used to predetermine sample size and 
experiments were non-randomized. All analyses were performed using SAS Version 9.3 
(SAS Institute). P values less than 0.05 were considered statistically significant. 
Quantification of cell movement in microrafts. For cell movement experiments, pairs of 
PCs, IESCs, and IESC–PC pairs were identified in microraft images at t = 0 hr. Distance 
between each cell in a pair was measured at t = 0 and t = 24 hr. Relative change in 
distance (d∆) was calculated by subtracting distance at t = 24 hr (d24) from distance at t 
= 0 hr (d0) and normalizing to d0 (Fig. 4). Pairs of cells were included in the experiment 
only if they were alive at t = 24 hr, based on the presence of EGFP or DsRed 
fluorescence. Distances were measured from the center of each cell to account for 
changes in cell size. Statistics were analyzed in Prism 6 (GraphPad) by one-way 
ANOVA with Tukey’s multiple comparisons test. To control for measurement error, 
primary intestinal epithelial cells were isolated and fixed in 4% PFA for 30 min at room 
temperature, rinsed three times in PBS, and plated in CRA. Distance between fixed cell 
pairs (n = 50) was calculated as per live cells, above. Results from the fixed cell 
experiment were compared with each group of live cell pairs by unpaired Student’s t-
test to determine statistically significant movement. 
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Results 
Reconstructing basal-luminal signaling gradients in vitro and measuring gradient 
influences on organoid compartmentalization 
A Wnt3a/R-Spondin1 gradient enhances polarization of the stem/progenitor cell 
compartment 
The highest levels of Wnt activity are thought to exist in the crypt base with the 
Wnt concentration tapering off in a gradient toward the luminal surface. R-Spondin1 
(Rspo1) is co-expressed with Wnts in the stem cell zone and functions to potentiate Wnt 
activity through its receptor LGR5, which is G-protein coupled receptor expressed 
almost exclusively in colonic stem cells114. To determine whether a dual gradient of 
Wnt-signaling along the microchannel might promote enhanced polarization of 
proliferative and differentiated cellular compartments, R-Spondin1 and Wnt3a were 
placed at high concentration in the source reservoir (75 ng/mL Wnt3a, 110 ng/mL R-
Spondin1) to generate an environment with a steep factor gradient. To assess whether 
a Wnt3a/R-Spondin1 gradient enhanced polarization of the stem/progenitor and 
differentiated compartments, Sox9EGFP and EdU location was measured in each 
colonoid under the dual factor gradient. Nearly all the 24 colonoids assessed displayed 
IESC patterning with a Sox9EGFP vector that orientated toward the source reservoir 
containing Wnt3a/R-Spondin1. Polarization was not related to its location in the 
microchannel. Nearly all of the colonoids assessed also showed proliferative polarity 
with an EdU vector oriented towards the Wnt3a/ R-Spondin1 source. (Appendix A: Fig. 
5) 
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Effect of a Wnt3a/R-Spondin1 Gradient on Growth and Polarization of Colonoids 
Derived from a Single Stem Cell 
The experiments above utilized multicellular colonoid fragments or whole crypts 
as the source material for development of colonoids. While the fragments were small 
(~30 μm diameter with ~25 cells), the fragments did contain many cell types 
(differentiated, stem, and TA cells), and thus may have had pre-established cellular 
interactions that might impact spatial lineage allocation of a colonoid developing under 
an externally imposed growth-factor gradient. All evidence to- date indicates that the 
cells within these colonoids are representative of those in vivo and maintain a normal 
karyotype, it is conceivable that the cultured colonoids differ in an as yet unknown 
manner from their in vivo counterparts64,90,115.  For this reason, single stem cells were 
isolated from freshly obtained Sox9EGFP-CAGDsRed mouse crypts by fluorescence-
activated cell sorting of the stem cells (Sox9EGFPHi:CAGDsRED)120. The stem cells 
suspended in Matrigel were loaded into a microchannel and cultured for 5 days in the 
presence of a Wnt3a/R-Spondin1 gradient. The Sox9EGFP polarization was significantly 
exaggerated in the single-cell-derived colonoids with expression vectors of 20 of the 23 
colonoids assessed pointing towards the gradient source. (Appendix A: Fig. 6) 
Developing self-renewing monolayers of primary colonic epithelial cells 
Lineage Tracing confirms the presence of stem cells 
To determine whether self-renewing colonic stem cells persisted in the 2D 
monolayers, we performed genetic lineage tracing by using the 
Lgr5EGFPCreERT2xR26Confetti transgenic mouse. Colonic crypts were isolated from a 
tamoxifen-treated Lgr5EGFPCreERT2xR26Confetti mouse and plated on the surface of 
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collagen hydrogel at a low density of 30 crypts/cm2 (to track the growth of individual 
crypts). At 24 hours after plating, tracing events (4 out of 3000 crypts) expressed red 
fluorescent protein (RFP), which marked them as derived from Lgr5 stem cells 
(Appendix B. Fig. 4). The RFP+ regions expanded into large red fluorescent patches 
inter-mixed with the progeny of non-fluorescent stem cells. RFP+ cells were isolated 
from 2D patches and subcultured to determine whether the RFP+ patches contained 
cells with colonic stem cell properties. The RFP+ cells continued to expand into patches 
composed only of RFP+ cells (Appendix B. Fig. 4). The RFP+ cell monolayers 
possessed proliferative (EdU+) cells and all the differentiated cell types: goblet cells 
(Muc2+), enteroendocrine cells (ChgA+), and absorptive colonocytes (ALP+) (Appendix 
B. Fig. 4). These data demonstrate that the 2D monolayers possessed Lgr5+ IESCs 
that expanded as a proliferative monolayer and produced differentiated descendants in 
vitro. (Appendix B: Fig. 5) 
Developing a high throughput microfabricated IESC culture platform to describe 
intrinsic and extrinsic regulation of stem cell growth 
CRAs are adaptable to intestinal stem cell culture and imaging 
Previously described polydimethylsiloxane (PDMS)/polystyrene CRAs could be 
used to isolate and culture single IESCs in 3D embedded in ECM hydrogel. As IESCs 
require several days to develop into organoids, CRAs had to be amenable to media 
changes13,57. To meet these requirements, polycarbonate cassettes, with dividers to 
create multiple media reservoirs, were bonded to CRAs (Fig. 1A,B). Cassettes were 
fabricated with two or four culture chambers (∼2,500 or 5,000 microrafts per culture 
chamber, respectively). Physical well addresses, stamped into PDMS at 5-microraft 
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intervals, were included in the array design to allow for tracking. Conventional IESC 
cultures are capable of supporting organoid growth for many weeks. IESCs were 
maintained up to 8 weeks in CRAs, with retention of organoids in their original 
microrafts (Fig. 1L). At 8 weeks, organoids had grown into large structures containing 
many crypts (Fig. 1L,M). These observations demonstrate feasibility for long-term CRA-
based culture of primary IESCs. 
Tile-scanning microscopy produced high-resolution images of whole CRAs for 
downstream analysis. 
Tile-scanning of the CRA in the DsRed wavelength immediately after plating and 
at 48 hr revealed that isolated IESCs had begun to produce primitive organoids, 
indicative of biocompatibility (Fig. 1F,I). Large, high-resolution mosaic images of the 
entire array surface could be segmented into indexed individual microraft images using 
the segmentor.m script, referencing the microraft location on the array surface in the 
microraft image file name. 
Post hoc image analysis can quantify microraft contents and identify microrafts 
containing specific numbers of cells 
To rapidly assess the cellular contents in each of the microrafts, we developed a 
computational pipeline with the following analytical goals: to identify microrafts 
containing IESCs; exclude empty microrafts; exclude microrafts containing debris or 
imaging artefacts; and quantify the number of IESCs per microraft. To achieve this, we 
developed an image analysis computational pipeline (Fig. 3A) that was able to 
accurately identify microrafts containing targeted initial cellular contents. Computational 
analysis could accurately quantify the cellular contents of each microraft especially for 
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single IESCs (99.87%; n=2,258 visually validated; Fig. 3H). Owing to stringency settings 
adapted specifically for clonal analysis, the percentage of identified microrafts was 
reduced for wells containing multiple cells, but the incidence of falsely identified 
microrafts remained 0% for all cell numbers examined (Fig. 3H,I).  
Cell-cell contact is required for increased organoid formation in vitro 
As previous studies have speculated that PC-secreted Wnts are responsible for 
enhancing IESC growth in vitro, IESC–PC co-culture experiments were carried out in 
the absence of exogenous Wnt, to avoid ‘masking’ the potential impact of PCs on 
organoid formation 57,113,116. The GSK3β inhibitor CHIR99021, a Wnt agonist, was also 
excluded from co-culture experiments. To address the possibility that a PC in one 
microraft might affect the growth of an IESC in an adjacent, but separate microraft, we 
modelled diffusion dynamics of cell-secreted molecules in CRAs. Diffusion between 
microrafts was deemed negligible under models relying on liberal rates of diffusion and 
decay115. We reasoned that increased numbers of PCs would result in increased 
secretion of Wnts and IESC growth, and examined microrafts with initial contents 
consisting of any combination of 1–5 IESCs and 0–2 PCs. IESCs were isolated from 
Sox9EGFP or Lgr5EGFP mice and PCs from Sox9EGFP:CAGDsRed mice (Fig. 4A). DsRed 
fluorescence was used as a readout of IESC contamination in PC populations. 
Replicate experiments were conducted for each IESC biomarker to increase sample 
size per IESC–PC combination, and data were analyzed from four total CRA 
experiments, consisting of 4,830 data points, each corresponding to an individual 
microraft containing any combination of IESCs and PCs (Fig. 4B,C). Surprisingly, 
examination of survival percentages across all combinations of IESCs and PCs 
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revealed no statistically significant trends, regardless of whether IESCs were isolated 
using Sox9EGFP or Lgr5EGFP (Fig. 4B,C). To investigate the overall effect of PCs on 
organoid survival, we next analyzed the percentage of organoids formed in microrafts 
containing any number of IESCs or any number of IESCs with any number of PCs (Fig. 
4D). These analyses also failed to produce statistically significant differences between 
IESC-alone and IESC–PC microrafts, suggesting that PC presence alone is insufficient 
to increase organoid formation in vitro at physiologically relevant numbers. Previous 
studies have suggested that cell-to-cell contact between IESCs and PCs may influence 
organoid formation, but this has not been formally tested by comparison between 
touching and non- touching IESCs and PCs113. Using the same data generated in our 
IESC–PC co-culture experiments, we reanalyzed initial CRA contents to classify 
microrafts by cell-to-cell contacts at t = 0 hrs and correlated this status with organoid 
formation outcome (Fig. 4F). This comparison yielded results with overall statistical 
significance (conditional logistic regression, P = 0.0282), indicating that IESCs in direct 
contact with PCs are more likely to form organoids than IESCs alone, or IESC–PC wells 
that are not in direct contact. Interestingly, IESC–IESC contact events were also more 
likely to form organoids than non-touching IESCs, suggesting that cell-to-cell contact 
between two or more IESCs may also positively influence organoid formation. As 
expected, PC–PC contact did not result in the formation of organoids, consistent with 
the post-mitotic status of PCs in vivo and the high level of purity observed in PC 
populations (Fig. 4G).  
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Single cells do not form de novo contacts after plating 
The contact-dependent effects on organoid formation prompted us to examine 
whether de novo cell–cell contacts occurred after initial classification as ‘non-touching’ 
at t = 0 hrs. To assay this, we measured the distance between IESC–IESC, IESC–PC 
and PC–PC pairs in microraft images acquired at t = 0 hrs and calculated positive or 
negative changes in cell–cell distance at t = 24 hrs (Fig. 5A). Microwells in which both 
cells were alive at 24 hrs were included for analysis, resulting in n=905 pairs (521 
IESC–IESC; 345 IESC–PC; 39 PC–PC; Fig. 5B). To control for background movement 
due to known changes in extracellular matrix integrity that occur over time, 
measurements were taken on pairs of fixed intestinal epithelial cells for comparison 
(n=50). Analysis of change in distance in alive pairs demonstrated that: cell movement 
was statistically significant compared with measurements taken on pairs of fixed cells; 
and no observed cells formed de novo contacts after initial plating of CRAs. 
Interestingly, non-touching pairs of cells with an initial cell–cell distance ≤ 25 µm seem 
to grow further apart within the first 24 hr of culture (Fig. 5C). Together, these data 
demonstrate that single cells migrate within Matrigel cultures and that cell–cell signaling 
may repel single cells from one another over short distances in vitro. Previous studies 
demonstrate significant organoid movement and merging in vitro124. To further examine 
cell movement in the CRA platform, we performed time-lapse imaging of microrafts. 
Single cells demonstrated appreciable movement as they developed into organoids 
over the first 24 hrs of culture. Larger clumps of cells merged into single organoids, 
suggesting that the movement and merging of IESCs in vitro may be influenced by cell 
number or heterogeneity within populations.  
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Conclusions 
Reconstructing basal-luminal signaling gradients in vitro and measuring gradient 
influences on organoid compartmentalization 
Microfabricated platforms can produce steep linear gradients of morphogenic 
factors across individual colonoids or single stem cells recapitulating the crypt axis. A 
simple linear gradient of Wnt3a/Rspondin1 was sufficient to induce polarization of the 
proliferative and differentiated cellular architecture in colonoid tissue constructs derived 
from both single colonic stem cells and small multicellular colonoids composed of 
heterogeneous cell types. Combining a R-Spondin1 (110 pg/mL/μm) gradient with a 
Wnt3a (75 pg/mL/μm) gradient acted synergistically to produce enhanced polarization of 
the colonoid body. Maintenance of colonoids derived from single stem cells under the 
combined gradient condition produced the most highly polarized colonoid structure 
suggesting that the multicellular fragments possessed some internal patterning which 
limited the ability of derived colonoids to maximally respond to morphogenic 
gradients.(Appendix A: In Vitro Polarization of Colonoids to Create an Intestinal Stem 
Cell Compartment) 
Developing self-renewing monolayers of primary colonic epithelial cells 
The Allbritton lab developed a self-renewing, 2D monolayer derived from primary 
intestinal tissue and possessing all cell lineages found within the colon. Remarkably, the 
monolayers self-pattern to create peripheral stem/proliferative and central differentiated 
cell zones. The interior of the monolayer yields a large surface area occupied 
predominantly by differentiated cells, a feature mimicking that of the intestinal surface 
area in vivo. Genetic lineage tracing from the Lgr5EGFPCreERT2 allele is the gold standard 
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in the GI field to validate the presence of potent IESC populations11. Confirming that 
Lgr5+ IESCs are present in the monolayer culture systems validates their use as an 
alternative to embedded organoid cultures in a platform to study the apical mucosa 
surface more readily manipulated by addition of compounds to the media. This structure 
enables facile assay of drugs, toxins, and metabolites using conventional cell-based 
assay systems, not possible in the embedded organoid systems.(Appendix B: Appendix 
B: Self-renewing Monolayer of Primary Colonic or Rectal Epithelial Cells) 38 
Developing a high throughput microfabricated IESC culture platform to describe 
intrinsic and extrinsic regulation of stem cell growth 
CRAs have broad applicability to assaying stem cell–niche interactions and 
organoid development and serve as a high throughput culture platform to interrogate 
gene expression at initial stages of stem cell fate choices. Stem cell niches provide 
critical extrinsic signals that govern stem cell self-renewal and differentiation, but their 
anatomical locations and complexity often present significant challenges to the study of 
stem cell renewal in vivo. PCs express soluble and insoluble IESC niche signaling 
components, including Wnt and Notch ligands113,116. We examined the impact of PC 
presence and contact with IESCs on organoid formation. Interestingly, we find that PC 
presence alone is not predictive of organoid formation. Rather, direct cell-cell contact 
between IESCs and PCs is required for enhanced IESC growth, suggesting that 
insoluble or very short-range soluble signals support IESCs in vitro. These results 
support in vivo findings that stemness is most strongly correlated in cells that exist in 
intimate contact with PCs, and provide insight into the functional role of PCs in 
maintaining stemness117. Importantly, the CRA platform was critical in testing dose and 
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contact dependency of PCs in a microscale format. in maintaining stemness. 
Importantly, the CRA platform was critical in testing dose and contact dependency of 
PCs in a microscale format.  
Array-based stem cell culture platforms are growing in use and present an 
efficient and cost-effective alternative to conventional cell culture126,127. However, most 
platforms are not amenable to long-term cultures, such as required for the development 
of IESC-derived organoids and other self-assembled, stem-cell-derived organoids. 
CRAs facilitate the culture of thousands of primary stem cells over many days and 
weeks as well as high throughput reconstitution of the stem cell niche at physiologically 
relevant cell numbers. The power of the CRA platform is further highlighted by the ability 
to retrospectively ‘mine’ existing high throughput CRA data sets to test new hypotheses, 
such as niche cell dose dependency, cell-cell contact and cellular movement within 
microrafts.106,107,114 
CRAs provide robust methodology for screening candidate mitogens and 
morphogens for their effect on organoid formation and development, and the study of 
other IESC niche cells, such as pericryptal myofibroblasts, endothelial cells and 
neurons. Furthermore, CRAs have broad potential for in vitro reconstruction of stem cell 
niches across a range of cell and tissue types, especially those that require three-
dimensional extracellular matrices. The ability to easily retrieve a high replicate number 
of organoids early in their development allows investigators to associate functional 
observations with dynamic changes at the genetic and transcriptomic level, facilitating 
next- generation forward genetic screens in primary stem cells.106,107,114
Parts of this chapter previously appeared as an article in the journals NCB, Plos1, and CMGH the original citations are as follows: 
Gracz, A. D. et al. A high-throughput platform for stem cell niche co-cultures and downstream gene expression analysis. 
Nat. Cell Biol. 17, 340–349 (2015). 
 
Attayek, P. J. et al. Automated microraft platform to identify and collect non-adherent cells successfully gene-edited with 
CRISPR-Cas9. Biosens. Bioelectron. 91, 175–182 (2017). 
 
Wang, Yuli, DiSalvo, Matthew, Gunasekara, Dulan B., Dutton, Johanna, Proctor, Angela, Lebhar, Michael S., Williamson, 
Ian A., Speer, Jennifer, Howard, Riley L., Smiddy, Nicole M., Bultman, Scott J., Sims, Christopher E., Magness, Scott T. & 
Allbritton, Nancy L. Self-renewing Monolayer of Primary Colonic or Rectal Epithelial Cells. Cmgh 4, 165–182.e7 (2017). 
 
Williamson, Ian A., Arnold, Jason W., Samsa, Leigh Ann, Gaynor, Liam, DiSalvo, Matthew, Cocchiaro, Jordan L., Carroll, 
Ian, Azcarate-Peril, M. Andrea, Rawls, John F., Allbritton, Nancy L. & Magness, Scott T. A High-Throughput Organoid 
Microinjection Platform to Study Gastrointestinal Microbiota and Luminal Physiology. Cell. Mol. Gastroenterol. Hepatol. 1–
38 (2018). doi:10.1016/j.jcmgh.2018.05.004 
  
Chapter 3: A High throughput Organoid Microinjection Platform to Study 
Gastrointestinal Microbiota and Luminal Physiology 
Synopsis 
A high-throughput organoid microinjection platform was developed to study 
gastrointestinal physiology and the microbiome. Monitoring and quantification of injected 
microbes and other cargos was achieved by automated imaging. Human fecal 
microbiota including highly oxygen-sensitive anaerobic taxa were transplanted into the 
organoid lumen and maintained over time in stable monocultures or microbial 
communities. 
Overview 
Aims: The human gut microbiota is becoming increasingly recognized as a key factor in 
homeostasis and disease. The lack of physiologically relevant in vitro models to 
investigate host-microbe interactions is considered a substantial bottleneck for 
microbiota research. Organoids represent an attractive model system because they are 
derived from primary tissues and embody key properties of the native gut lumen; 
however, access to the organoid lumen for experimental perturbation is challenging. 
Here, we report development and validation of a high-throughput organoid 
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microinjection system for cargo delivery to the organoid lumen and high-content 
sampling. Methods: A microinjection platform was engineered using off-the-shelf and 
3D-printed components. Microinjection needles were modified for vertical trajectories 
and reproducible injection volumes. Computer vision (CVis) and microfabricated 
CellRaftTM Arrays (CRAs) were used to increase throughput and enable high-content 
sampling of mock bacterial communities. COMSOL modeling predicted a hypoxic 
luminal environment that was functionally validated by transplantation of fecal-derived 
microbial communities and monocultures of a non-sporulating anaerobe. Results: CVis 
identified and logged locations of organoids suitable for injection. Reproducible loads of 
0.2 nl could be microinjected into the organoid lumen at ~90 organoids/hour. CVis 
analyzed and confirmed retention of injected cargos in ~500 organoids over 18 hrs and 
revealed the requirement to normalize for organoid growth for accurate assessment of 
barrier function. CVis analyzed growth dynamics of a mock community of GFP- or 
DsRed-expressing bacteria, which grew within the organoid lumen even in the presence 
of antibiotics to control media contamination. Complex microbiota communities from 
fecal samples survived and grew in the colonoid lumen without appreciable changes in 
complexity. Conclusions: High-throughput microinjection into organoids represents a 
next-generation in vitro approach to investigate gastrointestinal luminal physiology and 
the GI microbiota. Keywords: Organoid, microinjection, high-throughput, fecal 
microbiota, anaerobic, barrier function, high-content sampling 
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Background & Aims 
 The human gastrointestinal tract contains a remarkably dense and diverse 
microbial community38,118. The interactions between gut microbiota and host are 
becoming increasingly recognized as key factors in homeostasis and disease43. Many 
studies indicate that community imbalances, known as dysbioses, are associated with 
onset and progression of diseases including diabetes119, obesity120–122, colorectal 
cancer27,50,51, and inflammatory bowel disease (IBD)44. Despite tight statistical 
associations between dysbiosis and disease, the ability to formally test cause-and-effect 
relationships is severely limited by lack of in vitro experimental models that enable 
controlled interrogation of host-microbe interactions.  
 Sequencing of the 16S rRNA gene is routinely used to characterize microbial 
communities and is a powerful tool to identify bacteria that may contribute to disease32. 
While 16S rRNA gene sequencing provides a ‘signature’ of microbial composition within 
a community, alone it is insufficient to define specific microbial mechanisms that impact 
host biology. Germ-free (gnotobiotic) animal models are commonly used to investigate 
host-microbe interactions in a physiologically relevant system, but germ-free animal 
models are often impractical for researchers to employ because of the scarcity of 
gnotobiotic facilities and high cost of gnotobiotic experimentation 13. Additionally, the 
inherent low throughput nature of germ-free rodent studies limits the ability to decipher 
the individual role that each microbial species plays in health and disease.  
A recent assessment of microbiota research in the United States identified the 
development of high throughput tools as a key, common unmet need for this field 14. 
With the recognition of this problem, concerted efforts are now being made to build a 
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‘translational microbiome toolbox’ to create innovative and high-throughput approaches 
to test detailed mechanisms of host-microbe interactions123. For instance, engineering 
Bacteriodes thetaiotaomicron, B. fragilis, B. vulgatus, B. ovatus, B. eggerthii, and B. 
uniformis with 6 different fluorescent proteins enabled delineation of species within the 
gut of mice, and revealed that the priority of gut colonization determines colonic crypt 
microbial occupancy124. Similarly, engineering inducible promoters in Bacteroides has 
enabled study of host-microbe interactions through measurement of commensal 
sialidase activity and liberation of mucosal sialic acid, a nutrient for pathogens125. 
Further, new methods have been developed that permit genetic manipulation and 
analysis of “genetically intractable” bacteria from the intestine126. As these sorts of tools 
are being increasingly developed to test mechanistic questions, and studies are 
expanded to interrogate the thousands of different microbes that inhabit the gut, high-
throughput in vitro models will be essential for these next-generation microbiome 
studies. 
 Transplanting the complex microbial communities found in the gut lumen to a 
physiologically relevant system in vitro is particularly challenging since most microbes 
comprising the human GI microbiota are highly sensitive to oxygen exhibited limited 
viability or proliferative capacity in the presence of oxygen127. A recent study suggests 
that 50%-60% of the oxygen-sensitive bacterial genera in the GI microbiota can produce 
resilient spores and can be detected on specialized agar plates incubated in an 
anaerobic environment127, however, non-sporulating anaerobes remain difficult or 
impossible to cultivate in vitro, and require an environment sufficiently hypoxic for 
survival and growth127. Minibioreactors without a host cellular component have been 
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built to cultivate fecal samples in a hypoxic environment128. This system increased 
throughput by allowing up to 48 communities to be cultivated per anaerobic chamber. 
While this system proved sufficient to stably culture complex communities, only 15%-
25% of the initial fecal OTUs were observed suggesting that other system components 
are required to cultivate the full complexity of fecal microbiota.  
 Designing culture environments that possess a host cellular component in 
combination with physiologically relevant luminal environment may enable more 
complex communities to be cultivated while facilitating the studys of host-microbial 
interactions. Culturing techniques have been developed that permit growth of primary 
intestinal epithelium on 2D surfaces129–131, however, generating a steep oxygen gradient 
over a single cell layer in monolayer cultures remains an engineering challenge due to 
the requirement of a constantly intact monolayer, which is difficult to achieve in 2D 
cultures. Gut organoids, also known as enteroids or colonoids132, represent an 
alternative in vitro system to culture fecal derived microbiota by the virtue of their 
morphologic, cellular and physiologic properties that are unavailable in 2D culture 
systems.  
 Organoids are microscale spherical structures comprised of an epithelial 
monolayer that surrounds a hollow lumen containing mucous and cellular debris, and 
serves as a natural physical barrier to the ambient atmosphere57. Organoids form in 
culture from isolated crypts or single intestinal stem cells13,57,64,115,133, retain long-term 
self-renewal properties due to stable intestinal stem cells compartments (e.g. crypt 
buds) interspersed between zones of differentiated cells, and  possess cell lineage 
ratios, polarization, and cell migration patterns that mimic those found in vivo64. 
49 
 
Clostridium difficile, a sporulating pathogenic anaerobe, has been microinjected and 
monocultured for 12 hours in the organoid lumen suggesting that the organoid luminal 
environment can support oxygen-sensitive sporulating taxa74,134. While organoids are a 
potentially suitable environment to model physiology of the gut lumen, microinjection 
currently represents the most direct method for delivering defined cargo to the lumen135.  
 In this study, we developed a high-throughput organoid-specific platform to study 
luminal physiology and the gut microbiome. We leveraged advances in organoid culture, 
microfabricated culture devices106,107,114, computer vision (CVis)114, and semi-automated 
microinjection technologies to enable high-content sampling of a number of 
microinjected cargos, including materials to study epithelial barrier integrity and fecal 
isolates from human donors. The platform can be extended to organoids derived from 
other tissues like the lung and stomach, and injectable cargos can be tailored to study a 
broad range of topics related to gut epithelial biology including microbe-microbe and 
host-microbe interactions, nutrient transport, and barrier function. 
Results 
Development of an organoid injection system  
 The apical side of the gut epithelium is exposed to a complex mixture of luminal 
contents including nutrients, microbiota, metabolites, and indigestible material. While 
there is merit to using the organoid lumen to model gut physiology, the apical surface of 
the organoid epithelium is inaccessible because the organoid epithelial monolayer 
creates a barrier to the luminal space (Fig. 6A). Material can be introduced into the 
organoid lumen by incubating fragments of dissociated organoid with compounds that 
are then passively enveloped into the organoid as the lumen re-forms135. Though this 
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technique can be effective, it lacks precision in that there is no control over the quantity 
of material that can be delivered to the organoid. Moreover, this strategy cannot be 
used to introduce materials into the lumen of mature organoids. Microinjection is an 
alternative approach that offers the ability to accurately, reproducibly, and precisely 
place a wide variety of cargos into the organoid lumen. However, microinjection is 
technically challenging and requires a high-level of expertise that limits its broad use by 
investigators.  
 Using common hardware with some simple modifications, we developed a semi-
automated, high-throughput organoid microinjection system that can be easily 
reproduced in many laboratories. To develop this system, conventional remote-
controlled microinjection hardware, and a fluorescent microscope fitted with an 
automated stage and imaging system were combined in a single platform (Fig. 6B). The 
system is contained within a physiologic chamber to maintain appropriate temperature 
and CO2 levels to support long-term organoid viability for time intensive experiments 
(Fig. 6B). Three 3D-printed custom fittings were engineered to enable precise needle 
articulation over organoids cultured in conventional tissue culture plates or CRAs for 
high-throughput applications (Fig. 6B; CAD files available in Supplemental 
Materials)106,136.  
 Needle approach for pronuclear or zebrafish embryo microinjection typically 
occurs at a ~45° angle. These angles are incompatible with the use of multi-well plates 
because the walls of the wells prohibit needle articulation. Additionally, diagonal needle 
approaches result in an unacceptable level of needle breakage when moving the needle 
through the hydrogel that surrounds organoid. To circumvent these issues, 
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microinjection needles were fashioned from glass capillaries, then heated and bent to a 
90° angle, allowing for a vertical needle approach to organoid targets (Fig. 6C). 
Positioning of the needle over the target organoid did not obstruct the microscope visual 
field due to the inverted orientation of the objective lens and optical clarity of the needle.  
 Accurate and reproducible microinjection requires high quality glass 
microneedles. We found that needle construction techniques for conventional zebrafish 
embryo microinjection produced needles that were not suitable for organoid 
microinjection and required substantial optimization137. Specifically, needle taper and tip 
length were increased to promote smooth entry and exit from the organoid and rapid re-
sealing. Needle bore diameter was optimized to 1 µm to reduce the size of epithelial 
puncture and enable reproducible nanoliter injections (Fig. 6D). Preliminary attempts to 
inject organoids revealed that microforged needles were highly susceptible to retention 
of cellular material resulting in high incidence of clogging, and impaired insertion and 
removal of needles in subsequent injection attempts. At the microscopic level, the 
borosilicate needles are littered with microscopic defects137, which we surmised caused 
retention of cellular material on the needles after injection. Wet etching using HF was 
adapted to remove these defects and produce a smooth external needle tip137. A high 
internal pressure was maintained in the needle body during wet etching to reduce 
buildup of acid or salt residues that might cause clogging or contaminate cargos. These 
microneedle design features proved essential for efficient and reproducible high-
throughput microinjection into organoids. 
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Validating the organoid injection system  
Precise and reproducible microinjection volumes are critical for quantitative 
studies. The minimal microinjection volume was determined for the organoid-optimized 
needle design by injecting single droplets of aqueous FITC conjugated dextran into oil 
(Fig. 6E). The accuracy of five different microinjection needles was tested by imaging 
injection droplets, measuring the cross-sectional area of single injection droplets using 
CVis, and calculating the spherical volumes of each droplet (Fig. 6E). Optimized 
microinjection needles were capable of reproducibly delivering 0.2 nl ± 1.4% of cargo. 
Each 0.2 nl droplet is approximately half the theoretical lumen volume of a 100 µm wide 
organoid. Injection duration is a property of pneumatic injection systems that changes 
injection volumes. Though injection duration necessary to produce a 0.2nl droplet varied 
from 24 ms to 51 ms between five different needles, there was little variability in droplet 
volume (<1%). This indicates that variation in needle tip geometry requires fine-tuning of 
injection durations to produce extremely small volumes. In contrast, longer injection 
durations of 200ms produced consistent 2.0nl droplets from five different needles with 
minimal variation (± 2.1%) (Fig. 6F). These data demonstrate that highly consistent 
volume droplets can be generated between 0.2nl and 2.0nl when modulating the 
injection duration. 
 When diagonal needle approaches are used for microinjection the needle tip can 
be observed in the focal plate of the target. When using a vertical needle approach the 
needle is not visible in the focal plane of the organoid until the puncture. The 90° 
articulation of the microinjection needle required a modified workflow to efficiently 
microinject organoids (Fig. 6G). Visual cues caused by light refraction off of the needle 
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tip enables alignment above the organoid (Fig. 6G.1); the needle tip is then advanced 
until it touchs the top surface of the organoid (Fig. 6G.2). As the needle contacts the 
organoid exterior, deflection and bending of the epithelial monolayer are visualized as 
creasing and stretching of the organoid perimeter (Fig. 6G.3). Once punctured, the 
organoid retracts to its original diameter and cargo is delivered by pneumatic pulse (Fig. 
6G.4). After needle retraction, creases in the organoid monolayer are no longer 
observed (Fig. 6G.5). If cargo is fluorescent, imaging can then be performed (Fig. 6G.6) 
(Supplemental Video 1).  
 Based on the diameter of the needle tip (1 µm), we estimate that a ~5-10 µm 
hole (about 1 cell thickness) is generated as a result of the puncture through the 
epithelium. To evaluate whether cargo remained in the organoid lumen after needle 
withdrawal, luminal retention of an inert 70kDA fluorescein-dextran impermeable to the 
membranes and intercellular junctions was assessed138. Immediately after injection, the 
fluorescent dextran quickly diffused and equilibrated throughout the luminal space (Fig. 
7A). Over time, signal intensity decreased as the organoid grew and expanded (Fig. 7B; 
Supplemental Video 2). While the decrease in fluorescent cargo might be due to 
leakage, it was hypothesized that reduction in fluorescent signal was due to increased 
luminal volume, effectively diluting the fluorescent cargo with organoid growth. To test 
this, CVis measured the mean intensity and area of the florescent signal every 30 
minutes for 18 hours (Fig. 7C). While the mean intensity decreased to approximately 
half of the original intensity during the 18-hour time course, the signal area doubled (Fig. 
7D,E). When the signal intensity was integrated over the observed area, the normalized 
signal was demonstrated to remain constant over the 18-hours (Fig. 7F). These data 
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indicate that the injected cargo was effectively retained in the organoids and suggests 
there is unappreciable leakage from the needle puncture.  
Automated computer vision facilitates high-throughput organoid identification, 
injection and quantification of injected cargos 
 Major limitations to efficient and high-throughput microinjection are manual 
identification of organoids suitable for injection, and the manual tracking and 
quantification of cargos post-injection. To address these problems a CVis program was 
developed to automatically identify suitable organoids cultured on a Cell Raft Array 
(CRA). CRAs are commercially available microculture well arrays that enable efficient 
imaging, identification, and position recall of thousands of organoids in a small footprint 
(Fig. 7G)106. There are ~15,000 microwells in a 2.0cm2 area of the microfabricated 
device. Passaged organoids were randomly seeded using a Poisson distribution such 
that there was approximately 1 organoid per 200µm2 microwell (Fig. 7G). Organoids 
were cultured for 3 days to achieve a population of organoids that were of a practical 
size for injection. The CRA was imaged in brightfield and fluorescence channels using 
MATLAB scripts, which serially collected indexed images of individual rafts. Images of 
each raft were then processed through OrganoidMorph, a custom computational image 
analysis pipeline developed in the open-source platform CellProfiler with a simple user 
interface135,139. Total organoid area and luminal area was measured using CVis, and 
monolayer width was determined by subtracting the overlapping area (Fig. 7H; 
Supplemental Video 3). Organoid area and monolayer width metrics for each organoid 
was associated with a specific address on the CRA to enable automated recall for 
microinjection. To validate OrganoidMorph identification, CVis-identified organoids were 
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compared to manually-identified organoids (Fig. 7I). Automated organoid identification 
in ~15,000 CRA wells took about 2 hours and was >95% accurate. Lumen 
segmentation was 96.8% accurate based on comparison to manual measurements (Fig. 
7H,I). These data demonstrate that a CVis pipeline can be used to accurately and 
efficiently identify the location of hundreds of organoids, and quantify their morphology 
to identify sub-sets of organoids suitable for injection. 
 Anecdotally, microinjection efficiency is highly variable between organoids of 
different sizes, shapes, luminal volumes, and monolayer widths. Average monolayer 
widths and cross-sectional areas from ~1,800 organoids from CAG:DsRed mice were 
automatically determined by OrganoidMorph CVis analysis and the data was binned 
according to width and area (Fig. 7J, K). To test whether distinct morphologies were 
more suitable for microinjection, ~500 organoids with different monolayer widths and 
cross-sectional areas were targeted for microinjection with 0.4 nl of membrane 
impermeable 70kDA Fluorescein-Dextran (Fig. 7L). Microinjection was scored as 
‘successful’ if FITC signal was entirely contained within DsRed-positive cell boundaries 
immediately after injection, or ‘unsuccessful’ if FITC signal was detectable outside of 
organoid boundaries (Fig. 7L). Organoid cross-sectional area, which is a proxy for 
luminal volume, was positively correlated with successful microinjection and injection 
efficiency (microinjection time vs area) (Fig. 7M). The smallest organoid successfully 
injected measured 10,000 μm2. In general organoids with cross-sectional areas of 
<10,000 µm2 were not suitable for microinjection. Approximately, 50% of organoids with 
cross-sectional areas between 10,000 µm2 and ~18,000 µm2 were successfully injected; 
100% of organoids with >18,000 µm2 cross-sectional areas were successfully injected. 
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In contrast, there was no significant correlation between microinjection success and 
monolayer width (Fig. 7N). However, there was a positive correlation between injection 
speed and monolayer width for organoids with monolayers wider than ~15 µm. When 
organoid monolayers were >15 µm, each injection took an average of 39.1 ± 12.5 
seconds, while monolayers <15 μm2 took an average of 82.2 ± 14.4 seconds to inject 
(Fig. 7O). These data provide important organoid morphology metrics and guidelines to 
increase efficiency and success of organoid microinjection.  
Growth dynamics of transplanted microbial communities and colonoid barrier 
integrity can be monitored by computer vision  
 A number of studies have piloted monoculture of bacteria in the lumen of 
organoids138,140–144. We sought to explore whether our high-throughput microinjection 
system could be used to culture microbial communities in the lumen of colonoids, which 
are organoids derived from colonic epithelium, and whether CVis could be used to 
monitor growth dynamics of fluorescently labeled bacteria within a community. An 
inoculum of ~1,500 non-pathogenic E. coli NC101 constitutively expressing GFP was 
injected into five individual colonoids to assess whether the fluorescent signature could 
be detected by microscopy. Confocal microscopy demonstrated that the GFP 
expressing E. coli NC101 could be easily detected (Fig. 8A). Orthogonal views of image 
projections invariably demonstrated a large E. coli NC101-GFP signal in close proximity 
to the colonoid monolayer (Fig. 8A; Video: S4). A mock community of two different 
traceable bacterial species, E. coli expressing DsRed, and Y. pseudotuberculosis 
expressing GFP, was injected into colonoids, detected by fluorescence microscopy, and 
monitored over time to determine whether growth dynamics of each species could be 
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quantified by CVis. Comparable to E. coli NC101-GFP alone, E. coli K12-DsRed and Y. 
pseudotuberculosis-GFP could be readily imaged together in the same organoid by epi-
fluorescence microscopy at 2, 12 and 24 hours post-injection (Fig. 8C). There were no 
appreciable changes observed in epithelial thickness, budding, or growth rate after 
organoid lumen colonization. 
 Contamination of culture media due to off-target injection, needle leakage, or 
minor leakage out of the colonoid lumen would compromise colonoid cultures and 
complicate analysis of injected microbial communities. To address this issue, two 
different antibiotics, tetracycline and chloramphenicol, were added to the colonoid 
media to inhibit growth of free bacteria outside of the organoid lumen. E. coli K12-
DsRED was resistant to tetracycline and Y. pseudotuberculosis-GFP was resistant to 
chloramphenicol. To test the efficacy and specificity of antibiotics added to the media, 
an inoculum of ~1,500 of each fluorescent strain was injected into 10 colonoids per 
antibiotic condition, 5 µl of media was collected over time, cultured for 24 hours, then 
cultures were qualitatively assessed for bacterial growth and fluorescent signature. 
While there was no apparent bacterial contamination observed visually in the colonoid 
culture media at any time point, small amounts of active tetracycline-resistant and 
chloramphenicol-resistant microbes could be cultured from all conditions 2 hours after 
the injections (Fig. 8D). Neither strain could be cultured from media collected at 24 hour 
or 48-hour time points when both tetracycline and chloramphenicol were employed, 
indicating the antibiotics were effectively controlling contaminating bacteria outside of 
the colonoid lumen.  
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 To determine if the growth of the mock community could be quantitatively 
monitored over time, 40 colonoids were injected with ~1500 E. coli K12-DsRED and 
~1500 -Y. pseudotuberculosis-GFP bacteria, and fluorescence signal was quantified by 
time-lapse CVis every 30 minutes (Fig. 8B). The integrated DsRED and GFP intensity 
within the colonoid lumen steadily increased over the 24-hour time course (Fig. 8E), 
suggesting both strains of bacteria in the community were growing. Although colonoids 
were exposed to antibiotics in the media, the data demonstrate only a modest decrease 
in fluorescence. A powerful feature of the CRA platform is that the contents of each raft 
can be individually retrieved for downstream analyses106. To determine whether bacteria 
were active and growing within the colonoid lumen, each colonoid injected with the 
mock community was retrieved from the CRA, and the number of live bacteria was 
quantified by colony formation assays (Fig. 8F). No significant difference was observed 
in the number of bacteria cultured from the luminal contents of colonoids retrieved 2 
hours following injection, suggesting that the majority of the microbial load was retained 
in the colonoid lumen (data not shown). Twenty-four hours post-injection of the mock 
community, significantly more bacterium were retrieved from all colonoids indicating 
growth within the colonoid lumen (Fig. 8F). These findings demonstrate that growth 
dynamics of different bacterial species within a community can be monitored in the 
colonoid lumen by fluorescent signature and colony forming assays.  
 We next wanted to determine whether the signal level of fluorescent proteins 
expressed by bacteria could be directly correlated to the microbial load. Forty-eight 
colonoids were transplanted with 24ms, 48ms, 72ms, or 96ms injections consisting of 
~800, ~1350, ~1700, or ~2000 K12-DsRED bacteria, ~200, ~300, ~500, or ~700 
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NC101-EGFP bacteria, and 70kDa dextran as an internal reference to monitor barrier 
function. Forty-five of the 48 attempted injections were successful (93.75%). Signal from 
both E. coli strains as well as the inert dextran could be observed immediately following 
microinjection and throughout the 24-hour incubation time. There was no apparent loss 
of barrier function as determined by a consistent signal from fluorescent dextran (Fig. 
8G). The transplanted bacteria demonstrated increased growth as measured by CFU 
over the 24-hour period, and the fluorescent signal from each strain also showed a 
steady increase in the integrated DsRED and GFP intensity regardless of starting load 
(Fig 3H). As predicted from the visual observations, the integrated signal produced by 
the inert dextran remained steady during the 24-hour time course indicating that 
epithelial barrier function was preserved (Fig. 8I). The ratio of CFU to intensity 
demonstrated a non-linear relationship indicting that integrated fluorescence signals 
cannot be used to directly measure luminal microbial loads, but can serve as a proxy for 
growth (Fig 3. J,K).  
The colonoid lumen supports the growth of aerobic and obligately anaerobic 
human microbiota taxa  
 Investigating interactions of native microbial communities with the host epithelium 
in culture is technically challenging and many times impossible because native enteric 
microbial communities are dominated by obligate anaerobic species, which are difficult 
or impossible to cultivate in vitro127. Because of the relatively small colonoid lumen 
volume, which is surrounded by oxygen metabolizing epithelium, it was hypothesized 
that the colonoid lumen might be sufficiently hypoxic to cultivate the complex anaerobic 
microbial communities found in the human gut. Direct measurement of luminal oxygen 
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in very large human organoids derived from induced pluripotent stem cells has been 
performed using an oxygen microprobe145, however, these microprobe tips are far too 
large to directly measure oxygen in most organoids derived from primary tissues. 
Therefore, a computational model was developed to estimate the oxygen concentration 
using dimensions of a representative colonoid (Fig. 9A). Monolayer thickness and 
luminal volume was modeled based on this colonoid, and empirically-determined 
oxygen diffusion and oxygen consumption rates were applied to the model146 (Fig. 9A). 
COMSOL Multiphysics modeling suggested that the lumen of colonoids has an 
estimated 10% of atmospheric O2 (~180 nM) reaching the apical surface of the organoid 
due to respiration by the enclosing epithelial monolayer (Fig. 9A,B). The model is 
remarkably consistent with oxygen levels measured in hiPS-derived organoids where 
luminal oxygen was measured at ~8% and media levels at 18%145. 
 While complex communities of human GI microbes can be easily acquired by 
stool sampling from donors, unprocessed stool samples contain large particles that can 
clog microinjection needles. We developed and validated a method for processing stool 
samples such that they could be loaded into microinjection needles without clogging the 
small needle aperture or causing appreciable loss of community diversity (Fig. 9C). 
While centrifugation of stool diluted in saline is a conventional method to prepare fecal 
samples for transplantation into gnotobiotic animal models, it was not sufficient to 
remove enough of the large material that causes needle clogging. Two different 
commercially available filters were used to filter stool samples diluted in PBS, and the 
flow-through was compared to untreated samples and centrifuged samples by 16S 
amplicon sequencing. The results demonstrate little difference in observed species 
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between untreated, centrifuged, and filter #1, while there was an appreciable decrease 
in observable species when filter #2 was used. Similar trends were seen by principal 
component analysis (PCA) of the Operational Taxonomic Units (OTUs) where filter #1 
samples closely clustered with OTUs in untreated samples (Fig. 9D). No needle 
clogging was observed when using stool flow-through from filter #1, which was used to 
process all stool samples prior to microinjection.  
 To determine whether aerobic and anaerobic communities could be transferred 
and cultivated within the colonoid lumen, a simple workflow was developed that enabled 
anaerobically collected stool samples to be efficiency injected into colonoids similar to 
the high throughput applications described above. Essentially, stool samples are filtered 
and loaded into the microinjection needles in an anaerobic chamber, followed by 
microinjection of a 0.2nl inoculum into the lumen of colonoids (Fig. 9E). This workflow 
was used to evaluate the compatibility of the colonoid lumen with fecal derived microbial 
communities (Fig. 10).  
 Fecal transplants were performed by injecting ~0.2 nl of the filtered stool sample 
into 30 murine colonoids. At each specified time point, 5 of the colonoids were collected 
and mechanically disrupted under anaerobic conditions to release bacteria into a 
solution, which was applied to broth plates for CFU assays (Fig. 10A). There was no 
apparent effect of colonization on colonoid viability throughout the timecourse. After 
fecal transplantation, increasing numbers of colonies were observed over time on plates 
incubated in both aerobic and anaerobic conditions (Fig. 10B). Few or no colonies were 
recovered from off-target injections, indicating that growth was specific to the lumen 
environment (Fig. 10C). To assess whether the colonoid lumen could support stable 
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fecal communities over time, the remaining 5 colonoids from each time point were 
subjected to 16S amplicon sequencing to monitor taxonomic changes (Fig. 10D). While 
the Firmicutes represented the most abundant phylum in the stool samples and 
colonoids at each timepoint, there was a notable expansion of the relative abundance in 
Actinobacteria and Proteobacteria phyla in the colonoids. Compared to stool, microbial 
communities injected into colonoids and cultured over time demonstrated no significant 
difference in the number of observed species or Shannon index, which is a quantitative 
metric to describe the numbers and dominance of a species within a community (Fig. 
10E,F). Together these data demonstrate that complex bacterial communities isolated 
from donor fecal samples can be efficiently microinjected into the colonoid lumen and 
cultivated over a 4-day period with little change in the relative composition of the 
communities. 
 Obligate anaerobes can be subclassified as ‘sporulating anaerobes’, which 
exhibit some oxygen tolerance, or ‘non-sporulating anaerobes’, which are highly 
intolerant to oxygen146. The diarrheal pathogen Clostridium difficile, produces highly 
resistant spores that can be transmitted through an oxygen rich environment to colonize 
a new host127. C. difficile has been injected into organoids derived from hiPSc to study 
the impact of C. difficile toxins on host epithelium134,147. We wanted to test whether non-
sporulating and highly oxygen-intolerant species could survive and grow inside the 
colonoid lumen. Bifidobacterium is a Gram-positive genus often associated with 
anaerobic bacteria and was represented in the healthy fecal microbiota sample. When 
the fecal microbial community was microinjected into colonoids this genus increased in 
relative abundance suggesting it is growing in the colonoid lumen (Fig. 10G).  
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While 16S rRNA gene amplicon sequencing indicates the presence and relative 
abundance of bacterial taxa, it does not access their viability. To validate whether non-
sporulating obligately anaerobe species of the Bifidobacterium genera could survive and 
grow within the colonoid lumen, a monoculture of Bifidobacterium adolescentis, a highly 
oxygen-intolerant species that is an early colonizer of the infant gut 62, was 
microinjected into colonoids (Fig. 10H). Survival and growth of B. adolescentis in the 
colonoid lumen was evaluated at 6, 12, 24, 48, or 60 hours following microinjection. 
Since B. adolescentis was not capable of growing on plates63 activity was evaluated by 
culture capacity in anaerobic broth and growth was evaluated by copy-number qPCR for 
the B. adolescentis 16S rRNA gene, which can be used as a proxy for microbial load. 
While control injections exposed to oxygen were unable to grow in culture at the earliest 
time point tested (6 hours), B. adolescentis could be cultured in broth through 3 days of 
cultivation in the colonoid lumen (Fig. 10I). There was an ~4.5-fold increase in the 
relative abundance of B. adolescentis within the colonoid lumen between injection (t = 
0) and 6 hours of cultivation (Fig. 10I). While B. adolescentis could survive through 3 
days post-injection, there was a significant loss of 16S rRNA gene abundance at 2 days 
post-injection, suggesting factors required for growth had diminished. Together, these 
results indicate that the colonoid lumen is sufficiently hypoxic to support survival and 
growth of non-sporulating anaerobes found within the larger community of fecal 
microbiota.  
Conclusions 
 In response to the call for high-throughput platforms and physiologically relevant 
in vitro culture models to study ‘unculturable’ taxa148,149 and their effect of GI physiology, 
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we developed and validated a semi-automated high-throughput microinjection device 
that enables highly efficient and reproducible injection of cargos into the lumen of gut 
organoids.  The microinjection device was married to CVis algorithms and microculture 
arrays (CRAs) for high-content sampling of inert and biological cargos injected into the 
organoid lumen. The microinjection platform was used to monitor and quantify the 
growth dynamics of mock microbial communities harboring fluorescent reporter genes. 
With the knowledge that the organoid lumen was sufficiently hypoxic to support 
cultivation of more oxygen-tolerant sporulating anaerobes such as C. difficile138,140, we 
predicted that complex microbial communities containing highly oxygen-sensitive non-
sporulating anaerobes might be able to be cultivated in the colonoid lumen. Indeed, 
computational models suggested a 10-fold decrease in oxygen concentration at the 
apical membrane of the organoid due to the oxygen-consumption rate of colon epithelial 
cells and known oxygen diffusion properties. New methods to prepare human fecal 
samples for microinjection were developed and validated to functionally test whether 
complex microbial communities would survive and persist in the colonoid lumen. 
Microinjection of fecal samples into the colonoid lumen demonstrated efficient fecal 
microbial transplantation based on similar relative abundance of taxa compared to the 
transplanted fecal sample. Additionally, the microbial communities persisted over a 4-
day period with relatively little change in relative composition. As a benchmark for 
‘functional anoxia’ of the colonoid lumen we mono-transplanted B. adolescentis, a highly 
oxygen-sensitive anaerobe, into the colonoid lumen and demonstrated growth and 
survival over a 4-day period. Together these findings strongly support the concept that 
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the environment of organoid lumen can serve as a suitable model to investigate many 
aspects of human fecal microbial communities.    
 Aside from the utility of this platform for study of the microbiome, our findings 
indicate that robust retention of cargos injected into the organoid lumen that will be 
useful for screening compounds and toxins that impair epithelial barrier function. Our 
high-content CVis applications demonstrate the ability to monitor retention of membrane 
impermeable compounds in hundreds or thousands of organoids using time-lapse 
imaging. A pioneering study using hiPSC-derived organoids to study barrier function 
demonstrated that C. difficile toxins disrupted the epithelial barrier resulting in a loss of 
fluorescent membrane impermeable probe134. While these studies and our findings 
indicate that retention of membrane impermeable probes are useful for measuring 
epithelial membrane integrity, our results indicate that the fluorescent signal should be 
normalized to the organoid growth volume to account for loss of signal that could be 
misinterpreted as a leaky epithelial barrier.  
 Organoids are not all created equal. Studies at the single organoid level 
demonstrate large variations in cell lineage composition, gene expression, and function 
of transporters107,150. In a previous study we isolated 96 organoids at different stages of 
ontogeny and demonstrated that while there was a stereotypical pattern of lineage gene 
expression at early organoid development, mature organoids exhibited highly variable 
gene expression consistent with heterogeneous ratios of cell lineages within the 
organoid114. Functional heterogeneity in organoids has also been shown in high-
throughput analysis of single organoids using a swelling assay, which is commonly used 
to assess function of the Cystic Fibrosis Transmembrane Conductance Receptor150,151. 
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Interestingly, at the single organoid level, two categories of organoids were observed; 
responders to forskolin-induced swelling, and non-responders. And even within each of 
these populations substantial variation in swelling dynamics was documented. These 
findings highlight the importance of designing organoid experiments with sufficient 
biological and technical replicates to provide adequate statistical power. Our 
microinjection and CVis platform currently enables microinjection of ~90 organoids per 
hour with subsequent automated time-lapse monitoring of injected cargos. Since the 
organoids are injected in a physiologic chamber, data can be collected continuously 
over several days, or the CRAs can be returned to the conventional incubator and data 
can be sampled by returning the CRA to the automated stage for data sampling at 
specified time points. While this throughput is likely adequate for most experiments, the 
data indicate that optimum throughput can be achieved by culturing organoids to a point 
that the cross-sectional area is >18,000µm. Further optimization of automated needle 
positioning in the center of the organoid, and z-plane articulation during the puncture 
sequence are predicted to substantially increase microinjection throughput.  
 The ability to efficiently and reproducibly introduce a variety of cargos into the 
organoid lumen is a significant methodological advance that will be useful to investigate 
a broad range of topics related to luminal-epithelial physiology, such as barrier function, 
nutrient absorption, drug transport and metabolism, and the impact of dietary 
compounds or pharmaceuticals on stem cell maintenance and differentiation. While this 
study focused on analysis of bacterial communities, our system could be easily adapted 
to studies focused on the fungi, parasites, and viruses that impact human GI health.  
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Methods 
Automated Imaging System 
Microinjection hardware was fitted within a Precision Plastics (USA) enclosure 
mounted on an Olympus IX81 (Japan) inverted microscope outfitted with a ProScan 
(Prior, UK) automated stage and controller. Images were acquired by an ORCA-03G 
(Hamamatsu, Japan) high-speed camera at parameters controlled through a HF204 or 
HF202 (Prior, UK) automated shutters and a HF108IX3 (Prior, UK) filter wheel. The 
system was controlled using custom image acquisition software (MathWorks, USA) and 
MicroManager (Vale Lab, UCSF)152. 
Microinjection Hardware Custom Fittings 
Custom adaptors were 3D-printed to house a commercially available MM-89 
(Narashigi, Japan) motor-drive manipulator within the confines of a microscope 
mounted atmospheric regulating chamber. The physiologic chamber was necessary to 
preserve biological function of organoids during injection, high throughput, and time-
lapse imaging. A spacer was 3D-printed to increase the clearance between the rear wall 
of the chamber and the NO-PIX-3 (Narashigi, Japan) manipulator mounting bar. Pilot 
studies showed that pneumatically-driven microinjectors were best suited to remotely 
deliver nanoliter cargo loads within the chamber constraints. The Pico-spritzer III 
(Parker-Hannifan, USA) was suitable for use within the IX81 chamber with a low rate of 
valve malfunction occurrences, which can lead to pressure buildup and needle 
rupturing. A custom control arm was 3D-printed to orient the injection needle holder 
perpendicular to the MM-89 shaft collar and parallel to the stage, facilitating vertical 
needle articulation. A stage insert with a compression fitting was 3D-printed to hold 
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CellRaftTM Array (CRA) devices tightly and reduce stage position error when devices are 
moved in and out of the microinjection platform152. All CAD files for 3D-printed fittings 
are available in the online supplementary materials. 
Optimized Microinjection Needle Processing 
To generate microinjection needles tailored to organoid microinjection, 1 mm 
filament capillaries (World Precision Instruments, USA) were pulled to fine point using a 
P-2000 (Sutter,USA) laser-based micropipette puller at parameters modified from the 
standard “bee-stinger” needle production protocol to reduce the diameter of the needle 
point137. A 90o bend was formed in the needle body ~1.5 cm from the needle tip by 
heating the needle body with an open flame while horizontally suspended, allowing the 
bend to form by gravity. The needle pulling process produced microscopic defects that 
impaired efficient organoid microinjection. To remove the defects, the needle aperture 
was polished through 6 minutes of wet-etching in 5% hydrogen fluoride (HF). The 
needle tip was subsequently submerged in sodium bicarbonate to neutralize HF coating 
the needle tip. To prevent HF and sodium bicarbonate from traveling up the internal 
filament into the needle body and contaminating cargos, compressed air was fed into 
the needle body as the tip was submerged in all solutions.  
Colonoid culture and expansion 
Crypts were isolated from the colon of adult (10-16 week old) Wild type (WT) or 
CAG:DsRED (constitutively DsRED expressing) male mice reared on Bed-o’-cobs 
(Anderson’s Lab Bedding, USA) and fed a soy free, grain based diet (Envigo, USA) as 
described38. In brief, the whole colon was resected, flushed with cold PBS, opened 
longitudinally, and then treated with ‘isolation buffer130. After 90-minutes, whole crypts 
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were released from the tissue by gentle shaking then collected by centrifugation at 1000 
x g. Crypts were embedded in laminin rich Cultrex hydrogel (Corning, USA) at ~4 
crypts/μL. Colonoids were expanded in 50% L-WNR media and 50% ‘LCM’ media 
produced according established protocols with the minor modification of removing 
antibiotics during the conditioning phase to prevent carryover into organoid cultures153. 
In these studies, we utilized media shown to produce colonoids containing all of the 
native differentiated lineages153. For passaging, colonoids were dissociated into small 
cell aggregates by digesting in TrypLE (Gibco, USA) supplemented with 10 μM Y-27632 
(Selleck,USA) for 4-6 minutes. Cold serum (10% v/v) was added to the dissociated cells 
to quench enzymatic activity. For injection experiments, large aggregates were 
excluded prior to culture by passing dissociated colonoids through a 40μm filter. 
Organoids were grown for 72hr before injections were performed and sampled by 
168hrs to prevent overgrowth that could compromise luminal integrity. Aggregate 
concentration was visually quantified (fragments/volume) by microscopy. All protocols 
for animal use were reviewed and approved by the University of North Carolina 
Institutional Animal Care and Use Committee. 
Plating Colonoids on CRA devices 
Colonoid fragments were added to CRA reservoirs at 1.5 fragments per raft in L-
WNR culture media and centrifuged at 51 x g for 5 min at 4oC to deposit fragments on 
the rafts. Following centrifugation, the culture media was gently aspirated so not to 
disrupt fragments, and 150μL of Cultrex (Trevigen, USA) was added per cm2 of array 
surface. A second centrifugation for 5 min at 51 x g was used to ensure hydrogel 
embedded fragments were deposited at the bottom of the raft. The hydrogel was 
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allowed to polymerize at 37oC for 30 min before 200 μl of L-WNR culture media 
supplemented with 10 μM Y-27632 was added per cm2 of array surface. Media was 
exchanged every 72-hours154. Y-27632 was only included in the media at initial plating. 
Colonoids were grown until they occupied ~80% of each raft (typically 72-hours after 
plating) prior to injection assays. 
Computer Vision Identification of Organoids 
Organoids were cultured on CRAs (Cell Microsystems, USA), which are 
microculture devices that contain ~15,000 wells in a 2.0 cm2 footprint114,155. Organoids 
were passaged and dissociated to small fragments, which were plated on CRAs such 
that there was a density of ~1 organoid/well. When organoids had grown to a point they 
exhibited a defined luminal space (~3 days), the entire CRA was tile-imaged using a 
MATLAB automated imaging script, which operated the MMCore API component of the 
open-source MicroManager (Vale Lab, UCSF) automated microscope controller152. 
Autofocus was used to correct for variations in the flatness of the CRAs. To determine 
whether an organoid suitable for injection was contained on a raft, individual images of 
each raft were evaluated by a novel CVis algorithm, OrganoidMorph (see supplemental 
files). The OrganoidMorph image analysis pipeline was developed in the open-source 
computational image analysis platform CellProfiler139. OrganoidMorph identifies the 
contents in each raft using a Gaussian mixture model that identifies positive from 
negative pixels156. This creates a binary image mask of the fluorescent signal. The size 
and shape of the mask is then filtered using threshold cut-offs that are consistent with 
organoid morphology (schematized in Fig. 7H). The location of organoids that passed 
the OrganoidMorph filtering algorithm was automatically logged so that it could be easily 
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returned to for microinjection. The luminal compartment was identified by inverting the 
signal within the colonoid area and segmenting by Otsu thresholding (Supplemental 
Software: OrganoidMorph.cpproj).  
Computer Vision Quantification of Injected Cargos 
To identify the fluorescent cargos that were microinjected into the organoid 
lumen, images were analyzed by CVis (Supplemental Software: OrganoidCargo.cpproj). 
Specifically, the fluorescent signal area of each image was identified by Otsu 
thresholding, which is a computational method that decides positive and negative 
pixels157. Masks were generated from the positive fluorescent signal and the area and 
mean pixel intensity within the mask was measured. These values (intensity x area) 
were normalized to t = initial values for each organoid, and integrated (mean intensity x 
area) to account for volumetric changes. 
Assessing Efficiency of Microinjection Device 
Efficiency of the platform was assessed by targeting dsRED colonoids of various 
size and morphology for microinjection with 0.4nL ±0.8% of 70kDA fluorescein 
conjugated dextran (Thermofisher, USA). Colonoids were grown for 72-hours on a CRA 
device and identified using the OrganoidMorph pipeline. 500 identified colonoids were 
randomly targeted and microinjection was attempted with the duration of each attempt 
recorded. microinjection success was assessed by fluorescent microscopy and 
recorded immediately following each attempt. Microinjection success and duration was 
related to colonoid size and monolayer width post-hoc based on the CRA address of 
colonoids targeted for microinjection. 
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Retrieving Bacteria from the Organoid Lumen 
Live microbes were retrieved from the colonoid lumen by passing intact 
organoids through a 30-gauge needle (BD biosciences, USA), disrupting the 
surrounding monolayer. Whole colonoids were retrieved from culture platforms by 
pipetting and suspended in sterile DPBS (Gibco, USA) before loading into a standard 
syringe (BD biosciences, USA). Organoids transplanted with anaerobic species were 
suspended in anoxic DPBS intact and transferred into an anaerobic chamber (COY, 
USA) prior to passage through a 30-gauge needle. 
Bacterial Cultivation 
Aerobic bacteria strains Aerobic bacteria strains (Escherichia coli NC101 and 
Yersinia pseudotuberculosis YPIII) were cultivated in Luria broth shaken at 240 rpm or 
on broth agar plates. E. coli NC101 transformed with pEGFP was grown at 37oC in 
medium containing 10mg/ml carbenicillin. E. coli NC101 transformed with pRZT3 was 
grown at 37oC in medium containing 10mg/ml tetracycline. Y. pseudotuberculosis YPIII 
containing the PfrdA::gfp vector was grown at 30oC on media supplemented with 20% 
tryptone and 10mg/mL chloramphenicol. Bifidobacterium adolescentis was isolated from 
the stool of a healthy patient (NCBI: BioProject ID PRJNA291486). The strain was 
maintained in anaerobic conditions until the time of injection46. B. adolescentis was 
grown from frozen glycerol stocks (-80°C) in oxygen depleted MRS broth supplemented 
with 0.2% cysteine overnight in an anaerobic chamber (5% CO2, 10% H2, 85% N2) at 
37°C without agitation. Fecal microbiota communities were processed or retrieved from 
the organoid lumen in an anaerobic chamber, plated on MRS medium and incubated in 
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the anaerobic chamber (5% CO2, 10% H2, 85% N2) at 37°C, or were cultured 
aerobically at 37oC. 
High Resolution Imaging of Microinjected Colonoids 
GFP expressing E. coli NC101 was grown to stationary phase (overnight) before 
~1,500 CFUs were injected into 5 CAG:DsRED colonoinds grown on 50mm tissue 
culture dishes. Colonoids were fixed 2 hours following injections with 4.0% 
paraformaldehyde before injected E. coli was observed within the colonoid lumen using 
an Olympus FV1000MPE upright confocal microscope. A 20X/1.00W immersion 
objective was used to collect 1024x1024 pixel Z-stacks at 2.0 μm intervals through each 
organoid with sequential detection of E. coli (GFP), colonoid epithelium (DsRED) and 
non-specific debris (DAPI) with Kalman averaging of 2-4X line scans. Detector and laser 
setting were adjusted to account for signal attenuation due to variable colonoid size and 
imaging depth. ImageJ was used to adjust brightness and contrast for optimal 
visualization158. 
Mock Community Response to Media Antimicrobials 
WT colonoids were grown for 72 hours on a CRA device separated into 4 
discrete media chambers. Chambers were treated with either chloramphenicol, 
tetracycline, both antibiotics, or no antibiotics. Broth monocultures of E. coli K12 
expressing DsRED and Y. pseudotuberculosis expressing EGFP were grown to 
stationary phase (overnight for E.coli, 48 hours for Y. pseudotuberculosis). Equal 
volumes of stationary phase cultures were mixed, diluted in LB to 20%, and washed 
repeatedly in LB by centrifugation at 18,000 x g for 15 minutes to remove residual 
antibiotics. 20 μl of the mixed sample were loaded into injection needles and transferred 
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to the injection apparatus. Injection droplets were collected in sterile media and plated 
on selective LB agar plates to measure microbial cargo load before targeting colonoids 
greater than 100μm in diameter for microinjection. Following injections additional 
injection droplets were collected in sterile media and plated on LB agar plates to ensure 
similar microbial cargo loads were delivered during the injection process. 2-hours 
following injection, successfully injected organoids were retrieved from each condition 
and luminal contents were cultured to assess transplant efficiency. The remaining 
colonoids were fluorescently imaged at 30-minute intervals for 24 hours before retrieval 
and luminal contents were cultured to assess microbial growth. As controls for antibiotic 
activity, 10 µL samples of the organoid culture media from each condition collected 2 
hours, 24 hours, and 48 hours following injections were collected and used to seed 
conventional broth cultures treated with tetracycline or chloramphenicol.  
Relating Fluorescent Signal to Microbial Load 
Colonoids were injected with increasing loads of fluorescent inert and microbial 
cargos and imaged before sampling the luminal contents. WT colonoids were grown is 
the presence of tetracycline for 72 hours in conventional culture devices allowing larger 
colonoids to be cultivated. E. coli K12 expressing DsRED and E. coli NC101 expressing 
EGFP were grown to stationary phase (overnight) in LB  containing tetracycline. Equal 
volumes of stationary phase cultures were mixed, diluted in LB to 20%, and washed 
repeatedly in LB by centrifugation at 18,000g for 15 minutes to remove residual 
antibiotics. The washed microbial sample was diluted to 50% in 70kDA Alexa Fluor 647 
conjugated dextran (Thermofisher, USA). 20 μl of the mixed sample were loaded into 
injection needles and transferred to the injection apparatus before 12 organoids were 
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targeted for microinjection at 4 different durations (24ms, 48ms, 72ms, 96ms). All 
injected organoids were imaged before 6 organoids from  each microinjection duration 
were collected and luminal contents were cultured to assess the delivered microbial 
load. The remaining colonoids were fluorescently imaged at 30-minute intervals for 24 
hours before retrieval and luminal contents were cultured to assess microbial growth.   
Stool Sample Preparation 
 A stool sample (100 µl) from a healthy human host (UNC IRB:15-2133) was 
homogenized in sterile, anoxic PBS (1.0 ml) inside the confines of an anaerobic 
chamber. The homogenized stool sample was then subject to differential centrifugation 
(5 minutes at 1000 x g), filtration through 5.0 μm syringe filters (Millipore, filter #1), (GE, 
filter #2), or left unprocessed. Samples (100 μl) were stored at -80°C until subjected to 
DNA isolation and 16S rRNA gene amplicon sequencing (see below).  
Colonoid Fecal Microbiota Transplantation 
A homogenized healthy donor stool sample was processed using a 5.0 μm 
Millipore syringe filter and loaded into injection needles in anaerobic conditions. Needles 
were immediately transferred to the injection apparatus and tested to verify reproducible 
cargo delivery prior to targeting a single colonoid in individual wells of a 96-well plate for 
injection. Colonoid injections that were off-target or showed observable leakage were 
used as controls, and wells with a single successful injection were sampled to assess 
microbial colonization by 16S rRNA gene amplicon sequencing and culturing. Colonoid 
injections were completed within an hour of removing needles from the anaerobic 
chamber. Retrieved fecal microbial communities were split by volume and cultured 
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anaerobically and aerobically on MRS broth agar plates to determine colonoid microbial 
load.  
DNA Isolation 
DNA from stool samples was isolated using a DNeasy kit (Qiagen, USA) as 
directed. DNA from microbe-associated colonoids was subject to the Qiagen DNeasy kit 
protocol with an additional 5-minute bead-beating step at room temperature to facilitate 
separation of bacteria from colonoids and improve cell lysis. Isolated DNA was subject 
to spectrophotometric quantification via NanoDrop™ (Thermo Fisher), assessing both 
quantity (ABS260nm) and purity (260/280nm ratio). 
16S rRNA Gene amplicon sequencing 
Total DNA (12.5 ng per sample) was amplified using primers consisting of the 
locus-specific sequences targeting the V3-V4 region of the bacterial 16S rRNA gene48. 
Primer sequences contained overhang adapters appended to the 5’ end of each primer 
for compatibility with Illumina sequencing platform. Complete primer sequences: 
(F) 5’-
TCGTCGGCAG:CGTCAGATGTGTATAAGAGACAGGTGCCAGCMGCCGCGGTAA-3’ 
(R) 5’-
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGACTACHVGGGTWTCTAAT-
3’. 
PCR reaction mixes contained 12.5 ng of total DNA, 0.2 µM of each primer and 
2x KAPA HiFi HotStart ReadyMix (KAPA Biosystems, USA). The thermal profile for the 
amplification of each sample had an initial denaturing step at 95°C for 3 minutes, 
followed by 28 cycles of denaturing of 95°C for 30 seconds, annealing at 62°C for 30 
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seconds and a 30 second extension at 72°C. Post cycling, a 5 minutes extension at 
72°C was performed, and a final hold at 4°C. Each 16S rRNA gene amplicon was 
purified using the AMPure XP reagent (Beckman Coulter, USA). Illumina dual-index 
barcodes (index 1(i7) and index 2(i5)) (Illumina, USA) were added to each amplicon 
target using a limited cycle PCR program. The thermal profile for the amplification of 
each sample had an initial denaturing step at 95°C for 3 minutes, followed by a 
denaturing cycle of 95°C for 30 seconds, annealing at 55°C for 30 seconds and a 30 
second extension at 72°C (8 cycles), a 5 minutes extension at 72°C and a final hold at 
4°C. The final libraries were again purified using the AMPure XP reagent (Beckman 
Coulter), quantified via Quant-IT™ PicoGreen® dsDNA Assay Kit (Thermo Fisher) and 
normalized prior to pooling. The DNA library pool was then denatured with NaOH, 
diluted with hybridization buffer and heat denatured before loading on the MiSeq 
reagent cartridge (Illumina) and on the MiSeq instrument (Illumina). Automated cluster 
generation and paired–end sequencing with dual reads were performed according to 
the manufacturer’s instructions. 
Sequencing data analysis 
Multiplexed paired-end fastq files were produced from the sequencing results of 
the Illumina MiSeq using the Illumina software configureBclToFastq. The paired-end 
fastqs were joined into a single multiplexed, single-end fastq using the software tool 
fastq-join. Demultiplexing and quality filtering was performed on the joined results. 
Quality analysis reports were produced using the FastQC software. Bioinformatics 
analysis of bacterial 16S amplicon sequencing data was conducted using the 
Quantitative Insights Into Microbial Ecology (QIIME) software159. OTU picking was 
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performed on the quality-filtered results using pick_de_novo_otus.py. Chimeric 
sequences were detected and removed using ChimeraSlayer. Alpha diversity and beta 
diversity analysis were performed on the data set using the QIIME routines: 
alpha_rarefaction.py and beta_diversity_through_plots.py160,161. Summary reports of 
taxonomic assignment by sample and all categories were produced using QIIME 
summarize_taxa_through_plots.py and summarize_otu_by_cat.py.  
Colonoid Anaerobe Monoculture Assay 
B. adolescentis cultured until the cells reached late-log growth (OD600 nm = 
~0.6) before loading injection needles with 20 μl of culture inside an anaerobic chamber. 
Loaded needles were immediately transferred to the microinjection apparatus and 
tested to verify reproducible cargo delivery prior to targeting a single colonoid in 
individual wells of a 96-well plate for injection. Colonoid injections that were off target or 
showed observable leakage were used as controls while wells with a single successful 
injection were sampled over 60-hours and subjected to qPCR targeting the B. 
adolescentis 16S rRNA gene and cultured in MRS broth access B. adolescentis growth 
and validate activity organoids. 
Statistics 
Normalcy of colonoid morphology was assessed by D'Agostino-Pearson and 
Shapiro-Wilk normality tests. Monolayer width and cross-sectional area of 1827 
colonoids grown on 3 CRA devices and quantified by OrganoidMorph did not 
demonstrate a normal distribution by either test at an alpha level of 0.05. Colony counts 
from agar plates were compared by the Tukey-Kramer method with an alpha level of 
0.05. Droplet volumes were compared between needles by Tukey-Kramer method at an 
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alpha level of 0.05. No statistical method was used to predetermine sample size and 
experiments were non-randomized. All analyses were performed using GraphPad Prism 
7 ( GraphPad Software, USA). 
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Figures 
 
Limitation of Organoid Technology Possible Solution(s) 
Lack of cell types/ tissue layers normally 
interacting with the of stem cell niche. 
Incorporate other cell types with organoid cultures 
for co-culture systems 
Absence of microbial populations limit modelling 
of host-microbe interactions 
 
Complement with organotypic culture systems 
with microbiota culture and characterization 
technologies. 
Lack of in vivo growth factor/ signaling gradients in 
three-dimensional culture 
Generate ligand concentration gradients using 
microfluidic technologies  
Lack of biomechanical ques present in the 
intestinal environment 
Vary physical attributes culture hydrogel such as 
composition, porosity and stiffness 
Organoids are highly heterogeneous in viability, 
size, shape, and cellular composition impeding 
phenotype screens 
Organoids can be tracked individually using 
microfabricated devices facilitating high 
throughput imaging 
Organoids develop as enclosed spheres limiting 
access to the enclosed apical lumen 
 
1) Spherical organoid monolayers can be opened 
into more planer monolayers exposing the apical 
membrane, enabling direct manipulations 
2) Material can be specifically delivered to the 
enclosed organoid lumen using microinjection 
technologies  
 
Table 1: Factors limiting the use of organoid technologies. 
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Figure 1. Modified CRAs are compatible with long-term culture of primary IESCs.  
(A) CRAs consist of polystyrene ‘raft’-lined PDMS microwells mounted to a glass slide 
with a thin layer of PAA, and attached to a cassette containing media chambers. (B) 
Cassettes can be scaled to divide a single CRA into 2 or 4 separate media reservoirs. 
(C) Microwells are 200 μm2, arranged in a grid, with the physical addresses stamped 
into the PDMS at 5-well intervals. Scale bar represents 600 μm. (D) IESCs are isolated 
from Sox9EGFP :CAGDsRed transgenic mice, which express DsRed throughout the 
intestinal epithelium. Scale bars represent 50 μm. (E) Isolated cells are seeded into 
microwells through centrifugation in media, and then overlaid with Matrigel. (F-H) IESCs 
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are randomly distributed across arrays immediately after plating (F), with some 
microwells containing single IESCs (g, arrow), and others containing multiple IESCs (H, 
arrowhead). (I-K) Imaging of the same array at 48 hr reveals widespread organoid 
formation (i), with typical cystic growth of early structures (J,K). Scale bars for f–k 
represent 600 μm. (l,m) Long-term culture experiments demonstrate that developed 
IESCs grow out from their original microwells over the course of 4 weeks (l; black 
arrowhead indicates well address corresponding with CRA position; white arrowhead 
indicates organoid at 120 hrs), and can be sustained in the array format for 8 weeks or 
longer (m; upper two wells are empty in this image). Scale bars represent 200 μm. 
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Figure 2. Retrieval of magnetic rafts for downstream gene expression analysis. 
(A) Raft retrieval. A device containing a fine needle positioned in the center of a clear 
plexiglass window was fitted onto a 10X objective lens. Z-plane focus was used to 
puncture the bottom of the PDMS liberating the raft. A magnetic wand was used to 
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collect the magnetic raft. (B) The magnetic wand facilitates efficient retrieval of magnetic 
rafts (note red magnetic raft on tip of wand). (C) The raft is liberated from the magnetic 
wand when placed in a 96-well format dish that is positioned over a stronger magnet 
place on ice. (D) Time lapse image of raft retrieval (frame 1-4). The raft with organoid 
depicted in frame 1 was captured by magnetic wand and placed in PBS (frame 5). 
Enteroid was efficiently lysed in RNA lysis buffer prior to cDNA syndissertation (frame 
6). (E) A large well-developed organoid was identified in the CRA and retrieved using 
the magnetic wand. (F) Matrigel anchors the large organoid to the magnetic raft for 
efficient capture. (G) Rafts and associated images can be ordered in a conventional 96-
well format for indexing and retrospective analysis. Scale bars represent 100μm 
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Figure 3. Software-assisted post hoc analysis identifies initial well contents of 
CRA culture.  
(A) A defined workflow facilitates post hoc image analysis to identify well contents in 
CRA cultures. (B) Tile-scanned images are stitched together to form a single composite 
image, which is then segmented into individual microwell images, each with a unique 
address corresponding to its physical position in the array. Scale bars represent 100 
μm. (C) Visual examination of individual microwells reveals the presence of debris and 
fluorescent glare as well as IESCs. Scale bars represent 50 μm. (D-F) To distinguish 
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between true IESCs and debris/noise, visually scored wells were analysed by 
CellProfiler to determine the distribution profiles of target events (IESC, blue) and debris 
(red) for the variables compactness, form factor and eccentricity. (G) A new CellProfiler 
pipeline that identifies objects and applies filters based on the size and shape profiles of 
known IESCs is used to analyze segmented microwell images. If the number of objects 
initially identified by CellProfiler is equal to those that pass filtering parameters, the 
microwell passes inclusion criteria (G, top microwell), otherwise it is excluded as debris 
containing or empty (G, middle and bottom microwells). Scale bars represent 50 μm. 
(H,I) Application of the optimized pipeline to randomly selected microwell images 
reveals an overall accuracy of 99.87%, 71.53%, 46.51% and 29.03% for wells 
containing 1, 2, 3 and 4 IESCs, respectively (n= 2,254 randomly selected microwells). 
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Figure 4. Cell-to-cell contact is required for PC-influenced survival of IESCs in 
vitro.  
(A) PCs are isolated from Sox9EGFP :CAGDsRed mice and co-cultured with IESCs from 
Sox9EGFP or Lgr5EGFP mice lacking the constitutive DsRed transgene, allowing for 
independent tracking of IESC and PC growth in CRAs. (B,C) Quantification of organoid 
formation across 15 combinations of IESCs and PCs in experiments using IESCs 
isolated on the basis of Sox9 and Lgr5 biomarker expression demonstrates no 
significant increase in organoid formation at 120 hr associated with any one condition. 
Furthermore, we were unable to identify any clear trends between PC number and 
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organoid development by IESCs (conditional logistic regression, n= 816 microwells). (D) 
Analysis of overall organoid formation by IESCs alone and IESC–PC co-cultures, 
regardless of cell number per microwell, also fails to produce a significant effect 
associated with PC presence (conditional logistic regression, n= 816 microwells). (E) As 
all data were analysed post hoc from existing images, we were able to test the 
alternative hypodissertation that cell–cell contact is required for PCs to have a niche 
effect in vitro. (F,G) Interestingly, when we grouped initial well contents by whether or 
not IESCs were in contact with other IESCs or PCs at t=0 hrs, we found that IESC–PCs 
in direct contact were more likely to form organoids than IESCs alone (conditional 
logistic regression, P=0.0282, n=5,672 microwells). Single PCs and PC–PC doublets 
did not form organoids and were excluded from statistical analysis. Data are derived 
from experiments conducted in replicate for each IESC biomarker. Cell-to-cell contact 
data are pooled from 8 independent CRAs from 4 Sox9EGFP and Lgr5EGFP animals. All 
scale bars represent 50 μm. 
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Figure 5. Single cells do not form cell–cell contacts in microwells after initial 
plating.  
(A) Initial (d0) and 24 hr (d24) distances were measured from the centers of non-touching 
cells to determine positive or negative changes in distance, normalized to the initial 
distance (d1). To examine the possibility that cell-cell signaling might be affecting 
relative cell movement, pairs were grouped and compared in 25 μm d0 increments. SC: 
stem cell; PC: Paneth cell. Scale bars represent 50 μm. (B) Number of non-touching 
pairs examined per distance. (C) Non-touching pairs of cells with a d0 value 25 μm 
demonstrate statistically significant movement away from one another, relative to d1 
associated with pairs having a d0 value >25 μm. d1 was calculated for pairs of fixed 
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cells (n=50) and compared with live cell movement to control for nonspecific changes in 
distance. Asterisks represent statistically significant movement, relative to fixed cells; 
error bars represent standard deviation. (unpaired t-test, P <0.05).  
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Figure 6. Robotically Articulated Colonoid Microinjection Maintains Atmospheric 
Control Facilitating Long-term Sampling of Large Batches of Colonoids:  
A) Organoids grown from adult stem cells in 3D-culture form complex monolayers 
organized around a hollow, mucus filled “lumen” cavity analogous to the colon lumen. B) 
3D-printed customized fittings were used to mount robotic microinjection hardware 
within an atmospheric imaging chamber of an automated imaging system. C) A 90o 
bend in the injection needle allows for vertical articulation of the microinjection needle 
minimizing hydrogel disruption and needle breaking during injections. D) Wet etching 
mechanically pulled borosilicate capillaries produces clean, fine aperture needles 
capable of injecting large batches of organoids without disturbing monolayer integrity. E) 
Computer vision made and measured the area of masks from images of the smallest 
droplets of fluorescent cargo delivered reproducibly by five replicate needles facilitating 
volume estimation. F) Optimized needles produce varying volumes at the same injection 
duration (black) but similar minimal volumes when the minimal duration reproducibly 
delivering cargo from each needle is used (blue). G) Organoid-microbe injections can 
be performed visually by locating an organoid of interest (1), aligning the needle to the 
organoid lumen (2), articulating the needle against the organoid monolayer distorting its 
appearance (3), puncturing the monolayer and injecting cargo (4), and retracting the 
needle from the organoid lumen (5) to visualize specific transplantation of DSRED 
expressing E. coli within the lumen (needle tip marked with *).  
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Figure 7. Increasing Microinjection Throughput Using Computer Vision to 
Quantify Cargo Retention, Organoid Morphology and Injection Success:  
A) Inert high molecular weight fluorescent cargos fill the organoid lumen with no signal 
observed in the adjacent areas. B) Inert cargos are retained long term as the organoid 
expands in size over 18 hours. C) CellProfiler computational image analysis pipelines 
were used to create masks of the fluorescent signal of images collected during the 18-
hour time course and quantified the area and mean intensity of the signal. D) The mean 
signal intensity observed from fluorescent inert cargos deceased over time to about half 
of the original intensity. E) The area of fluorescent signal doubled during the 18-hour 
time course as the organoid expanded in size. F) Integrated the fluorescent signal 
across the observed area shows relative stability suggesting that the inert cargo was 
retained within the organoid lumen. G) Culture protocols were optimized to grow 
organoids on 2.5 cm2 microfabricated culture array devices containing retrievable 200 
μm2 rafts separated by 50 μm walls regularly addressed to facilitate downstream 
sampling. H) Modified CellProfiler image cytometry pipelines can identify DsRED 
fluorescent organoids and automatically segment identified organoids of varying 
morphologies into lumen and epithelial monolayer compartments. I) Automated 
organoid identification was >95% accurate (n=1681 rafts) allowing for >96% accurate 
lumen identification. J) Organoid cross-sectional area exhibited a bimodal distribution 
with an average of 18511 ± 5916 µm2. K) Organoid monolayer width also exhibits a 
bimodal distribution with an average of 16.4 ± 9.3 µm. L) The area and morphology of 
500 DsRED expressing organoids was quantified before targeting each for 
microinjection with 0.36 nl of 7kD FITC-dextran solution, which could be observed 
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specifically within the lumen of successfully injected organoids with fluorescence signal 
observed outside the organoid of unsuccessful injections. M) Successfully injected 
organoids were larger (19642 ± 8970µm2) than unsuccessfully injected organoids (9142 
µm2 ± 8970 µm2). N) Organoids with wider monolayers were injected in shorter intervals 
(51.1 ± 35.6sec) than thinner organoids (74.1 ± 35.6 sec). O) Organoids larger than 
18,000 µm2 with monolayers > 15 µm wide were microinjected with the highest 
efficiency and accuracy with all targeted organoids of that range successfully 
microinjection in 39.1± 12.5 seconds. 
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Figure 8. The colonoid lumen forms a discrete compartment compatible with 
specific microbial growth:  
A) GFP expressing E. coli can be visualized after microinjection into DsRED expressing 
colonoids and appears to sit in the bottom of the lumen cavity in all colonoids observed. 
B) The effects of antibiotics in the colonoid culture media on lumen microbe 
compatibility was investigated using a CRA device to culture colonoids in 4 discrete 
reservoirs treated with tetracycline and/or chloramphenicol. Colonoids from each well 
were targeted for microinjection with a mixed microbial culture of DSRED expressing E. 
coli resistant to tetracycline and GFP expressing Y. pseudotuberculosis resistant to 
chloramphenicol. Injected colonoids were monitored over time by live fluorescent 
imaging before lumen contents were harvested to assess microbial growth by colony 
formation on conventional agar plates. C) Fluorescent signal from both microbes could 
be observed within the lumen of successfully injected colonoids during the entire time 
course. D) Antibiotics were essential for preventing off target growth by excess bacteria 
delivered to the media during microinjection with no active microbes discovered in 
culture media treated with chloramphenicol and tetracycline 24 hours after 
microinjection. E) Computational analysis shows an increase in integrated DsRED and 
EGFP fluorescence signal of raft images containing successfully injected colonoids 
suggesting an increase in DsRED and EGFP expressing microbes.  F) More E. coli and 
Y. pseudo colonies were recovered from the lumen of colonoids from all media 
conditions compared to the input injection droplet suggesting the colonoid lumen 
protected the injected microbes from chloramphenicol and tetracycline delivered in the 
culture media (n=10 colonoids in each condition). Significantly more colonies were 
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recovered from untreated colonoids correlating with increased integrated fluorescence 
signal. G) Fluorescent signal from both microbes as well as inert fluorescent cargo 
could be observed within the lumen of successfully injected colonoids during the entire 
time course. H) More K12 and NC101 colonies were recovered from colonoids collected 
24 hours following microinjection compared to those collected immediately following 
microinjection suggesting that both microbes grew regardless of the delivered load 
(n=5-6 colonoids from each injection duration). I) Computational analysis shows an 
increase in integrated DsRED and EGFP fluorescence signal in injected colonoids 
suggesting an increase in DsRED and EGFP expressing microbes. Computational 
analysis also showed stable integrated Alexa Fluor 647 signal suggesting that delivered 
dextran was well retained. J) The measured ratio of recovered NC101 colonies to 
integrated EGFP signal varied significantly between the 2 hour and 24 hour timepoints 
suggesting that integrated EGFP signal cannot be used to directly measure E. coli 
NC101-EGFP microbial load. K) The measured ratio of recovered K12 colonies to 
integrated EGFP signal varied significantly between the 2 hour and 24 hour timepoints 
suggesting that integrated EGFP signal cannot be used to directly measure E. coli-
DsRED microbial load. 
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Figure 9: Monolayer Respiration Makes the Colonoid Lumen a Hypoxic 
Environment Capable of Supporting the Growth of Anaerobic Enteric Microbes:  
A) COMSOL modeling of suggests the lumen of the average colonoid (left panel) is 
maintained in a state of hypoxia (right panel) due to respiration by the colonoid 
monolayer. B) Modeling suggests that O2 levels drop rapidly from the basal to the apical 
colonoid surface to about 10% of atmospheric O2 levels (180mM). C) Stool filtered using 
a 5 µm polyethylene glycol membrane (Filter #1) was compatible with microinjection 
needles and contained the majority of species present in the unfiltered or conventionally 
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processed (centrifuged) stool. D) Stool filtered using a 5 µm polyethylene glycol 
membrane (Filter #1) showed greater similarity to the unfiltered and conventionally 
processed stool than stool filtered using a 5 µm polypropylene membrane. E) Colonoid 
compatibility with human microbial populations was investigated by loading a filtered 
healthy human fecal sample into a microinjection needle under anaerobic conditions 
before 30 colonoids were microinjected with ~0.2 nl of filtered stool. Injected colonoids 
were harvested across a 96hr time course and assessed for growth by colony formation 
in anaerobic and aerobic conditions.  
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Figure . The Colonoid Lumen Is Compatible with Patient Derived Microbial 
Communities and Non-sporulating Anaerobes:  
A) Few colonies were recovered from colonoids retrieved 6hrs following 
microinjection grown under anaerobic or aerobic conditions, with increasing microbial 
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loads recovered over time. B) Significantly more anaerobic and aerobic colonies were 
recovered from injected colonoids 12 hours following microinjection with microbial loads 
peaking 72 hours following microinjection. C) 10 µL samples of the filtered stool 
collected and cultured under anaerobic conditions grew robustly as expected (top 
panel), while unsuccessfully and non-injected samples produced no colonies in either 
atmospheric condition (lower panels). D) The composition of the microbial communities 
changed quickly after injection but remained stable throughout the 96-hour time course 
with not significant shifts in 5 dominant phylum. E) No significant changes were 
observed in the number of species present in the microbial community following 
injection or incubation within the colonoid lumen. F) The even composition of the 
microbial community remained following injection and did not significantly change during 
the 96-hour time course. G) Bifidobacteria, a genus containing non-sporulating 
anaerobes and aerobes, were a minor member of the healthy stool sample and was 
detected at increased levels in the communities retrieved from colonoids. H) Colonoid 
microinjection compatibility with anaerobic non-sporulating microbes was verified by 
monoculture microinjection of Bifidobacteria adolescentis quantified by 16s qPCR and 
culturing. I) An increased abundance of B. adol was detected in successfully injected 
colonoids by targeted qPCR 6 hours following microinjection and was maintained for 48 
hours with no increase observed in unsuccessfully injected colonoids. Active B. adol 
was recovered specifically from successfully injected colonoids by anaerobic culturing 
throughout the 60-hour time course suggesting that increases in 16S abundance was 
due to growth within the colonoid lumen.
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Appendix A: In Vitro Polarization of Colonoids to Create an Intestinal Stem Cell 
Compartment 
Introduction  
Gradients of morphogens, differentiation factors and dietary metabolites are 
believed to participate in producing a polarized cellular architecture in the crypts of the 
colon and small intestine by regulating cell proliferation and position72,91,96,162. Within the 
crypt, the stem cells reside at the crypt base where they undergo self-renewal and 
produce proliferative transit amplifying (TA) progenitor cells. TA progenitor cells 
terminally differentiate and migrate up the long axis of the crypt to eventually populate 
the colonic epithelium with differentiated lineages: absorptive enterocytes, goblet cells, 
and enteroendocrine cells72. After cells reach the luminal surface, they undergo 
apoptosis but are replaced by a new generation of cells that maintain the functional 
absorption, secretion and barrier properties of the epithelium. Intestinal and colonic 
epithelial stem cells drive renewal of the epithelium every 4–7 days making it one of the 
most actively self-renewing tissue in the body163. It is believed that the orderly 
movement of cells along the crypt axis from the stem cell compartment to the luminal 
surface is orchestrated by both intrinsic and extrinsic signaling mechanisms involving 
gradients of mitogens and morphogens5,164. Crypt patterning is thought to be critically 
dependent upon the spatial organization of these signals with perturbations of key 
signaling pathways resulting in disrupted cell positioning and disordered epithelial 
renewal88,89,164,165. Despite established roles for certain factors in crypt patterning, less 
is known as to how discreet levels or gradients of a particular factor regulate crypt 
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morphogenesis166. Testing the impact of factor gradients such as Wnt-3a and R-
spondin1 on crypt patterning is technically challenging. Studies to date have relied on 
indirect readouts of gradients using gene and protein expression, and genetic 
engineering of signal transduction pathways87,93–96,167, but have fallen short of directly 
testing the influence of gradients on specific cell types. Recently developed culture 
methods permit the culture of primary colonic epithelial organoids (e.g. colonoids) that 
possess stem cell and differentiated cellular compartments and self-pattern into crypt 
units. This major advance in the field now provides a physiologically relevant culture 
model to test important mechanisms that rely on factor gradients57,101. Colonoid culture 
requires defined growth conditions that mimic the stem cell niche environment, which 
promotes stem cell self-renewal and also appropriate differentiation. Essentially, cells 
are suspended in a 3-D extracellularmatrix (MatrigelTM), which is rich in collagen and 
laminin similar to the colonic basal lamina propria57,101. The culture system is further 
supplemented with a mixture of factors includingWnt-3a, R-spondin1/2, Epidermal 
Growth Factor (EGF), Noggin, and Jagged to maintain stem cell multipotency and self-
renewal57,96,101.  When placed in these defined culture conditions, isolated crypts or 
individual stem cells develop into colonoids with multiple cryptlike buds projecting 
randomly outward a central lumen from 64. These buds have a vague resemblance to 
crypt architecture in vivo, and the colonoids often display a disorganized pattern of 
proliferating cells. The absence of properly formed crypts in the colonoids is likely due to 
the absence of factor gradients thought to be necessary to define appropriate cell-type 
locations. Conventional intestinal stem cell culture systems utilize standard tissue 
culture dishes which lack of spatial variation in concentrations of chemical factors have 
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hindered the ability to test the influence of fundamental, morphogenic cues in crypt 
homeostasis and cellular organization. Microfluidic culture systems, however, can 
readily sustain both simple and complex gradients over sustained times168–170. Some of 
these devices also possess the capability to chemically pattern the environment 
surrounding cells and tissues170, so that a device with gradient-forming capabilities can 
recreate a physiologically-relevant microenvironment for testing mechanistic 
hypotheses. Microfluidic devices incorporating gut-derived tumor cells or primary mouse 
intestinal cells have been described for a number of assays on epithelial cells; however, 
none have been utilized to replicate the complex 3-D architecture of the colonic 
crypt58,171,172. Efforts have been made to produce scaffolds with a 3-D architecture 
including crypt- like invaginations in an attempt to place tumor cells into the shape of an 
intestinal epithelial surface173–175. For the most part these studies have employed Caco-
2 cells, a tumor derived model gut epithelial cell line, as a surrogate for the intestinal 
epithelium. While simple to maintain in culture, this tumor cell line has little resemblance 
to normal epithelium in terms of growth factor response, gene expression and 
susceptibility to apoptosis making it a poor mimic of the in vivo condition176. One report 
used primary murine and human intestinal organoids within a Matrigel layer to promote 
growth on the surface of a scaffold, but neither the crypt morphology or polarity were 
recapitulated175.  
Recently our group described a microfluidic gradient device specifically 
developed for optimizing growth factor concentrations for the efficient culture of 
colonoids92. In this study colonoids were grown within a gradient-channel that exposed 
each colonoid to a distinct concentration of Wnt and/or R-spondin1 enabling the survey 
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of a wide range of factor concentrations. Colonoids at different ends of the factor 
gradient displayed distinct phenotypes, i.e. differentiated or stem/proliferative cells. 
However, no individual colonoid demonstrated polarized locations of proliferative and 
differentiated cellular compartments. The absence of cell segregation within a single 
colonoid was likely due to a shallow gradient imposed across each colonoid effectively 
placing the entire organoid within the same chemical environment. In the present work, 
we optimize a microengineered, gradient-forming device to create a steepWnt- 3a 
and/or R-spondin1 gradient across the length of a single colonoid exposing the cells 
within the same tissue subunit to different concentrations. The goal was to determine 
whether a simple, linear gradient of 1 or 2 factors was sufficient to produce polarization 
of proliferative and differentiated cellular compartments along a colonoid length. 
Materials and Methods  
Transgenic Mouse Models and Isolation of Colonic Crypts  
Crypts were isolated from either Sox9EGFP mice or Sox9EGFP-CAGDsRed 
mice (6–9 weeks old) using previously described methods92. The CAGDsRed mouse 
line ubiquitously expresses the red fluorescent protein DsRed under the control of a 
chicken beta-actin promoter (CAG). The Sox9EGFP mouse possessed the Sox9 
promoter controlling Sox9EGFP (enhanced green fluorescent protein) expression on a 
modified bacterial artificial chromosome13,115,177. Mice genetically engineered with this 
construct express Sox9EGFP in intestinal stem cells and TA cells13,115,177. Crypts were 
obtained from colons harvested from mice that were bred, handled and sacrificed under 
protocols approved by the University of North Carolina at Chapel Hill Institutional Animal 
Care and Use Committee (http://research.unc.edu/offices/iacuc/). The University of 
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North Carolina at Chapel Hill Institutional Animal Care and Use Committee approved 
the animal work described in this paper (approval #13–200). Prior to euthanasia, all 
mice are anesthetized with isoflurane followed by cervical dislocation to minimize any 
stress or pain. Single intestinal stem cells were obtained from crypts harvested from 
heterozygous Sox9- EGFP:CAGDsRED mice between 6 and 10 weeks of age by 
fluorescence-activated cell sorting (FACS) (S1 Methods). 115 
Colonoid Culture  
Culture media (CCM) was prepared as previously described92 and consisted of a 
mixture of advanced DMEM/F12 medium (Invitrogen), Wnt-3a (120 ng/mL) and R-
spondin1 (175 ng/mL) unless otherwise specified. CCM also contained Noggin (100 
ng/mL), EGF (50 ng/mL), Y27632 ROCK inhibitor (10 μM), NAC (1 mM), GlutaMAX 
(1×), HEPES (10 mM), penicillin (100 unit/mL), and streptomycin (100 μg/mL). Wnt-3A 
and R-spondin1 were prepared from conditioned medium as described previously or 
purchased purified from a supplier (R&D Systems, Minneapolis, MN). The CCM was 
prepared in a bulk volume of 500 mL, split into 6-mL aliquots, and stored at -80°C until 
use. For crypt culture, 100% Matrigel (Dow Corning, Midland, MI) was used. Crypts 
were isolated from the distal colon of a mouse as previously described 56,96,119,153–156. 
The crypts were pelleted by centrifugation at 300×G for 90 s. The supernatant was 
aspirated and the crypts were mixed with cold liquid Matrigel (100% in CCM, 4°C). A 1 
mL suspension of freshly isolated crypts (5000 crypts/mL) was added to standard 12-
well plates at 4°C. The Matrigel was then polymerized for 15 min at 37°C. After 
polymerization, 1.5 mL of CCM was overlaid onto the Matrigel. After 5 days in culture, 
colonoids were retrieved from the Matrigel using collagenase digestion (15 min, 37°C) 
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and then fragmented using trypsin/EDTA (2 min, 37°C in 0.02 mM trypsin and 0.48 mM 
EDTA). The slurry was pipetted vigorously for 30 s to break the colonoids into 
multicellular fragments. These colonoid fragments were then rinsed, counted and re-
embedded in Matrigel for culture in CCM. This process was repeated to grow colonoids 
in continuous culture as well as to prepare fragmented colonoids to load into the 
microdevice.3,89,117,118,150,153–157 
Diffusion-Based Gradient Generation and Characterization 
Devices were fabricated as described in S1 Methods. Gradient formation through 
the Matrigel layer on the device was characterized by imaging the movement of a 40 
kDa fluoresceinlabelled dextran (Sigma-Aldrich, St. Louis, MO) in 100% Matrigel by 
time-lapse imaging using an Olympus MVX10 Macroview microscope. Fluorescence 
images were acquired every 15 min over 24 h to measure gradient formation. The 
volume of the source and sink was 500 μL and that of the channel was 1.5 μL. Gradient 
formation over time was modeled using Fick’s Law:178 
 
where A is a constant, x ranges from 0 to 1 mm corresponding to the positions 
along the length of the channel, t is time, D is the diffusion coefficient, erfc is the 
complementary error function, and CO is the concentration of the species of interest 
loaded into the source. COMSOL Multiphysics with finite-element analysis (FEA) was 
used to model the data. For experiments applying gradients to colonoids, the media in 
both the source and sink were replaced every 24 h. 
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Culture of Colonic Cells in the Microchannel of the Gradient Device  
Before use, the device was sterilized with 70% ethanol and rinsed with 
phosphate buffered saline (PBS) ×5. The gradient-generating region of the device was 
pre-coated by incubation with 2% Matrigel in PBS for 6 h at 4°C and then rinsed with 
PBS ×3 prior to loading cells. This pre-coating step resulted in deposition of a thin 
Matrigel surface layer on the channel walls which improved subsequent cell/Matrigel 
loading into the gradient region and enhanced adhesion of the gelled plug to the device 
walls. Cells were mixed with cold liquid Matrigel (100% in CCM, 4°C) and loaded into 
the device’s gradient-generating region. The Matrigel plug was gelled by incubation at 
37°C for 15 min. Once the Matrigel solidified, CCM (500 μl) was immediately added to 
each reservoir. For experiments in which a gradient was formed, Wnt-3a and/ or R-
spondin1 were omitted from the CCM added to the sink as indicated in the text. 
Microscopy  
Colonoid formation and growth was monitored over time using a Nikon Eclipse 
TE2000-U microscope fitted with a Photometrics Cool SNAP HQ2 digital camera. 
Objective lenses used were 10× and 20× with numerical apertures of 0.30 and 0.55, 
respectively. Fluorescein-dextran diffusion in the microchannel was tracked by wide-
field imaging of the entire device using an OlympusMVX10Macroview fluorescence 
microscope with a 1.0×, 0.25 N.A. objective and 0.63× demagnification. Confocal 
images of gradient formation were obtained using a Zeiss CLSM710 Spectral Laser 
Scanning Microscope equipped with a 488 nm laser to excite fluorescein. 
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Immunofluorescence and EdU Assays  
Crypts isolated from a Sox9EGFP-only mouse were used for 
immunofluorescence staining to avoid interference from the DsRed fluorescence. For 
immunofluorescence staining, crypts or colonoids were fixed with 4% paraformaldehyde 
for 20 min, followed by permeabilization with 0.5% Triton X-100 (Thermo-Fisher, 
Waltham, MA) for 20 min. After rinsing ×3 with PBS containing 100 mM glycine, the 
sample was incubated in immunofluorescence wash (0.2% Triton X-100, 0.1% BSA, 
0.05% Tween-20, 7.7 mM NaN3 in PBS and 5% normal goat serum) for 90 min to block 
nonspecific binding. The polyclonal rabbit α-Muc2 primary antibody (1:200, Life 
Sciences) in immunofluorescence wash was then incubated with the sample for 12 h at 
4°C. Secondary antibody (α-rabbit-Cy3, 1:500, Life Sciences) in immunofluorescence 
wash was then incubated with the sample for 45 min. All nuclei were stained with 
Hoechst 33342 (10 μg/ mL in PBS) using a 30 min incubation. Microdevices were 
imaged by brightfield and fluorescence microscopy. An EdU-based assay was also 
used to identify cells undergoing active DNA syndissertation in S-phase of the cell cycle 
per manufacturer’s protocol (Life Technologies, product #10640). 
Colonoid Segmentation using DsRed or Hoechst 33342  
A custom script written in MATLAB (MathWorks; Natick, MA) was used to 
segment the colonoids by identifying DsRed or Hoechst 33342 positive pixels. 
Fluorescence images were filtered using a top hat filter with a disk-shaped structuring 
element to remove background fluorescence and uneven background illumination179–181. 
The images were then thresholded using minimum cross entropy thresholding180. In the 
resultant binary image, all interior holes within objects were filled and objects with a total 
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area less than 1000 μm2 were removed to generate a mask of the segmented colonoids 
(S1 Fig). Brightfield images were then used to remove large cellular debris by applying 
a Chan-Vese active contour to the brightfield image using the previously generated 
mask as an initialization179. Cellular debris was defined as objects that possessed 
brightfield segmentation boundaries that were 20% larger than the segmentation 
boundary obtained from the DsRed or Hoechst fluorescence suggesting an object 
consisting of noncellular or degrading cellular material. The area of each colonoid was 
determined and used as a proxy for the total number of cells within each colonoid.  
Measurement of the Percentage of Colonoids Positive for a Fluorophore 
Colonoids were identified and segmented as described above based on either 
DsRed or Hoescht 33342 fluorescence. The fluorescence images of the Sox9EGFP, 
Muc-2 immunofluorescence staining, or the EdU fluorophore were filtered to reduce 
background noise (top-hat filtering) and the fluorescence intensity of each pixel 
previously identified as being within the boundaries of a colonoid (using the DsRed or 
Hoescht 33342 mask) was summed. The number of pixels positive for EGFP, Muc-2 
immunofluorescence staining, or the EdU fluorophore was then quantified based on 
empirically set fluorescence intensity thresholds for these fluorophores (in comparison 
to control samples). Based on empiric observation, colonoids were marked as positive 
for Sox9EGFP, Muc-2 or EdU if 25%, 10%, or 25% of the pixels, respectively, in the 
colonoid were positive for the fluorophore.92 
Measurement of Sox9EGFP Polarization in a Colonoid 
Colonoids were segmented as described above. The DsRed mask obtained for 
the segmented colonoids was applied to the Sox9EGFP fluorescence image to identify 
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the colonoid boundaries in the Sox9EGFP image. Sox9EGFP fluorescence intensity 
was then divided by DsRed intensity for each pixel. This acted to normalize the 
Sox9EGFP fluorescence with respect to the cell number in different regions of the 
colonoid. Each colonoid was then cropped from the resultant image. Within each 
cropped image, the mean intensity of a 20-μm horizontal slice through the center of the 
colonoid was calculated to generate an intensity profile along the center of the colonoid. 
The cropped image was rotated by 1 degree about the centroid of the bounding box of 
the colonoid using nearest neighbor interpolation and the mean intensity of a 20-μm 
horizontal slice through the center of the colonoid was again calculated. This was 
repeated for 180 degrees of rotation. A linear fit was performed on each intensity profile 
to obtain the slope of that profile. The rotated image that produced the largest absolute 
value of the slope was identified. The angle of the rotated image and sign of the slope 
determined the direction of colonoid polarization. The absolute value of the slope of the 
linear fit was used as the magnitude of the polarization (S2 and S3 Figs). 
Measurement of EdU Polarization in a Colonoid 
Colonoids were segmented based on Hoechst 33342 and the EdU image divided 
by the Hoechst 33342 image as described above for Sox9EGFP and DsRed. This acted 
to normalize the EdU fluorescence with respect to the cell number in different regions of 
the colonoid. Each colonoid was then cropped from the resultant image. Since a 
minority of cells stained with EdU, the EdU fluorescence exhibited a punctate 
distribution in images (unlike Sox9EGFP fluorescence). For this reason the polarization 
measurements were altered for the EdU-based measurements. For each segmented 
colonoid, the Hoechst 33342 geographic centroid and the EdU intensityweighted 
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centroid were identified. The angle of the vector between the two points was used as 
the angle of polarization. The magnitude of the vector was normalized to the total length 
of the colonoid (length along the axis of polarization) (S4 Fig). For EdU polarization 
measurements, the axes were defined as described for the Sox9EGFP polarization 
measurements. 
Statistics 
Boxplots were used to represent the non-normal distribution of colonoid area and 
Sox9EGFP fluorescence intensity of the developing colonoids182. Within the boxplots, 
stars represented the mean, a bar represented the median, and the upper and lower 
boxes showed the 75% and 25% percentile of the data, respectively. The whiskers 
extended to the 5th and 95th percentile with outlying data shown as individual points. 
The data are presented in the text as medians, first- and third-quartile values for 
colonoid DsRed area and colonoid Sox9EGFP fluorescence intensity within the regions. 
For statistical comparison, the data were converted to a normal distribution using a 
logarithmic transform and then assessed using Q-Q plots for their fit to a normal 
distribution. The adjusted coefficient of determination (R2) values for the Q-Q plots was 
always 0.91. Statistical differences between data were identified using a Holm-Sidak t 
test in the analysis of variance183. Data are also presented as average ± standard 
deviation where appropriate, with the compass plot data being represented as the 
standard deviation. Propagation of uncertainty using the standard deviation was used to 
calculate the variation in the Sox9EGFP/EdU polarization angle and magnitude. Once 
this was found, statistical differences in the compass plot data were assessed using a 
Holm-Sidek t-test to determine whether the differences in polarization directions of 
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colonoids grown in the presence of specific gradients was statistically significant184. 
Similarly, a Holm-Sidek t-test was used to examine the statistical differences between 
the percentages of colonoids possessing stem/TA cells (Sox9- EGFP), goblet cells 
(Muc2+) and actively proliferating cells (EdU+) in colonoids cultured in the microchannel 
and the multiwell plate (S5 Fig). For all statistical analyses, a p-value less than 0.05 was 
considered to be significant. 
Results and Discussion 
Design and Characterization of Gradient-Microdevice 
Poly(dimethylsiloxane) (PDMS) was selected as the material of choice for the 
device as PDMS is gas permeable and compatible with colonic stem cell culture92,185. 
Devices formed from PDMS are also readily fabricated using soft lithography186. The 
device incorporated a central microchannel (1×5×0.3 mm with a volume of 1.5 μL) 
across which a linear gradient (1 mm in length) was formed between two large fluid 
reservoirs. The two fluid reservoirs (16×16×5 mm with a volume of 1.3 mL) were placed 
to either side of the microchannel and served as a source or sink (Fig 1A and 1B and 
S6 Fig). Matrigel was loaded into the central channel via a small inlet and outlet port 
(1.5 mm diameter) at the ends of the microchannel. An array of hexagonal posts (250 
μm height, 6 μm face and 50 μm inter-post spacing) bounded the sides of the gradient- 
generating region and acted to localize Matrigel to the central microchannel via surface 
tension forces. Every third post was labelled with a number permitting the channel 
location to be reproducibly identified over time during microscopy. The diffusion of 
fluorescein-labeled dextran (40 kDa) was used to characterize the time evolution and 
stability of a gradient formed across the 1-mm width of the Matrigel-filled microchannel. 
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Fluorescein-dextran was loaded into the source reservoir and the microchannel was 
imaged over time. By 1 h, a gradient of fluorescence had begun to form across the 
microchannel decreasing linearly from the concentration in the source to that in the sink. 
When the temporal evolution of the fluorescence intensity was fit to Fick’s Second Law 
of Diffusion, a diffusion coefficient of 7.2 ± 0.6 × 10−11 m2/sec (n = 3 devices) was 
calculated for the fluorescein- dextran which was similar to that measured by other 
investigators for the 42-kDa protein vascular epithelial growth factor in Matrigel (7.0 × 
10−11 m2/sec) (S7 and S8 Figs)187,188. To maintain the linear gradient over long time 
scales (5 days), the source and sink solutions were replaced every 24 h. Modeling the 
device and solution changes suggested that once a gradient was established, the 
concentration of a 40 kDa analyte across the microchannel varied by no more than 
0.9% over a 5 day period (S9 Fig). The daily reservoir refreshment combined with the 
870× volume of the source and sink reservoirs relative to that of the gradient-forming 
microchannel enabled the source and sink reservoirs to behave as infinite 
compartments and permit formation of a time-invariant molecular gradient189. Similar 
gradient strategies have been employed successfully by others. These data also 
suggest that stable, linear gradients of Wnt-3a (39.7 kDa) and R-spondin1 (40.0 kDa) 
could be formed across the Matrigelfilled microchannel.189,190 
Microchannel devices support colonoid development similar to conventional 
cultures  
 Colonoid growth in a standard format (12-well plate) was compared to that on 
the microdevice in the absence of factor gradients. Dual transgenic reporter mice 
(Sox9EGFP:CAGDsRed) were used to identify and monitor changes in stem/progenitor 
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cells and differentiated cells. Sox9- EGFP marks stem/progenitor cells and CAGDsRed 
is ubiquitously expressed in all cells. As cell differentiate, DsRed-only expression serves 
as a proxy marker for differentiated cell types115. DsRed+ colonoid area was used to 
determine colonoid size. Freshly isolated crypts were mixed with Matrigel and loaded 
into the microchannel. Wnt-3a (60 ng/mL) and R-spondin1 (90 ng/ mL) were placed into 
both the source and sink reservoirs and replenished every 24 h during culture. In 
parallel, crypts were cultured in a conventional Matrigel patty placed in a multiwell plate 
and overlaid with media containing 60 ng/mL of Wnt-3a and 90 ng/mL of R-spondin1. 
The media was replenished every 24 h for both formats. Of the Sox9EGFP-CAGDsRed 
crypts plated in the microdevice, 55 ± 14% (avg. ± s.d.) developed into colonoids with a 
median DsRed area/colonoid of 13,236 μm2 (S1 Table). In comparison, 60.0 ± 8.5% of 
crypts plated and cultured for 5 days in the Matrigel patties developed into colonoids 
with a median DsRed area/colonoid of 12,752 μm2 after 5 days in culture (Fig 1D and 
S1 Table). The presence of a differentiated cell type producing mucous (Goblet cells) 
was assayed by immunofluorescence staining of Mucin 2 (Muc-2) after Sox9EGFP 
crypts were plated in the microdevice and cultured for 5 days13. The percentage of 
colonoids in the microchannel with Goblet cells (Muc-2+ staining in 10% of the colonoid 
area) was 90 ± 5% compared to 92 ± 7% in the multiwell plate (Fig 1C, S5 Fig and S2 
Table). These data indicate that microchannels support colonoid development and 
differentiation similar to convention Matrigel-patty cultures. To assess the impact of the 
microchannel devices on proliferative cells, Sox9EGFP crypts were plated into 
microchannels or the conventional platform and cultured for 5 days. Sox9- EGFP 
expression and EdU were used to assess the numbers of proliferative stem/progenitor 
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cells in all colonoids on the devices. The percentage of colonoids demonstrating 
Sox9EGFP expression in 25% of the colonoid area was similar for the microchannel 
and conventional multiwell environments with 83 ± 8% and 85 ± 9% of colonoids 
positive for Sox9EGFP, respectively (S3 Table). The median integrated Sox9EGFP 
fluorescence/colonoid in the microchannel was 118,822RFUs (S4 Table). In 
comparison, the median integrated Sox9EGFP fluorescence/ colonoid in the multiwell 
plate was 133,490 RFUs (Fig 1D and S3 Table). A second assay based on an EdU 
pulse, which marks cells in the S-phase of the cell cycle, was used to quantify 
proliferating cells191. The percentage of colonoids in the microchannel with EdU+ cells 
(occupying >25% of the colonoid area) was 96 ± 3%, compared to 92 ± 7% in the 
standard Matrigel patty on the multiwell plate (Fig 1C and S5 Table). These data 
indicate that microchannels and multiwells yielded colonoids containing similar numbers 
of proliferating stem/progenitor cells. 
Colonoids do not demonstrate overall polarization in the absence of an external 
gradient  
 The localization of Sox9EGFP within colonoids in the absence of an external 
chemical gradient was assessed to determine the extent to which individual colonoids 
might polarize the stem/ progenitor cell compartments on the microchannel devices. 
Colonoids derived from a Sox9- EGFP-CAGDsRed mouse were loaded into 
microchannels or multiwell plates and cultured in the presence of Wnt-3a (60 ng/mL) 
and R-spondin1 (90 ng/mL). We developed vector-based computational image analysis 
pipelines to measure the relative location of Sox9EGFP expressing cells in the colonoid. 
For the microchannel device, a line perpendicular to the long axis of the microchannel 
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was defined as the line through 0 to 180 degrees. Zero and 180 degrees were arbitrarily 
defined for each multiwell plate, but was consistent across all wells. A Sox9EGFP 
polarization vector was calculated by searching for the steepest gradient in Sox9EGFP 
intensity as the colonoid was rotated through 180 degrees. Using this strategy, an 
unpolarized colonoid is characterized by a Sox9EGFP vector magnitude that 
approaches zero while a highly polarized colonoid is near 0.04. For the conventional 
multiwell platform, the average Sox9EGFP polarization vector possessed a length of 
0.0006 ± 0.0006 and an angle of 150 ± 110 degrees. The colonoids in the microchannel 
displayed an average Sox9EGFP polarization vector with a length of 0.0009 ± 0.0007 
and an angle of 152 ± 107 degrees.When the Sox9EGFP polarization angle was 
examined for each colonoid in both the multiwell plate and microchannel, the angle 
appeared to be randomly distributed through all quadrants and the magnitude of the 
vectors near zero. Additionally, the initial location of a colonoid in the microchannel or 
multiwell plate had no impact on its likelihood of being polarized (S10 Fig and S6 
Table). Thus, colonoids cultured under these gradient-free conditions displayed 
Sox9EGFP fluorescence nearly equally distributed about the colonoid in all locations of 
both culture formats (Fig 2). Using a similar vector-based approach, we assessed the 
extent to which the proliferative cell compartment (marked by EdU) was polarized in the 
absence of an external gradient. Colonoids were cultured in both microchannel and 
conventional platforms for 5 days at which time EdU was added to the culture for 2 h. 
Since only a small subset of cells were marked by EdU, the algorithm used for 
Sox9EGFP polarization could not be employed. Instead the geographic centroid and the 
intensity-weighted centroid were identified and the vector between these two locations 
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was used to assess EdU polarization. Using this algorithm, unpolarized colonoids 
possessed an EdU vector magnitude approaching zero while the largest possible vector 
magnitude for highly polarized colonoids was 0.5. For the conventional multiwell plate, 
the average EdU polarization vector possessed a length of 0.009 ± 0.064 and an angle 
of 61 ± 26 degrees. The colonoids in the microchannel displayed an average EdU 
polarization vector with a length of 0.011 ± 0.053 and an angle of 38 ± 41 degrees. As 
with the Sox9EGFP vectors, the EdU vector magnitudes suggested that in the absence 
of an external growth factor gradient the rapidly proliferating cells within a colonoid 
showed no spatial preference (Fig 3).   
A Wnt-3a gradient is sufficient to polarize the stem/progenitor cell compartments  
We next sought to test whether formation of a gradient of Wnt-3a, a factor that 
supports stem cell maintenance, would promote the polarization of the stem/progenitor 
cell compartment when applied across a single colonoid. To test this, colonoids were 
loaded into the microchannel and Wnt-3a (75 ng/mL) was added to the source reservoir 
only. After 5 d of culture under the linear Wnt-3a gradient, the colonoid area, Sox9EGFP 
expression, and EdU incorporation were measured. The median DsRed area/colonoid 
in the microchannel device was 14,096 μm2 per colonoid (S11 Fig). After 5 days in 
culture, the colonoid area under the Wnt-3a gradient was not statistically different from 
that without a gradient in either platform. The median integrated Sox9EGFP 
fluorescence per colonoid was 73,591 RFUs (S7 Table and S12 Fig). Similar to the 
DsRed fluorescence, the integrated Sox9EGFP fluorescence per colonoid was not 
statistically different from that of colonoids in the absence of a gradient. These data 
suggest that the colonoids under the Wnt-3a gradient possess similar numbers of 
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stem/progenitor cells as the colonoids cultured in the absence of a gradient. Although 
the total size and Sox9EGFP fluorescence per colonoid in the gradient and no-gradient 
conditions were similar, the distribution of stem or proliferating cells across the colonoid 
under these two conditions might be distinct. To assess this possibility, the average 
Sox9EGFP and EdU polarization vectors of the Wnt-3a-gradient-exposed colonoids 
after 5 d in culture was measured and compared to a no-gradient condition. Colonoids 
exposed to the Wnt-3a gradient possessed an average Sox9EGFP polarization vector 
magnitude of 0.0044 ± 0.0019 and an angle of 58 ± 21 degrees, both of which were 
statistically different from that of colonoids in the microchannel in the absence of a 
gradient (p<0.05). Of the 28 colonoids surveyed under the Wnt-3a gradient, 22 
colonoids (79%) possessed Sox9EGFP polarization vectors facing the Wnt-3a source 
(Fig 4A and 4B). The larger Sox9EGFP vector magnitude also suggested that the 
colonoids were more polarized than that without a gradient. However, the average 
vector was well short of the highly-polarized value of 0.04 so that the colonoids were not 
under maximal polarization conditions. The presence of Sox9EGFP polarization in a 
colonoid was not related to its location in the microchannel (S13 Fig and S6 Table). 
Under the influence of the Wnt-3a gradient, the average EdU polarization vector 
possessed a length of 0.02 ± 0.06 and an angle of 41 ± 39 degrees. The EdU 
polarization vector of colonoids exposed to Wnt-3a gradient demonstrated that eleven of 
the colonoids (73%) polarized the EdU expressing cells toward the Wnt-3a source (Fig 
4C and 4D). Thus the majority of the colonoids in the channel responded to the Wnt-3a 
gradient with their proliferating cells localized to colonoid regions with sufficient Wnt-
pathway activation creating discrete stem/TA cell compartment similar to what is seen in 
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vivo at the base of the crypt. This data also demonstrates that a Wnt gradient alone is 
sufficient to polarize a colonoid in the absence of other signaling gradients such as 
BMP, Noggin, or R-spondin.   
A Wnt-3a/R-spondin1 gradient enhances polarization of the stem/ progenitor cell 
compartment  
The highest levels of Wnt activity are thought to exist in the crypt base with the 
Wnt concentration tapering off in a gradient toward the luminal surface. R-spondin1 
(Rspo1) is coexpressed with Wnts in the stem cell zone and functions to potentiate Wnt 
activity through its receptor LGR5, which is G-protein coupled receptor expressed 
almost exclusively in colonic stem cells113. To determine whether a dual gradient of 
Wnt-signaling along the microchannel might promote enhanced polarization of 
proliferative and differentiated cellular compartments, R-spondin1 andWnt-3a were 
placed at high concentration in the source reservoir (75 ng/mL Wnt-3a, 110 ng/mL R-
spondin1) to generate an environment with a steep factor gradient. After 5 days under 
aWnt-3a/R-spondin1 gradient, the median DsRed fluorescence (area/colonoid) was 
22,146 μm2 and the median Sox9EGFP fluorescence (intensity/colonoid) in the presence 
of the dual gradient was 105,823 RFUs (S11 and S12 Figs and S8 Table). These values 
were not statistically different from that in the absence of a gradient or in the presence 
of a Wnt-3a gradient alone) suggesting that the number of stem/progenitor cells and 
differentiated cells were not changed in the presence of aWnt-3a/R-spondin1 gradient. 
To assess whether aWnt-3a/R-spondin1 gradient enhanced polarization of the 
stem/progenitor and differentiated compartments, Sox9EGFP and EdU location 
wasmeasured in each colonoid under the dual factor gradient. The average Sox9EGFP 
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polarization vector exhibited a magnitude of 0.0049 ± 0.0019 and an angle of 35 ± 31 
degrees, which was a statistically significant difference from that of the colonoids in the 
absence of a gradient, but not significantly different fromthat of a Wnt-3a gradient alone. 
Of the 24 colonoids assessed in the dual gradient, 92% possessed a Sox9EGFP vector 
that orientated toward the source reservoir containing Wnt-3a/R-spondin1 (Fig 5A and 
5B). As with theWnt- 3a gradient, the presence of Sox9EGFP polarization in a colonoid 
was not related to its location in the microchannel (S13 Fig and S6 Table). Analysis of 
EdU labeling under theWnt3-a/R-spondin1 gradient revealed an average EdU 
polarization vector magnitude of 0.09 ± 0.07 and an angle of 15 ± 19 degrees, which 
was a statistically significant difference from polarization vectors in the absence of a 
factor gradient or Wnt-3 alone (Fig 5C and 5D). Nearly all colonoids in theWnt-3a/ R-
spondin1 gradient exhibited proliferating cells oriented toward the highestWnt3a/R-
spondin1 concentrations similar to what is observed in vivo at the base of the crypt.   
Effect of a Wnt-3a and R-spondin1 Gradient on Growth and Polarization of 
Colonoids Derived from a Single Stem Cell  
The experiments above utilized multicellular colonoid fragments as the source 
material for development of colonoids. While the fragments were small (~30 μm 
diameter with ~25 cells), the fragments did contain many cell types (differentiated, stem, 
and TA cells), and thus may have had pre-established cellular interactions that might 
impact spatial lineage allocation of a colonoid developing under an externally imposed 
growth-factor gradient. In addition, the colonoid fragments were obtained 
fromcontinuously cultured colonoids (>1 month). While all evidence todate indicates that 
the cells within these colonoids are representative of those in vivo and maintain a 
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normal karyotype, it is conceivable that the cultured colonoids differ in an as yet 
unknown manner from their in vivo counterparts64,90,114. For this reason, single stem 
cells were isolated from freshly obtained Sox9EGFP-CAGDsRed mouse crypts by 
fluorescence-activated cell sorting of the stem cells (Sox9EGFPlow:CAGDsRED)115. The 
stem cells suspended inMatrigel were loaded into a microchannel and cultured for 5 d in 
the presence of aWnt-3a/R-spondin1 gradient. The median DsRed fluorescence area 
per colonoid was 16,576 μm2 so that the area of the 5-day colonoids in the dual 
gradient was not statistically different fromthat obtained in the prior experiments using 
multicellular colonoid fragments (S11 Fig). Similarly, the Sox9EGFP fluorescence/ 
colonoid of the single stem cell-derived colonoids (median of 95,734 at 5 days) did not 
display a statistically significant difference fromthat of prior experiments (S12 Fig and 
S9 Table). These data suggested that colonoids originating from individual stem cells 
grew robustly, catching up in size and stem/TA cell numbers to that of the cultured 
colonoid fragments. The Sox9EGFP polarization vector for the single-cell-derived 
colonoids was measured to test the hypodissertation that these colonoids might more 
readily polarize under the Wnt-3a/R spondin1 gradient since the single cells were 
initially free of cell-cell interactions. The average Sox9EGFP polarization vector of the 
single-cell-derived colonoids possessed a magnitude of 0.012 ± 0.002 and an angle of 
17 ± 16 degrees which was a statistically significant difference from that of colonoid-
fragment-derived colonoids under a Wnt-3a/R-spondin1 gradient (p<0.05). Of the 23 
colonoids surveyed in the dual gradient condition, 20 colonoids (87%) possessed 
Sox9EGFP vectors pointing in the direction of the growth factor source (Fig 6). A similar 
percentage of colonoids arising from the single cells and colonoid fragments polarized 
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to align with the growth factor gradient; however, colonoids developing from the single 
stem cells were more highly polarized as evidence by greater vector magnitudes than 
those arising from the colonoid fragments. In addition, colonoids located near the sink 
were more likely to be polarized than those located near the source (S14 Fig and S6 
Table). The above data suggest that cell interactions within the colonoid fragments exert 
an additional influence on the behavior of the stem and/or TA cells modifying the 
colonoid's ability to fully spatially orient in response to environmental cues. The growth-
factor gradient concentrations near the sink also appear more appropriate for that 
required to induce colonoid polarization. 3,89,117,118,150,153–157 
Conclusions 
Basal-luminal polarization of the stem/progenitor and differentiated cellular 
compartments in the intestinal and colonic crypts is considered to be dictated by 
gradients of morphogenic factors91,113. A number of studies indirectly demonstrate 
through gene expression assays that downstream targets of canonical Wnt signaling 
exist in a graded fashion along the crypt axis88,89. Formal testing of how specific growth 
factor or chemical gradients influence a number of biological processes like cellular 
differentiation and crypt patterning have been precluded by limitations in colonic stem 
cell culture and platforms that enable the generation of steep growth factor gradients. 
Here, we optimized a platform to introduce tightly controlled steep linear gradients of 
morphogenic factors, similar to those widely held to be present in vivo, across individual 
colonoids or single stem cells. We demonstrate that imposing a simple linear gradient of 
Wnt-3a/Rspondin1 is necessary and sufficient to induce polarization of the proliferative 
and differentiated cellular architecture in colonoid tissue constructs derived from both 
125 
 
single colonic stem cells and small multicellular colonoids composed of heterogeneous 
cell types. In these studies, a stem and proliferative cell niche was recreated within a 
single epithelial unit by imposing a simple, linear, 2-factor gradient suggesting that in 
vivo, polarization of Wnt-signaling along the crypt axis is likely to be sufficient to 
maintain the basal-to-luminal crypt organization. Introduction of a 75 pg/mL/μm gradient 
of Wnt-3a resulted in polarized colonoids with localization of proliferative stem and TA 
cells in regions of higher Wnt-3a concentration paralleling the in vivo cellular patterning 
of the intestinal crypt. In this single gradient experiment, R-spondin1, also an activator 
of the Wnt signaling pathway, was at a uniform concentration of 90 ng/mL throughout 
the microchannel. It is possible that the R-spondin1 alone provided sufficient Wnt 
pathway activation to support the Sox9EGFP-expressing cells throughout the colonoids. 
A combined gradient of Wnt-3a (75 pg/mL/μm) and R-spondin1 (110 pg/mL/μm) acted 
synergistically to produce enhanced polarization of the colonoid body. The 
concentration drop over distance for these factor gradients was similar to those reported 
in the literature for other critical factors controlling a variety of biological processes and 
organismal development192–194. Maintenance of colonoids derived from single stem cells 
under the combined gradient condition produced the most highly polarized colonoid 
structure suggesting that the multicellular fragments possessed some internal patterning 
which limited the ability of colonoids derived from them to maximally respond to 
morphogenic gradients. These experimental results demonstrate for the first time that a 
simple linear gradient of growth factors is capable of directing polarization of the cellular 
architecture along the crypt axis. 
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Appendix A: Fig 1. Characterization of the gradient-generating microdevice. 
(A) Photograph of the device. The Matrigel-filled gradient region resides between the 
sink (left with blue dye) and source (right with yellow dye) reservoirs. (B) Schematic of 
the gradient generating microchannel of the device. The 1.5-mm diameter circles mark 
the ports for loading Matrigel into the central microchannel. (C) Histogram showing 
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percentages of colonoids possessing Sox9EGFP expression (stem/TA cell), exhibiting 
Muc2 staining (goblet cells) and labeling with EdU (actively proliferating cells) when 
cultured in the microchannel (black) or conventional multiwell plate (white). (D) Colonoid 
area (top) and Sox9EGFP fluorescence (bottom) per colonoid are shown after 5 days in 
culture in either the microchannel or microwell. Boxplots were used to represent the 
non-normal data distribution. Colonoid area is represented as μm2 (x 104) and 
Sox9EGFP fluorescence intensity is represented as RFUs (x 105). For the boxplots, the 
black star indicates the mean of the data, the bar shows the median, and the upper and 
lower boxes represent the 75% and 25% of the data, respectively. The whiskers extend 
to the 5% and 95% of the data. 
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Appendix A: Fig 2. Colonoid properties in the absence of a gradient. 
(A, C) Brightfield (left) and overlaid red/green fluorescence (right) images of colonoids 
cultured within a standard multiwell plate (A) or microchannel (C) for 1, 3, and 5 days 
Scale bars represent 250 μm. (B, D) Compass plots displaying the Sox9EGFP 
polarization magnitude and angle for individual colonoids cultured in the multiwell plate 
(B) or microchannel (C) for 5 days (n = 49 colonoids in 10 microchannels and n = 30 
colonoids in 5 wells). The blue vectors represent individual colonoids while the average 
magnitude and angle of the vector is marked in red (poorly visualized due to the near-
zero magnitude). 
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Appendix A: Fig 3. Incorporation of EdU into colonoids after a 2 h pulse in the 
absence of a gradient. 
(A,C) Brightfield (left) and overlaid red/blue fluorescence (right) images of colonoids 
cultured within a multiwell plate (A) or microchannel (C) for 5 days then labeled with 
EdU (red) and the Hoechst 33342 (blue) (n = 18 colonoids in 5 microchannels and n = 
16 colonoids in 3 multiwells). Scale bars represent 50 μm. (B, D) Compass plots 
displaying the EDU polarization magnitude and angle for individual colonoids (blue) 
cultured in the multiwell plate (B) or microchannel (C) for 5 days and pulsed with EdU. 
The average magnitude and angle of the vector can be seen in red (poorly visualized 
due to the near-zero magnitude). 
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Appendix A: Fig 4. Colonoid growth in the presence of a Wnt-3a gradient across 
the microchannel.  
(A) Brightfield (left) and overlaid red/green fluorescence (right) images of colonoids 
cultured under a Wnt-3a gradient for 1, 3, and 5 d. The scale bar is 250 μm. (B) 
Compass plot displaying the Sox9EGFP polarization magnitude and angle for individual 
colonoids cultured under the Wnt-3a gradient for 5 days (n = 28 colonoids on 5 
devices). The average magnitude and angle of the vector can be seen in red. (C) 
Brightfield (left) and overlaid red/blue fluorescence (right) images of colonoids cultured 
under a Wnt-3a gradient for 5 days then pulse-labeled with EdU (red) for 2 h. Hoechst 
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33342 fluorescence is shown in blue. The scale bar represents 50 μm. (D) Compass 
plot displaying the EDU polarization magnitude and angle for individual colonoids (blue) 
cultured as described in (C) (15 colonoids in 5 microchannels). The average magnitude 
and angle of the vector can be seen in red. 
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Appendix A: Fig 5. Colonoid growth in the presence of a dual Wnt-3a/R-spondin1 
gradient.  
(A) Brightfield (left) and overlaid red/green fluorescence (right) images of colonoids 
cultured under a Wnt-3a/R-spondin1 gradient for 1, 3, and 5 days in the microchannel. 
The scale bar is 250 μm. (B) Compass plot displaying the Sox9EGFP polarization 
magnitude and angle for individual colonoids (blue) cultured under the Wnt-3a/R-
spondin1 gradient for 5 days (n = 33 colonoids from 6 microchannels). The average 
magnitude and angle of the vector can be seen in red. (C) Brightfield (left) and overlaid 
red/blue fluorescence (right) images of colonoids cultured the gradient for 5 days then 
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pulse-labeled with EdU (red) for 2 h. Hoechst 33342 fluorescence is shown in blue. The 
scale bar represents 50 μm. (D) Compass plot displaying the EDU polarization 
magnitude and angle for individual colonoids (blue) cultured as described in (C) (n = 11 
colonoids in 4 microchannels). The average magnitude and angle of the vector can be 
seen in red. 
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Appendix A: Fig 6. Growth of single stem cells in the presence of a Wnt-3a/R-
spondin1 gradient.  
(A) Brightfield (left) and overlaid red/green fluorescence (right) images of single stem 
cells cultured under a Wnt-3a/R-spondin1 gradient for 1, 3, and 5 days in the 
microchannel. The scale bar is 250 μm. (B) Compass plot displaying the Sox9EGFP 
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polarization magnitude and angle for the single colonoids (blue) under the Wnt-3a/R-
spondin1 gradient for 5 days (n = 23 colonoids in 5 microchannels). The average 
magnitude and angle of the vector can be seen in red. 
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Appendix B: Self-renewing Monolayer of Primary Colonic or Rectal Epithelial 
Cells 
Introduction 
Long-term culture of primary intestinal epithelial tissue as a planar monolayer has 
not been possible due to the rapid loss of stem and proliferative cells and rapid onset of 
apoptosis when primary epithelium is placed into culture.61 Investigators have 
traditionally relied on colon cancer cell lines, like Caco-2 and its derivatives, to study gut 
epithelial physiology because of their ability to grow indefinitely on conventional tissue 
culture plates.195 While cancer cell lines grow as confluent monolayers and can be 
efficiently passaged, they possess many non-physiologic characteristics including 
somatic mutations, chromosomal instabilities, altered metabolism, and aberrant 
proliferative and differentiation characteristics.196 Together, these non-physiologic 
properties of Caco-2 cells call into question their predictive ability in assays designed to 
understand normal epithelial physiology. 
Recent advances in epithelial culture conditions now promote intestinal stem cell 
(ISC) maintenance and indefinite culture of primary intestinal tissue as 3D 
organoids.197–201 The organoid culture system utilizes soluble growth factors including 
Wnt-3A, R-spondin, Noggin and epidermal growth factor (EGF) to mimic the ISC niche 
environment that support ISC survival, growth, and differentiation in a thick layer of 
Matrigel. 197,200,202,203 Like in vivo, organoid ISCs exhibit their defining properties by self-
renewing and giving rise to progenitors that differentiate into absorptive colonocytes 
(water and 
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electrolyte uptake), goblet cells (mucus production), enteroendocrine cells (hormones), 
and Paneth cells (antimicrobial and stem cell niche functions).197 By virtue of their non-
transformed condition, 3D organoids represent a physiologically relevant model 
enabling novel assays and pharmaceutical and dietary compounds screens that are not 
currently possible with colon cancer cell lines, such as Caco-2.196,204  
While organoid culture technology has had a major positive impact on the in vitro 
study of primary gut epithelium, the 3D geometry of organoids prevents access to the 
apical aspect of the epithelium producing a number of challenges to physiologically 
relevant studies. The apical surface of the organoid is analogous to the lumen of the gut 
where digested contents and microbial communities interact with the epithelium.  The 
spheroidal architecture of the organoids prevents access of exogenous compounds to 
the luminal epithelial surface limiting studies focused on apical transporters, receptors, 
metabolic enzymes, and microbiota.205 Matrigel embedded organoids exist in multiple 
planes making collection of experimental readout using conventional microscopy 
exceptionally challenging.206,207 Unfolding the spherical organoid into a 2D planar tissue 
construct is a solution that addresses these major challenges and has the potential to 
further transform in vitro study of the gut epithelium. 
We have previously demonstrated that primary intestinal epithelial cells can be cultured 
on polydimethylsiloxane (PDMS) and other artificial surfaces in the absence of a 
hydrogel.206 Although supplied with the requisite soluble growth factors for growth within 
Matrigel, culture of primary epithelium on non-hydrogel surfaces produced a short-lived, 
non-proliferative monolayer of cells. Dissociated 3D small intestinal and colonic 
organoids have been cultured on a porous membrane (coated with 0.1% gelatin or 10 
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µg/cm2 collagen) to form a monolayer, but these monolayers were not self-renewing 
suggesting that stem cells were lost from the monolayers over time and a self-renewing 
ISC compartment was not supported.208,209 The failure of existing 2D culture methods to 
produce long-term monolayers suggests that a biochemical environment composed of 
media and soluble growth factors alone is not adequate to sustain a self-renewing 
monolayer containing both stem and differentiated cells. To overcome the limitations in 
monolayer culture duration, we sought to identify parameters that would support self-
sustaining monolayers. 
 
Materials and Methods 
Isolation of crypts from mouse colon and human rectal biopsies.  
Male mice were used at age 6-10 weeks. All experiments were performed in 
compliance with the relevant laws and institutional guidelines at the University of North 
Carolina. All experiments and animal usage was approved by the Institutional Animal 
Care and Use Committee (IACUC) at UNC. Mice were humanely euthanized by lethal 
dose of isoflurane followed by cervical dislocation under the approved UNC IACUC-
approved protocol #13-200. A CAG-DsRed mouse model (CAG = CMV enhancer plus 
chicken actin promoter) in which all cells expressed the DsRed fluorescent protein was 
used to monitor the proliferation of colonic epithelial cells by fluorescence microscopy. 
CAG-DsRed heterozygous mice were bred on a CD-1 background and wild-type mice 
were bred on a C57BL/6 background. Wild type mice were used for fluorescence-based 
assays and compound screens. An Lgr5EGFPCreERT2xR26 confetti mouse was used 
for lineage tracing experiments on the 2D monolayer. The confetti mouse was injected 
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with 5 mg tamoxifen at 48 h before sacrifice and isolation of crypts from the large 
intestine.210 Human rectal biopsies were obtained from UNC Hospitals Meadowmont 
Endoscopy Center with consent of the patient (under the approved UNC IRB #14-2013).  
Isolation buffer was comprised of 5.6 mM Na2HPO4 (Sigma S7907), 8.0 mM 
KH2PO4 (Sigma P5655), 96.2 mM NaCl (Sigma S5886), 1.6 mM KCl (Sigma P5405), 
43.4 mM sucrose (Fisher BP220-1), and 54.9 mM D-sorbitol (Fisher BP439-500) in 
deionized water. The buffer was filter sterilized and stored at 4°C. EDTA (2 mM, 
ThermoFisher 15575020) and DL-dithiothreitol (DTT, 0.5 mM, ThermoFisher R0861) 
were added to 10 mL of isolation buffer and used within 2 hours. Colon tissue was 
incubated in the above EDTA/DTT solution at room temperature for 75 minutes. The 
tissue was then rinsed with 5 mL of isolation buffer twice, and vigorously shaken by 
hand in 10 mL isolation buffer to release the crypts. The density of crypts in the solution 
was obtained by adding a 10 µL suspension to a Petri dish and counting the number of 
crypts in this drop of suspension. Released crypts were placed into culture within 30 min 
of isolation. Isolated crypts were placed on the top of the collagen hydrogel at a density 
of 1,000 crypts/cm2 and cultured in 4 mL of medium in the 6-well plate. The medium 
was changed every 48 h. 
 
Preparation of the collagen hydrogel in a 6-well plate.  
Collagen hydrogel is generally prepared by neutralizing the acidic collagen 
solution with NaOH and incubating the mixture at 37°C for 30-60 minutes. The hydrogel 
properties (e.g. stiffness, clarity, adhesiveness, cell-binding sites) are highly dependent 
on the pH during gelation. Therefore, we used a customized neutralization buffer 
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(containing HEPES, NaHCO3 and NaOH in PBS) to neutralize the acidic collagen 
solution prior to gelation to ensure a final pH of 7.4 for the hydrogel. The neutralization 
buffer was prepared in 75 mL volumes and the reagents and their catalog numbers are 
listed in detail in the Supporting Information. To prepare 1 mL neutralized collagen at a 
concentration of 1 mg/mL, 750 µL neutralization buffer was first added to a 15-mL 
conical tube, and the tube was placed on ice. Then 250 uL collagen stock solution (type 
I, rat tail, Corning 356236, 4 mg/mL, 4°C) was added to the tube, and the mixture was 
homogenized by slow and repeated pipetting, carefully avoiding air bubble formation 
during pipetting. The collagen mixture (1 mL) was added to each well of a 6-well plate 
(Denville T1006). The plate was incubated at 37°C for 1 h to generate a clear hydrogel. 
PBS (4 mL) was placed over the hydrogel. The collagen hydrogel was generally used 
within two hours after preparation, but could be stored in a 37°C incubator up to one 
month without apparent loss of integrity, adhesion and cell culture outcome. The 
thickness of the collagen hydrogel was 1 mm in the 6-well plates.  
2D monolayer culture on a collagen hydrogel.  
The crypts were placed on top of the collagen hydrogel at a density of 1,000 
crypts/cm2 (unless otherwise stated) and cultured in medium (4 mL per well in the 6-well 
plate, and medium formulation is defined in the Supporting Information). The medium 
was changed every 48 h, and Y-27632 was added for the initial 48 h of culture. When 
the cell coverage was greater than 80% (typically after 3-4 days for mouse cells, 5-7 
days for human cells), the monolayers were sub-cultured by a gentle two-step 
dissociation method. The first step was to lift up the monolayer from the collagen 
hydrogel by scrapping the collagen (with cells) from the well, and transferring the 
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hydrogel to a 15-mL conical tube containing 1 mL of culture medium with 500 U/mL of 
collagenase (type IV, Worthington Biochemical LS004189). The gel was broken into 
small pieces by pipetting using a 5 mL serological pipette followed by a 1 mL pipet tip. 
The tube was then incubated at 37°C for 10 min to completely digest the collagen gel. 
The monolayers were rinsed with PBS buffer, and pelleted by centrifugation at 600×g 
for 1 min. The second step was to further breakup the monolayer pieces into smaller 
fragments by incubating the pellet in 150 µL of EDTA (0.5 mM) and Y-27632 (10 µM) in 
PBS at 37°C for 2 min (mouse cells) or 5 min (human cells). The monolayers were 
broken into small fragments by pipetting up and down 30 times using a 200 µL pipet tip. 
The cell fragments were re-suspended in medium and sub-cultured on a new collagen 
hydrogel at a passage ratio of 1:3. 
To convert 3D organoids to a 2D monolayer, the organoids were extracted from Matrigel 
by detaching the Matrigel patty, breaking it into coarse pieces and then pipetting the 
suspension using a 200 µL pipet tip. The cells were then cultured on a collagen gel at a 
density of 10 organoids/cm2. 
Characterization of the 2D monolayer.  
The proliferation and viability of cells was either quantified by surface area 
coverage or a cell viability assay (CellTiter-Glo luminescence assay, Promega G7572). 
To ensure the cells possessed grossly normal chromosomes, cells were karyotyped 
(KaryoLogic, Inc). Twenty cells from each sample were analyzed. To reveal the 
topographic features of 2D monolayer, the samples were dried with a critical point dryer 
(Tousimis Semidri PVT-3) and inspected by scanning electron microscope (SEM, FEI 
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Quanta 200 ESEM, FEI Company). For immunofluorescence (IF) staining, thin sections 
(8–10 µm) of the 2D monolayers were prepared on a cryostat. 
High-throughput screening of dietary metabolites and natural products.  
All 77 compounds were obtained from Sigma Aldrich. The names, categories and 
their working concentration are listed in supplementary Table 2. 75 µL collagen hydrogel 
was prepared in each well of 96-well plates (Corning #3603) by the protocol described 
above. Fragments of primary mouse colonic epithelial cells (75,000 cells per well) were 
cultured on the collagen hydrogel with 200 µL ENR-W (with “W” indicating a normal 
[Wnt-3A] of 30 ng/mL). At 24 h, the medium was aspirated, and the cells were cultured 
in medium (200 µL) containing a dietary/natural compound in ENR-w (with "w" indicating 
a reduced [Wnt-3A] of 10 ng/mL) for an additional 48 h. The decreased Wnt-3A 
concentration reduced the Wnt-3A signaling strength enabling cells to undergo 
differentiation in response to exogenous compounds. The cells were pulsed with 5-
ethynyl-2-deoxyuridine (EDU) (3 h), stained for ALKALINE PHOSPHATASE (ALP) (30 
min), and then fixed with 4% paraformaldehyde (15 min). The cells were then 
sequentially labeled with the Click-iT EDU reagent, α-Muc2 (MUCIN2) and Hoechst 
33342. Finally, the cells were thoroughly rinsed with PBS to remove excess reagents. 
Three 96-well plates were used for each experiment. 
Assaying for hit dietary compounds on mouse 3D organoids and human 2D 
monolayers. 
14 selected hit compounds were tested on 3D mouse colonic organoids. 
Fragments of mouse colonic epithelial cells (25,000 cells per well) were embedded in 4 
µL Matrigel in each well of a 96-well plate and cultured with ENR-W (200 µL). At 24 h, 
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the medium was aspirated, and the cells were cultured in ENR-w (200 µL) containing a 
dietary/natural compound for an additional 48 h. Seven selected hit compounds were 
tested on human rectal 2D monolayers. Fragments of human rectal epithelial cells 
(75,000 cells per well) were cultured on the collagen hydrogel in a 96-well plate with 
Human Intestinal Stem Cell medium (HISC) with high [Wnt-3A] of 100 ng/mL. At 48 h, 
the medium was aspirated, and the cells were cultured in medium (200 µL) containing a 
dietary/natural compound in HISC medium with reduced [Wnt-3A] of 30 ng/mL for an 
additional 96 h. The cells were then stained with ALP, EDU, α-Muc2 and Hoechst 
33342 in the same manner as the mouse 2D monolayers described above. 
Image Acquisition. 
  Following staining, each 96-well plate was imaged using an Olympus IX81 
epifluorescence microscope (4× objective, N.A. of 0.13, Olympus UPlanFL N). The 
imaging area consisted of a grid of either 4×3 or 6×4 overlapping images covering 47%-
54% of the total well area. Well-focused images covering the entire image area were 
obtained by autofocusing on each image position using a custom script written in 
MatLab. Each sample was imaged using blue, red, far red, and green filter sets 
(Chroma ET-DAPI 49000, Semrock TxRed-4040B, Chroma ET-Cy5 49006, and 
Semrock FITC-3540B, corresponding to the Hoechst 33342, ALP, EDU, and Muc2 
stains, respectively) and an exposure time of 150 ms for all channels. The total image 
acquisition time for a 96-well plate using a 6×4 image grid for each well was 456±7.5 
min. 
144 
 
Image Analysis.  
After cropping out the overlapping regions in the image data, the collected 
images obtained from each well were filtered using a Wiener filter with a 3×3 pixel 
neighborhood to reduce noise. The image background was subtracted using top-hat 
filtering, and then the images were empirically thresholded. Objects smaller than 3.1 µm 
in diameter were removed to eliminate cellular debris and artifacts produced by camera 
noise. The integrated raw fluorescence intensity over the area occupied by the supra-
threshold fluorescence was summed for all images of a sample and for each 
fluorescence emission wavelength. This summed fluorescence area was then 
normalized by the total cell area occupied by the Hoechst 33342 fluorescence and 
plotted against the compound number.  
Hit Selection.  
In high-throughput screens it is important to assess how much the test 
compounds and negative controls differ from one another. Strictly standardized mean 
difference (SSMD) was used to quantify the differences between the dietary compounds 
and negative controls.211 SSMD is commonly used statistic in compound screens and is 
calculated as the mean difference between the test sample and reference sample 
divided by the standard deviation of the difference between the test and reference. 
SSMD essentially measures effect size for the comparison of two groups. Sample #78 
was used as the negative reference for SSMD calculations for all tissue types. 
Compound effects were classified using standard SSMD thresholds:212 |SSMD| ≥ 5 for 
extremely strong, 5 >|SSMD| ≥ 3 for very strong, 3 >|SSMD| ≥ 2 for strong, 2 > |SSMD| 
≥ 1.645 for fairly strong, 1.645 > |SSMD| ≥ 1.28 for moderate, 1.28 > |SSMD| ≥ 1 for 
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fairly moderate, 1 > |SSMD| ≥ 0.75 for fairly weak, 0.75 > |SSMD| ≥ 0.5 for weak, 0.5 > 
|SSMD| ≥ 0.25 for very weak, and |SSMD| ≤ 0.25 for extremely weak effects. 
Compounds with “fairly strong” or stronger effects on nuclear coverage, ALP signal, or 
EDU signal were designated hits. Compounds with only “fairly moderate” or stronger 
effects on Muc2 signal were designated hits due to the weaker effects apparent across 
all Muc2 screens. Library screens were performed in triplicate across well plates 
(mouse and Caco-2 monolayers). The SSMD size effect was calculated using the 
paired uniformly minimal variance unbiased estimate (UMVUE) of SSMD.213 Library 
screens performed in triplicate within single wells plates (human 2D monolayers and 
mouse 3D organoids) and the SSMD size effect was calculated using the unpaired 
SSMD under unequal variance.211  
Other Statistics/Methods.  
Unless otherwise specified, the data shown for each experiment utilized crypts or 
cells obtained from a single mouse or one human biopsy. All data utilized three 
technical replicates (n=3) and the mean with a single standard deviation is shown 
unless otherwise specified. When the fate of a crypt was assayed, n=3 wells with 10 
crypts/well counted. Multiple experiments from different mice for all data (except the 
dietary compound screen) were performed and the results were consistent over time 
without outliers. While the data of each experiment represent that of a single mouse (to 
reduce animal usage), over 30 mice were used throughout the work with no observable 
difference in monolayer formation or growth rate. This translates into greater than 30 
different cell lines, but each typically used for no more than 5 passages to avoid any 
possibility of chromosomal aberrations. Animals from two different backgrounds were 
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used, CD-1 background (CAG-DsRed mice) and C57BL/6 background 
(Lgr5EGFPCreERT2xR26 and wild type mice).  Data from representative experiments 
are presented. Biopsies from 3 different humans were used to develop the human 
monolayer system. The biopsies were obtained sequentially with the first 2 biopsies 
used to optimize the conditions for human cell culture. The data in the paper are from 
the 3rd biopsy specimen. No difference was observed in the properties of the cells from 
the different biopsies, and the optimized conditions for the first 2 biopsy cells worked 
well for the 3rd specimen. 
Results 
A murine colonic epithelial monolayer proliferates on the surface of a collagen 
hydrogel 
Intestinal stem cells can be maintained as a proliferative culture by providing a 
media rich in growth factors and embedding the cells within Matrigel to form 3D 
organoids.7 We hypothesized that a 2D monolayer of epithelial cells would undergo 
long-term proliferation if provided with the appropriate matrix cues such as a suitable 
stiffness in addition to the required soluble factors (Figure 1a). Matrigel is widely used in 
3D stem cell culture systems as it resembles the extracellular matrix (ECM) found in 
many tissues.7 Crypts cultured on the surface of Matrigel failed to form a spreading 2D 
monolayer (supplementary Figure 1b). Instead the crypts grew into 3D organoids 
residing above the surface (100 ± 0% of crypts, 100 crypts counted per well, n=3) and 
possessed morphologies reminiscent of the organoids formed within a Matrigel patty, 
suggesting that Matrigel did not possess the ECM contacts and stiffness (Young’s 
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modulus ~ 50 Pa214) required to allow cells to spread on the surface  (supplementary 
Figure 1a). 
Polystyrene is the most commonly used 2D cell culture substrate,215 and PDMS is a 
dominant material in building cell-based lab-on-chip and microfluidic devices.216 Crypts 
plated on a bare, plasma-oxidized polystyrene or PDMS formed an adherent 2D 
monolayer, but the cells were short-lived and without evidence of self-renewal 
(supplementary Figure 1b). Similar outcomes were also observed for crypts plated on 
gelatin, agarose, and polyacrylamide (supplementary Figure 1d).  
The common practice of coating surfaces with ECM proteins or peptides (Matrigel, 
collagen, laminin, fibronectin, gelatin, vitronectin, or poly-D-lysine) on plasma-oxidized 
polystyrene or PDMS  did not improve the proliferative capability or viability of cells 
(supplementary Figure 1d), suggesting these materials lacked the softness (Young’s 
modulus of PDMS = 0.8-4 MPa,217 polystyrene = 3-3.5 GPa218) or other biophysical and 
biochemical properties that promote a self-sustaining monolayer. 
Collagen hydrogels are widely used matrices for cell culture.219 After crypts were 
plated on the surface of collagen hydrogel (type I, rat tail, 1 mg/mL, 1 mm thickness), 93 
± 6% crypts formed a surface-attached monolayer that expanded in area and cell 
number over time (Figure 1b). Collagenase was highly effective at liberating, 
disaggregating and sub-culturing cells grown on the hydrogels (Figure 1c,d). 
Karyotyping demonstrated that cells retained the appropriate number of chromosomes 
through passage number 5 (supplementary Figure 2). Monolayers grew to sizes >2 mm 
in diameter (Figure 1d) and were maintained in monolayer form for up to ten months 
(the longest time tested). Lower concentrations of collagen or collagen/Matrigel 
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composites did not support monolayer formation (supplementary Figure 1c,e) possibly 
due to inappropriate stiffness and ECM properties.  
Monolayers were subjected to a number of morphological and protein expression 
analyses to characterize key epithelial properties found in vivo. When examined by 
electron microscopy, the cells of the self-sustaining monolayers demonstrated the 
hallmark "cobblestone" arrangement of colonic epithelium (Figure 1e). In vivo, large 
numbers of microvilli cover the surface of the differentiated colonocytes and function to 
increase surface area for water and salt absorption. On the monolayers, the microvilli 
density on each cell was variable suggesting that cells might be at different states of 
differentiation (Figure 1e,g). High densities of ACTIN and VILLIN, which are 
concentrated within microvilli, were present only on the upper or apical cell surface 
(Figure 1f,h,i). In contrast, INTEGRIN-β4 and NA+/K+-ATPASE were localized to the 
basal and basolateral cell surfaces, respectively, demonstrating that the cells are 
polarized with the luminal surface exposed to the medium and the basal surface facing 
the collagen (Figure 1i).  Adherens and tight junctions were present between the cells of 
the monolayer as demonstrated by the localized ZO-1, E-CADHERIN and OCCLUDIN 
staining (Figure 1i). These results suggested that the collagen hydrogel supported 
epithelial monolayer development closely mimicking that in vivo, and also suggest that 
porosity, ECM proteins, and stiffness of the collagen hydrogel functionally recapitulated 
key properties of the native colonic basement membrane. 
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Equivalency of murine colonic 2D monolayers to 3D organoids  
Intestinal and colonic organoids embedded within Matrigel possess proliferative and 
differentiated cellular compartments and are widely accepted as an in vitro tissue model 
for the digestive tract.200 Therefore, we sought to compare proliferative capacity and 
lineage composition between the murine 2D monolayer and 3D organoid platforms. 
Colonic crypts were cultured in 3D (embedded inside Matrigel patty) to form organoids, 
and in 2D (on the surface of a collagen hydrogel) to form epithelial monolayers (Figure 
2a). Cell populations in both culture systems rapidly expanded with the monolayer and 
organoid cells demonstrating average doubling times of 23.7 hours (95% confidence 
interval [C.I.] bounds of 21.3 hours and 26.7 hours, n=4 technical replicates) and 31.2 
hours (95% C.I. bounds of 25.1 hours and 41.0 hours), respectively (Figure 2b,c). We 
observed S-phase cells (EDU+) at day 3 in both 3D organoids and 2D monolayers 
demonstrating actively proliferating cells indicating the presence of stem and progenitor 
cell lineages (Figure 2d,e). The numbers of organoids and monolayer patches with 
differentiated cell types (Muc2+ [goblet cells] and ChgA+ [enteroendocrine cells]) was 
also equivalent in the two culture systems suggesting that the 3D and 2D platforms are 
functionally similar with respect to differentiated secretory lineages (Figure 2d,e). Cells 
derived from dissociated monolayers were capable of generating organoids when 
placed into 3D culture conditions (supplementary Figure 3). Similarly, crypt-derived 
organoids could be removed from 3D culture and cultured on the surface of a collagen 
hydrogel to form a 2D epithelial monolayer. There was no distinguishable difference 
between monolayers derived from freshly isolated crypts or from 3D cultured organoids 
(supplementary Figure 3a,b). Serial interconversion between the monolayer and 
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organoid morphologies were possible for at least five passages (the greatest number 
tested) indicating that colonic stem cells are maintained in the monolayer 
(supplementary Figure 3c,d). These data demonstrate that a proliferative monolayer can 
be derived from multiple sources (crypts, 3D organoids, and 2D monolayer fragments). 
Mature organoids self-pattern into proliferative and differentiated zones by 
segregating a high density of stem and progenitor cells to the crypt buds (Figure 2f).220 
While stem cells are self-renewing and persist in the organoid crypt buds, differentiated 
cells in the organoid have a limited life span and are eventually sloughed into the central 
pseudolumen. Spontaneous patterning of proliferative and differentiated cellular 
compartments was also observed within the monolayers after 8 days in culture (Figure 
2f). Proliferative cells (EDU+) were enriched along the edges of the expanding 
monolayer while differentiated cells such as goblet cells were concentrated in the center 
of the monolayer.  These data demonstrate that monolayer and organoid culture 
systems readily interconvert, and are equivalent in terms of the cell proliferative 
capacity, lineage composition, and spontaneous compartmentalization of 
stem/proliferative cells and differentiated cells. 
 Lineage tracing confirms the presence of stem cells in the murine 2D monolayer 
To determine whether self-renewing colonic stem cells persisted in the 2D 
monolayers, we performed lineage tracing using the Lgr5EGFPCreERT2xR26 
transgenic mouse. Colonic crypts were isolated from a tamoxifen-treated 
Lgr5EGFPCreERT2xR26 confetti mouse and plated on the surface of collagen hydrogel 
at a low density of 30 crypts/cm2 (in order to track the growth of individual crypts). At 24 
h post-plating, tracing events (4 out of 3,000 crypts) expressed red fluorescent protein 
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(RFP), which marked them as derived from Lgr5 stem cells (Figure 3a). The RFP+ 
regions expanded into large red patches intermixed with the progeny of unmarked stem 
cells. RFP+ cells were isolated from 2D patches and sub-cultured to determine if the 
RFP+ patches contained cells with colonic stem cell properties. The RFP+ cells 
continued to expand into patches composed only of RFP+ cells (Figure 3b). The RFP+ 
cell monolayers possessed proliferative (EDU+) cells, and the differentiated cell types: 
goblet cells (Muc2+), enteroendocrine cells (CHROMOGRANIN A [ChgA]+) and 
absorptive colonocytes (ALP+) (Figure 3c). These data demonstrate that the 2D 
monolayers possessed Lgr5 ISCs that expanded as a proliferative monolayer and 
produced differentiated descendants in vitro.  
 
 
Human rectal epithelial cells form proliferative 2D monolayers 
To determine whether human rectal epithelial cells might form a proliferative 
monolayer, human rectal crypts obtained from rectal biopsies were cultured on collagen 
hydrogel in medium with the appropriate growth factors. 85 ± 5% crypts (n=3, 20 crypts 
monitored per experiment) formed a monolayer that expanded in area over time (Figure 
4a). The cells were sub-cultured every 5-7 days and maintained as a monolayer. The 
human 2D monolayer and 3D organoids could be interconverted without loss of 
proliferative capability (Figure 4b,c). Similar to 3D organoid culture, the cells remained 
proliferative with cell number increasing over time (Figure 4d). The doubling times 
measured during log-linear cell growth were 46.5 hours (95% C.I. bounds of 39.4 hours 
and 56.6 hours) for 2D monolayer and 47.1 hours (95% C.I. bounds of 40.8 hours and 
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55.8 hours) for 3D organoids. The human cells demonstrated a normal karyotype at 
passage number 6 (supplementary Figure 2). When examined by EM, the apical 
surface of the 2D monolayer demonstrated microvilli at varying density suggesting the 
presence of cells of absorptive colonocyte lineage since microvilli are a hallmark of 
these absorptive cells (Figure 4e). At day 3 in culture, all 3D organoids and 2D 
monolayer patches possessed actively proliferating cells (EDU+ and SOX9+) suggesting 
the presence of stem and progenitor cell lineages (Figure 4f,g).220–222 Goblet cells 
(Muc2+) and enteroendocrine cells (ChgA+) were observed in both human 3D organoids 
and 2D monolayers at day 6 in culture indicating the presence of differentiated cells 
(Figure 4f,g). Cells in the 2D monolayer possessed β-CATENIN at the intercellular 
borders suggesting the formation of tight intercellular connections (Figure 4g). The cells 
also demonstrated appropriate polarity with ACTIN and INTEGRIN-β4 localized to their 
apical and basal surfaces, respectively (Figure 4g). These data demonstrate that the 
collagen hydrogel system supports the proliferation of human rectal epithelial cells as a 
2D monolayer. 
Screening dietary components and food metabolites on murine colonic 
monolayers reveals specific impacts on cell proliferation and differentiation 
Sustainable 2D monolayers derived from primary tissue represent a transformative 
technology for personalized and precision medicine applications that rely on drug and 
compound screening. Critical for high-throughput screening platforms is the flat, 
accessible luminal surface of the monolayer, permitting cell interrogation with 
conventional assays and instrumentation including high-content microscopy.   
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To demonstrate the utility of the 2D murine colonic monolayers, 77 naturally 
occurring compounds found in food and metabolites of digestion were assayed for their 
ability to alter proliferation and differentiation, attributes that are central to intestinal 
barrier function and repair in the face of repeated chemical, physical, immune and 
infectious insults.  The 77 compounds represented a range of chemical classes with 
diverse or unknown impact on primary intestinal cells and included bioactive food 
components and metabolites such as fatty acids, bile acids, flavenoids, phytoestrogens, 
phenols, terpenoids, nitrates, and others (supplementary Table 2).  
Monolayers were grown for 24 h under normal Wnt-3A concentration of 30 ng/mL 
(ENR-W) followed by incubation with the dietary/natural compounds in a reduced Wnt-
3A concentration of 10 ng/mL (ENR-w) for 48 h. Decreased Wnt-3A in the media was 
used to bring the levels of Wnt signaling to a threshold that would make pro-proliferative 
or pro-differentiation effects of the compounds readily apparent. After exposing 2D 
monolayers to exogenous compounds, the monolayers were sequentially stained for 
proliferative (EDU) and differentiated cells (absorptive colonocytes and goblet) (Figure 
5, supplementary Figures 4 and 5). Quantitative image analysis of the fluorescence 
intensities for lineage readouts was used to compare monolayers exposed to the 
compounds and the control monolayers that lacked exposure to the compounds.  
Differences between the dietary compounds and negative controls were assessed 
using the strictly standardized mean difference (SSMD), a commonly used statistic to 
identify potential hits in a library screen.211 SSMD is a measure of the average fold 
change between a test compound and a negative reference penalized by the variability 
of the fold change. Multiple compounds (19/77, 25%) were growth suppressive, 
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reducing the Hoechst-stained area (e.g. cell number) relative to that of the control cells 
with fairly strong or stronger SSMD effect sizes (Figure 5a, b, supplementary Figure 4). 
Growth inhibitory compounds included many of the fatty acids, nitrates, terpenoids and 
curcuminoids. Only 9 of 77 (12%) compounds demonstrated increased cell numbers 
relative to that of the control with fairly strong or stronger SSMD effect sizes. A number 
of other compounds, such the phenols gallic acid (#28) and ellagic acid (#29), 
suppressed the number of cells in S-phase without reducing the number of nuclei. Other 
molecules such as valproate (#6) and β-carotene (#58) display a similar growth 
suppressive effect. A single compound, isorhamnetin (#21, a component of ginkgo 
biloba), greatly increased cell numbers in S-phase. Four of the 77 (5%) molecules 
(eucalyptol, #42; punicalagin, #31; phytol, #51; indole-3-butyric acid, #72) directed cells 
towards the absorptive colonocyte lineage as indicated by substantially increased ALP 
activity (Figure 5c). Finally, a single compound, N-nitrosoanabasine (#65), increased 
Muc2 expression with a moderate effect size (Figure 5c). These findings demonstrate 
the potential of this 2D format as a high-content screening system to assay the impact 
of dietary compounds and microbial metabolites on intestinal health and disease.  
To demonstrate the utility of 2D cultures over 3D cultures for enhanced compound 
screening, fourteen compounds yielding significant alteration in proliferation or 
differentiation of the murine 2D colonic cells were also assayed for their impact on the 
3D murine organoids (Figure 6a,b). The compounds were added to the 3D organoids 
embedded in Matrigel and then assayed in a manner similar to that for the monolayer. 
The general response of the organoids to many of the compounds was similar to that of 
the 2D monolayer (Figure 6c). However, compound assay on the 3D organoids was 
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significantly more complex relative to that on the monolayers and this may account for 
many of the differences that were observed. The organoids existed in multiple image 
planes and underwent uncontrolled shape and size changes during the fixation/staining 
process making quantification of fluorescence, area and volume challenging. The 
surface area occupied by the Hoechst stain in the monolayers acted as an easily 
quantifiable and reliable surrogate for cell number in the 2D monolayers; however, for 
the reasons stated above, this metric was not possible with the 3D organoids when 
using conventional microscopy. The inability to use a simple metric such as Hoechst 
fluorescence surface area or intensity to track changes in cell number highlights the 
challenges for high throughput compound screens using 3D organoids. Staining for ALP 
and MUCIN2 was a simple process in the 2D monolayers with staining reagents added 
to the luminal monolayer surface where these molecules reside. In contrast, reagents 
added to the 3D organoids must diffuse through a hydrogel and cell layer to access the 
luminal epithelium of the organoid. For example, we observed that fragmented or burst 
organoids stained more intensely for ALP (located at the luminal cell surface) relative to 
intact organoids in response to the same compound.  Tannic acid (#27) significantly 
reduced cell growth in the 2D monolayers but not in the 3D organoids. This may be due 
to the different cell surfaces (luminal side in 2D and basal side in 3D) to which the 
compound was added. Tannic acid’s lack of membrane permeability may have 
prevented exposure of the luminal organoid surface to this molecule. This comparison 
between the monolayers and organoids demonstrates the fundamental differences in 
the two systems as well as the significant advantages of the monolayers in screening 
applications 
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Screening dietary metabolites and natural products on human tumor cell lines 
and primary human rectal cells 
Tumor-derived Caco-2 cells have been adopted by pharmaceutical and 
biotechnology companies as the industry-standard for drug screening in the intestine. 
To determine if there are different responses of Caco-2 cells and the 2D primary tissue-
derived monolayers, the impact of 7 of the screened compounds on Caco-2 monolayers 
was assayed and compared to the results obtained from primary human monolayers. 
The tumor cells were cultured in their standard medium and human primary cells 
cultured in HISC for 24 h followed by addition of the library compounds. After 48 h, the 
primary human and Caco-2 cells were stained and evaluated for cell number, 
proliferation, absorptive-cell phenotype, and goblet cell attributes as described for 
murine 2D cultures (Figure 7). At least 50% of the measurements trended in the 
opposite direction when the response of the two cell types to the compounds was 
measured. For example, valproate (#6) decreased nuclear coverage and increased ALP 
expression in Caco-2 cells, but generated the opposite responses in the primary cells. 
Thus, valproate may direct Caco-2 cells but not primary cells into the absorptive-cell 
lineage under these conditions. Punicalagin (#31) strongly reduced EDU incorporation 
in the primary cells, but generated the opposite effect in the Caco-2 cells. Punicalagin 
slows the growth of primary cells, but may encourage proliferation in the tumor cells. 
These data demonstrate distinct differences between the Caco-2 tumor cells and the 2D 
primary monolayer for a number of compounds suggesting that a more physiologically 
relevant cell platform may provide results that more closely represent those in vivo. A 
larger compound screen would likely reveal a greater number of discrepancies between 
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the two cell types. Nevertheless, these data demonstrate that the human monolayers 
are suitable for compound screening in a manner similar to the murine monolayers.  
CONCLUSIONS 
Studies using 3D colonic organoids have provided novel insights into intestinal 
biology; however, the enclosed organoid architecture possesses severe limitations in 
screening applications and for many basic biomedical investigations. The organoid 
lumen buried within a hydrogel is inaccessible to drugs, toxins, probiotics, microbiota 
and other agents in contrast to the gut lumen of a living animal. We developed a self-
renewing, 2D monolayer derived from primary intestinal tissue and possessing all cell 
lineages found within the colon. Long-term cell proliferation on the collagen hydrogel 
was likely due to its similar chemical makeup and stiffness relative to that of the 
basement membrane underlining the colonic epithelium. Cells of the organoids expand 
at a slower rate than those of the monolayer potentially as a result of the added 
requirement of the hydrogel-embedded cells to remove and remodel the matrix during 
expansion. Remarkably, the monolayers self-pattern to create peripheral 
stem/proliferative and central differentiated cell zones. The interior of the monolayer 
yields a large surface area occupied predominantly by differentiated cells, a feature 
mimicking that of the intestinal surface area in vivo. Importantly, the chemical 
environment of the monolayer is readily manipulated by addition of compounds to the 
media overlying the cells. This programmable feature in combination with the open 
architecture and accessible luminal face enables facile assay of drugs, toxins, and 
metabolites not possible in the organoid systems. Standard high-content microscopy 
methods were readily paired with the 2D monolayers to identify the impact of dietary 
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metabolites and natural products on primary intestinal cells obtained directly from 
animal models.  
  
 
 
 
Appendix B: Figure 1. Proliferative 2D monolayer culture of murine colonic crypts 
on the surface of collagen hydrogel.  
(a) Workflow for culturing crypts on a matrix surface. Wnt-3A, R-spondin, Noggin and 
EGF are used in the culture medium. Proliferative stem cells and progenitors (green); 
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differentiated cells (red). (b) Time-lapse images of crypts cultured on the top of collagen 
hydrogel. Brightfield images are superimposed on DsRed fluorescence images. Crypts 
express DsRed under a constitutive chicken-actin promoter. (c) Workflow for 
subculturing 2D monolayers. Monolayers are dissociated from collagen and split. 
Brightfield images (bottom) demonstrate representative cells at workflow stages. (d) 
Time-lapse fluorescence (DsRed) images of crypt-derived cells on collagen at passage 
number 0 (P0, crypts) and passage number 5 (P5). Scale bar =100 µm (a-d). (e) SEM 
image of a monolayer on collagen gel at day 3 of culture. (f) Fluorescence image of a 
cross-section through the monolayer immunostained for ACTIN (green) and β-CATENIN 
(red). The distribution of β-CATENIN (an intracellular protein) demonstrating columnar 
shaped cells with a height of 9.4±0.8 µm and width of 7.5±0.9 µm (n=10). (g) High 
magnification view of a subregion of panel e. (h) High magnification view of a subregion 
of panel f. (i) Staining for ZO-1, E-CADHERIN, or OCCULUDIN (red); VILLIN or ACTIN 
(green); INTEGRIN-β4 and NA+/K+-ATPASE (red). Nuclei (blue). 
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Appendix B: Figure 2.  Proliferative capacity, lineage composition, and 
compartmentalization are highly similar between 2D murine colonic monolayers 
and 3D organoids.  
(a) Schematic showing the culture format for organoids and monolayers. (b) Time-lapse 
images demonstrating the growth and morphologies of crypt-derived organoids and 
monolayers at passage number 2 (P2). (c) Quantification of cellular growth over time in 
organoids and monolayers measured by a proxy assay (CellTiter-Glo luminescence, 
n=4). (d) Percentage of monolayer patches and organoids at day 3 demonstrating 
positive staining for proliferative and differentiated cell lineages (EDU, SOX9, Muc2 and 
ChgA; n=3, 20 monolayer patches or organoids per experiment). (e) Fluorescence 
images of organoids and monolayers at day 3 (EDU [green], SOX9 [green], Muc2 [red], 
ChgA [red], and nuclei [blue]). (f) Compartmentalization of proliferative stem/progenitor 
cells and differentiated cells. Brightfield (left column) and fluorescence (right column) 
images of organoids (top row) and monolayers (bottom row) at culture day 8 (EDU 
[green], Muc2 [red], and nuclei [blue]). Of the 3D mature organoids, 80±10% (10 
organoids/well, n=3 wells) demonstrated increased stem/progenitors (EDU+) collections 
in the buds while 100±0% (10 monolayer patches/well, n=3 wells) of the monolayers 
demonstrated EDU+ cells localized to the periphery of the patch. In a majority (83±6%, 
10 monolayer patches/well, n=3 wells) of monolayer patches, Muc2+ was found only in 
the central-most region of the patch. Mucin was present in the lumen of all 3D 
organoids. Scale bar = 100 µm unless denoted otherwise.    
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Appendix B: Figure 3. Lineage tracing of mouse colonic epithelial cells in the 2D 
monolayer.  
(a) Time lapse images after isolation and culture of a single colonic crypt from a 
tamoxifen-injected Lgr5EGFPCreERT2xR26 confetti mouse. The presence of stem cells 
or Lgr5+ cells (green, EGFP) is readily seen at day 0. At day 1 and later, a tracing event 
is observed with expression of RFP (red) marking the progeny of a single stem cell. (b) 
Post-isolation and passage of RFP+ cells from panel A. (c) EDU, Muc2, ChgA and ALP 
stains of monolayers of RFP+ cells revealed that the monolayer was composed of 
proliferative cells (EDU+, in the presence of Wnt-3A) and differentiated cells (Muc2+ 
goblet cells, ChgA+ enteroendocrine cells, ALP+ absorptive colonocytes) in the 
absence of Wnt-3A.  
162 
 
 
Appendix B: Figure 4. Human rectal epithelial cells can be cultured as a 
proliferative 2D monolayer. 
(a) A crypt cultured on the top of collagen hydrogel grew as a 2D monolayer. (b) 
Conversion of fragments of 2D monolayer to 3D organoids. The 3D organoids 
possessed a thin wall and cystic structure. (c) Conversion of 3D organoids to a 2D 
monolayer. 3D organoids were extracted from Matrigel (day 4 in culture) and plated on 
the top of the collagen hydrogel. (d) Cellular growth over time in organoids and 
monolayers measured by a cell viability assay (CellTiter-Glo luminescence, n=3). (e) 
SEM image of a monolayer on collagen hydrogel at day 3 of culture. (f) Fluorescence 
images of organoids showing EDU staining (green, at day 3), Sox9 (green, at day3), 
and Muc2 (red, at day 6) immunostaining. (g) Fluorescence images of monolayers 
showing EDU staining (green, at day 3), Sox9 (green, at day3), Muc2 (red, at day 6), 
ChgA (red, at day 6), β-CATENIN (red, at day 6), ACTIN (green) and INTEGRIN-β4 
(red, at day 6) immunostaining. In all images Hoechst 33342 (blue) marked the nuclei. 
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Appendix B: Figure 5. The impact of dietary compounds and natural products on 
primary murine colonic monolayers.  
(a) The percentage of the collagen surface area that was positive for Hoechst 33342 
and the normalized fluorescence intensity due to EDU incorporation, ALP activity, or 
Muc2 staining was plotted against the compound number. EDU, ALP and Muc2 
fluorescence signals were normalized by summing the fluorescence intensity and 
dividing by the nuclear percent area (i.e. an indicator of cell number). Hits were 
designated as: 6- extremely strong, 5- very strong, 4- strong, 3- fairly strong, 2- 
moderate, 1- fairly moderate (“Moderate” and “fairly moderate” effects were designated 
only for compounds within the Muc2 screen). †: cultures with extensive cell death (< 
10% nuclear coverage). (b) Map of hit compounds. Green and pink indicate an 
increased or decreased value (respectively) relative to that of the control (ENR-w). 
Black indicates cultures with extensive cell death. (c) Representative fluorescence 
images from the compound screen. Scale bar = 1 mm. 
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Appendix B: Figure 6. Assaying a subset of the dietary compounds and 
metabolites on murine 3D organoids.  
(a) The percentage of the collagen surface area that was positive for Hoechst 33342 
and the normalized fluorescence intensity due to EDU incorporation, ALP activity, or 
Muc2 staining was plotted against the compound number. EDU, ALP and Muc2 
fluorescence signals were normalized by summing the fluorescence intensity and 
dividing by the nuclear percent area (i.e. an indicator of cell number). Hits were 
designated as subtypes: 6- extremely strong, 5- very strong, 4- strong, 3- fairly strong, 
2- moderate, 1- fairly moderate (“Moderate” and “fairly moderate” effects were 
designated only for compounds within the Muc2 screen). †: cultures with extensive cell 
death (< 10% nuclear coverage for 2D or < 2% nuclear coverage for 3D). (b) 
Representative fluorescence images from the assay. Scale bar = 1 mm. (c) i) and ii)- 
Comparison of the effect of selected compounds on the 2D monolayer and 3D 
organoids. Green and pink indicate an increased or decreased (respectively) value 
relative to that of the control (ENR-w). Black indicates cultures with extensive cell death. 
iii) Direct comparison of the responses of the 2D monolayers and 3D colonoids to the 
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compounds. White indicates a strong response by both cultures in the same direction 
(enhanced or diminished effect) or a weak response by both cultures. Green-blue 
indicates a strong response in one culture system, but not the other. Orange indicates 
strong responses in both cultures, but in opposite directions. Grey indicates that no 
comparison of the two cell types was made.  
  
Appendix B: Figure 7. The impact of seven dietary compounds and natural 
products on human primary rectal and tumor Caco-2 cells.  
(a) The SSMD effect size was plotted against the compound number for the four screen 
readouts: the percentage of the image surface area that was positive for Hoechst 33342 
and the normalized fluorescence intensity due to EDU incorporation, ALP activity, or 
Muc2 staining. EDU, ALP and Muc2 fluorescence signals were normalized by summing 
the fluorescence intensity and dividing by the nuclear percent area (i.e. an indicator of 
cell number). |SSMD|>1.645 is required to designate a strong effect size. (b,c) 
Representative fluorescence images from the assays. Control media for Caco-2 cells 
was DMEM medium. Scale bar = 1 mm. 
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